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LIST OF ABBREVIATIONS 
 
 
Abm:   area enclosed by the epithelial basement membrane  
AHR:  airway hyperresponsiveness 
Amo:   area enclosed by the outer muscle (outer border of airway smooth muscle) 
ANOVA:  analysis of variance 
Ao:   area enclosed by the outer border of the adventitia 
BAL:   bronchoalveolar lavage 
BALF:  bronchoalveolar lavage fluid  
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BM:   basement membrane 
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PAF:  platelet activating factor 
PAS:   periodic acid shiff 
Pbm:   perimeter basement membrane 
PBS:  phosphate-buffered saline 
PC20FEV1:  provocative concentration causing a 20% fall in FEV1 from baseline 
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pCO2 :   arterial carbon dioxide tension 
PDGF-ß:  platelet derived growth factor-ß 
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PEP:   peak expiratory pressure 
PIP:   peak inspiratory pressure 
Pmo:   perimeter of te outer boundary of the smooth muscle 
Po:   outer adventitial perimeter 
pO2:  arterial oxygen tension 
Ppt :  transpulmonary pressure 
RL:   lung resistance 
rs :   Spearman’s rank correlation coefficient 
SEM:   standard error of the mean 
TBS:   tris-buffered saline 
Te:   expiratory time 
TGF-ß: transforming growth factor-ß 
Th:  T helper 
TIMP:   tissue inhibitor of metalloproteinase 
TMA:   trimellitic anhydride 
TNF-a : tumor necrosis factor-a  
Tr:   relaxation time 
vs:  versus 
VT:  tidal volume 
WAi:   wall area of the inner airway wall between basement membrane and outer 
boundary of the smooth muscle  
WAo:   wall area of the outer airway wall between outer boundary of the smooth 
muscle and the outer adventitia 
WAt:   wall area of the whole airway wall between basement membrane and outer 
adventitia 
WC:   wall area occupied by collagen 
WF:   wall area occupied by fibronectin 
wk:  weeks 
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SUMMARY 
 
 
Asthmatic airways display characteristic morphological alterations, part of which are 
structural changes, coined airway remodeling. These structural alterations include goblet-cell 
hyperplasia, increased subepithelial deposition of collagen, changes in extracellular matrix 
composition, neovascularization and smooth-muscle cell hyperplasia and/or hypertrophy. 
The mechanisms that regulate the remodeling process as well as its functional consequences 
remain to be fully elucidated. It has been postulated that airway remodeling results from an 
inappropriate regeneration process in an attempt at tissue repair following repetitive bouts of 
allergen-induced acute inflammatory changes in the airway wall. The functional consequences 
of remodeling have mainly been related to lung function. In particular, mathematical models 
predict that remodeling largely contributes to the development of bronchial 
hyperresponsiveness, the functional hallmark of asthma. Acquiring further insight in the exact 
pathophysiology of remodeling therefore seems important, for further optimizing asthma 
treatment.  
Human studies are often hampered by the limited accessibility to intrapulmonary airways. 
Bronchial biopsies display only a part of the airway mucosa and do not allow a proper 
assessment of the entire remodeling process throughout the airway wall. Relevant animal 
models can contribute significantly to a better understanding of the underlying processes and 
its functional consequences. Most animal models developed to date do not properly mimic 
aspects of airway remodeling. In this study an in vivo model for allergen-induced structural 
airway changes is described in rats and mice.  
Sensitization of the animals to the allergen ovalbumin followed by a prolonged allergen 
exposure period, resulted in both species in goblet cell hyperplasia, changes in extracellular 
matrix proteins and increased airway wall thickness. These structural alterations bear 
similarities to those observed in human asthma. Strikingly, for a same intensity of allergen 
exposure, young animals develop more intense structural alterations when compared to adult 
rats. An important observation, when relating these morphological alterations to lung function 
indices, is that depending on the extent and distribution of the structural changes, the allergen 
induced airway remodeling can oppose, rather than enhance bronchial responsiveness. These 
findings underline the importance of linking morphological observations to functional 
measurements, when evaluating the role of remodeling in asthma. 
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The models that we have developed should provide relevant data for a better 
understanding of the pathogenesis of remodeling, in relation to airway behavior. 
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SAMENVATTING 
 
 
Luchtwegen van astma patiënten vertonen een aantal karakteristieke morfologische 
veranderingen waaronder de structurele veranderingen of ‘remodeling’. Deze omvatten onder 
meer een verhoging van het aantal slijmbekercellen in het epitheel, een verhoging van collageen 
depositie onder het epitheel en een verandering in de samenstelling van de extracellulaire matrix 
van de luchtwegen, een toegenomen hoeveelheid gladde spiercelmassa en neovascularisatie. 
Hoe deze structurele veranderingen in stand worden gehouden in de luchtwegen en wat de 
functionele gevolgen ervan zijn, is echter nog niet volledig opgehelderd. Er wordt 
verondersteld dat bij astmatici de luchtwegen veranderingen kunnen vertonen als gevolg van 
herhaalde inflammatie na een allergeen blootstelling. Op basis van mathematische modellen 
gaat men ervan uit dat remodeling de bronchiale hyperreactiviteit, de voornaamste 
longfunctionele afwijking bij astma patiënten, in de hand werkt. De volledige pathofysiologie 
van deze structurele veranderingen is echter onduidelijk. Nochtans zou een beter inzicht in de 
relatie tussen remodeling en longfunctie kunnen leiden tot een betere therapeutische 
behandeling voor astma. 
Een belangrijk probleem bij humane studies is echter de beperkte toegankelijkheid tot 
representatief luchtwegen weefsel. Endobronchiale biopten genomen in de centrale 
luchtwegen zijn meestal beperkt tot mucosaal weefsel en het is niet duidelijk of de remodeling 
hierin representatief is voor de ganse luchtwegwand. Representatieve in vivo dierenmodellen 
kunnen bijgevolg een positieve bijdrage leveren aan het onderzoek van remodeling in 
luchtwegen bij astma. Aangezien de meeste dierenmodellen in astma het aspect van de 
structurele veranderingen onvoldoende benaderen, was het doel van dit werk om een model 
voor allergeen geïnduceerde structurele luchtwegveranderingen te ontwikkelen in ratten en 
muizen. 
Het sensibiliseren van de proefdieren met het allergeen ovalbumine gevolgd door een 
herhaalde allergeen blootstelling resulteerde in een toegenomen aantal slijmbekercellen, een 
verhoogde afzet van extracellulaire matrix eiwitten in de luchtwegen en een verdikking van de 
wand. Deze veranderingen vertonen gelijkenissen met remodeling van luchtwegen in humaan 
astma. Bovendien bleek dat in vergelijking met volwassen dieren, jonge ratten voor een zelfde 
graad van allergeen geïnduceerde inflammatie, een meer uitgesproken remodeling vertonen. 
Opvallend was ook dat in ons model afhankelijk van de exacte locatie en uitgebreidheid van 
de structuurveranderingen in de wand, deze kunnen beschermen tegen bronchiale 
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hyperreactiviteit in plaats van deze in de hand te werken. Hiermee werd aangetoond dat bij de 
studie van luchtweg remodeling in astma, het noodzakelijk is om morfologische observaties te 
koppelen aan functionele waarnemingen. 
In deze studie werden twee modellen voorgesteld, waarmee verscheidene vragen rond de 
pathogenese van remodeling en de functionele gevolgen ervan kunnen benaderd worden. 
 Summary vii
RÉSUMÉ 
 
 
Les voies aériennes de patients asthmatiques démontrent certains changements 
morphologiques caractéristiques, notamment des modifications d’ordre structurel, connues 
sous le terme de « remodeling ». Sous ces changements on distingue entre autres une 
augmentation du nombre de cellules « goblet » productrices de mucus, une augmentation de 
la déposition sous-épithéliale de fibres collagènes ainsi qu’un changement dans la 
composition de la matrice extracellulaire autour des voies aériennes. De surcroît, on observe 
une augmentation de la masse musculaire lisse et des signes de néovascularisation font leur 
apparition. Toutefois la manière dont ces changements structurels sont maintenus en place et 
les conséquences fonctionnelles de ce phénomène n’ont pas été complètement élucidés. On 
suppose que les voies aériennes des sujets asthmatiques manifestent de tels changements en 
raison de tentatives inappropriées de régénération tissulaire suite à une inflammation chronique 
due à l’exposition répétée à un allergène. Certains modèles mathématiques prédisent que l’ 
hyperréactivité bronchiale – l’anomalie fonctionnelle pulmonaire principale dans l’asthme – 
est une conséquence du remodelage de la paroi bronchiale. Toujours est-il que la réelle 
pathophysiologie de ces changements structurels reste encore à éclaircir, alors qu’une 
meilleure compréhension de la relation entre le « remodeling » et la fonction respiratoire 
pourrait mener à un traitement optimalisé de l’asthme. 
Malheureusement les études humaines se heurtent aux limitations d’accès à des tissus 
bronchiaux représentatifs. Des biopsies endobronchiales prélevées au niveau des voies 
aériennes centrales sont le plus souvent limitées au tissu mucosal et il n’est pas démontré que 
le remodelage que l’on y observe est représentatif pour toute la paroi bronchiale. Des modèles 
animaux in vivo représentatifs peuvent par conséquent fournir une réelle contribution dans la 
recherche concernant le remodelage des voies aériennes dans l’asthme. Cependant la plupart 
des modèles expérimentaux animaux ne reflètent pas suffisamment les changements 
structurels. C’est ainsi que le but du présent travail fût de développer dans le rat et la souris un 
modèle adéquat de changements structurels bronchiaux dû à l’exposition à un allergène. 
Dans les rongeurs cités, la sensibilisation à l’allergène ovalbumine, suivie d’une période 
d’exposition répétée au même allergène résulte en une hyperplasie des « goblet cells », une 
déposition accrue de protéines de matrice extracellulaire et un épaississement de la paroi 
bronchiale. Toutes ces altérations structurelles se rapprochent des changements observés 
dans l’asthme chez l’homme. Qui plus est, pour une même intensité d’exposition à un 
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allergène, les jeunes rats développent des altérations structurelles plus prononcées que leurs 
congénères adultes. Lorsqu’on en vient à rapporter de tels changements histologiques à des 
indices de fonction pulmonaire, il est surprenant d’observer qu’en fonction de l’étendue des 
changements structurels, le remodelage dû à l’exposition chronique à un allergène peut 
amortir plutôt qu’exacerber l’hyperréactivité bronchiale. Ces observations soulignent 
l’importance de lier les paramètres morphologiques aux mesures de fonction lorsqu’il s’agit 
d’évaluer le rôle du remodelage bronchial dans l’asthme. 
Les modèles que nous avons développés devraient fournir des données relevantes en 
vue d’une meilleure compréhension de la pathogenèse du remodelage en relation avec le 
comportement des voies aériennes. 
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1. Introduction 
 
As stated in its definition, asthma is a chronic inflammatory disease of the airways in 
which many cell types play a role, in particular mast cells, eosinophils and T lymphocytes 
(NHLBI/WHO workshop report, 1995). Persistent inflammation in asthma is considered to 
be critical to the presence of symptoms and lung function abnormalities including increased 
airflow obstruction and airway hyperresponsiveness. However it is increasingly recognized 
that inflammation alone cannot explain all aspects of airway physiology in asthmatics (Haley et 
al, 1998). Indeed, although airflow limitation in asthma has traditionally been thought to be 
entirely reversible, some patients with asthma have evidence of irreversible airway obstruction 
despite appropriate and aggressive anti-inflammatory treatment (Backman et al, 1997). 
Similarly, treatment rarely restores bronchial hyperresponsiveness, another characteristic lung 
function abnormality in asthma, to within normal limits. In addition it is shown that a number 
of patients with asthma have an enhanced decline in lung function over time (Lange et al, 
1998; Peat et al, 1987). Histological analysis of airway tissue from asthmatic patients reveals in 
addition to acute inflammatory changes, structural abnormalities. These far less reversible 
alterations coined airway remodeling are thought to be, at least in part, responsible for the 
pulmonary function abnormalities.  
At present, there are major gaps in our knowledge of the mechanisms regulating the 
remodeling process. It has been postulated that airway remodeling results from a pathologic 
regeneration process in an attempt at tissue repair following repetitive bouts of allergen-
induced acute inflammatory changes in the airway wall. Both inflammatory cells and resident 
structural tissue cells within the airway wall are thought to contribute to this process. How 
exactly airway remodeling is initiated and what causes perpetuation of the process is not 
completely understood. Whether there is a mechanistic link between the altered airway 
function observed in asthmatics and the structural changes throughout the airway wall also 
remains largely unclear. As a result it remains to be established to what extent prevention or 
reversal of remodeling should be an aim of asthma treatment. Hence the importance of gaining 
more insight in the pathogenesis of this process. 
Appropriate and relevant animal models of chronic airway inflammation and tissue 
alterations, despite their own inherent shortcomings, can aid in understanding the underlying 
processes that contribute to asthma. When developing an animal model it is necessary to 
know what should be modeled and what has already been achieved. This review of the 
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literature attempts therefore to cover the descriptive pathology of airway remodeling in 
asthma, describes the possible role of airway inflammation in the initiation and persistence of 
this process, tries to link physiologic characteristics of asthmatics with airway remodeling and 
briefly describes experimental models of airway remodeling.   
 
 
2. Histopathology of the asthmatic airway 
 
In the asthmatic airway it is important to differentiate between acute inflammatory and 
chronic structural changes. Acute alterations such as cellular infiltration and accumulation of 
edema fluid are usually reversible either spontaneously or by treatment. Chronic changes on 
the contrary, resolve more slowly or may become irreversible. Airway remodeling can be 
found in different compartments of the airway wall including airway epithelium, basement 
membrane, the extracellular matrix in inner and outer airway wall, smooth muscle, blood 
vessels and mucous glands (figure 1). The alterations might involve an increase in size and 
number of the tissue elements, a long-term functional change of airway-resident cells or the 
formation of new structures within the airway tissue.  
Remodeling is distributed throughout the bronchial tree (Awadh et al, 1998; Okazawa et 
al, 1996; Saetta et al, 1991) and is observed in different asthmatic subtypes (atopic, intrinsic 
or occupational) (Paganin et al, 1996).  
 
2.1. Description of chronic structural alterations 
 
Epithelium 
The surface of the intrapulmonary airways is covered by pseudostratified epithelium that 
forms an active barrier between the external environment and the internal milieu. Shedding and 
damage of the airway epithelium is a characteristic of asthma. Increased epithelial cell numbers 
were found in sputum samples and bronchoalveolar lavage washings of asthmatic compared 
to normal subject suggesting a more fragile epithelium in asthmatics (Taha et al, 2001; Chanez 
et al, 1999; Fahy et al, 1995; Montefort et al, 1992; Beasley et al, 1989). Deranged and/or 
damaged epithelial tight junctions might contribute to this increased epithelial fragility and 
weaker cellular attachment of columnar epithelial cells to the basal layer in asthma (Laitinen and 
Laitinen, 1994; Montefort et al, 1993; Montefort et al, 1992). Studies using bronchial biopsies 
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showed epithelial shedding in both fatal and mild asthma (Chanez et al, 1999; Jeffery et al, 
1989; Beasley et al, 1989; Laitinen et al, 1985) although others did not find differences 
between asthmatics and non-asthmatics (Boulet et al, 1997; Carroll et al, 1993; Lozewicz et al,  
1990). In some studies a correlation was found between epithelial damage and in vivo airway 
responsiveness (Jeffery et al, 1989; Beasley et al, 1989). 
 
Sub-basement membrane thickening: extracellular matrix proteins in lamina reticularis  
Asthmatic airways display an increase in collagen deposition just underneath the 
basement membrane. This distinct collagenous layer is thickened in patients with asthma 
measuring from 7 to 23 µm versus 4 to 5 µm in normal subject. Initially it was described as 
basement membrane thickening (Dunnill, 1960). Now it is confirmed that the basement 
membrane containing laminin and collagen type IV is not altered in asthma. In contrast, there 
is a substantial deposition of interstitial collagens type I, III and V, fibronectin and tenascin in 
the area below the true basement membrane, the lamina reticularis (Laitinen et al, 1997; Altraja 
et al, 1996; Roche et al, 1989). Activated bronchial myofibroblasts lying close to the 
epithelium are thought to be responsible for the production of these proteins in asthma. Their 
numbers are increased and correlate with the extent of collagen deposition (Brewster et al, 
1990).  
Whether a correlation exists between the thickness of the subepithelial fibrosis and the 
severity of asthma is debated. Although some authors found a correlation between the 
thickness of the lamina reticularis and the severity of the disease (Niimi et al, 2000c; Chetta et 
al, 1997; Boulet et al, 1997), this is not uniformly confirmed (Milanese et al, 2001; Chu et al, 
1998; Saetta et al, 1992; Jeffery et al, 1989). Subepithelial-layer thickness does not correlate 
with the disease duration nor etiology of asthma (Boulet et al, 2000; Niimi et al, 2000c; Jeffery 
et al, 1989). 
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Extracellular matrix components of the lamina propria  
The extracellular matrix stabilizes the physical structure of tissues and plays a role in 
regulating the behavior of cells. In the normal airway the extracellular matrix forms a complex 
three-dimensional network which consists of fibrous proteins (collagen and elastin), structural 
or adhesive proteins (fibronectin and laminin) embedded in a hydrated polysaccharide gel 
containing several proteoglycans and glycosaminoglycans. The deposition of some of these 
extracellular matrix proteins is altered in the airway wall of asthmatics.  
Collagen is the major structural component of the extracellular matrix (Dunsmore and 
Rannels, 1996). Increased amounts of collagen type III, V and VI have been found in the 
deeper layer of the submucosa of asthmatic airways (Lee et al, 1999; Wilson and Li, 1997). 
Total collagen was increased in the longitudinal bundles present in the submucosa of 
conducting airways (Carroll et al, 2000). A higher amount of collagen was also observed 
between the basement membrane and the smooth muscle layer in patients with asthma and the 
increase was correlated with asthma severity (Minshall et al, 1997). Of note is that these 
findings were not invariably confirmed, as others did not observe increased amounts of total 
collagen nor increased deposition of collagen type I and III in asthmatic subjects (Chu et al, 
1998; Godfrey et al, 1995; Roche et al, 1989).  
Elastin is a cross-linked protein that gives tissues their elastic recoil. The network of 
elastin fibers is fragmented in asthmatics (Bousquet et al, 1996) but the total amount of elastic 
fiber appears to be unchanged (Mauad et al, 1999; Godfrey et al, 1995). The elastin content 
of the longitudinal bundle was proportionally decreased in cases of asthma (Carroll et al, 
2000). Higher levels of elastase in asthma might cause the increased elastic fiber disruption in  
bronchi of asthmatics (Vignola et al, 1998a). Although the level of elastase in sputum was 
correlated with the severity of the disease (Vignola et al, 1998a), the alterations in elastic fibers 
in the submucosa observed in bronchial biopsies could not be linked to the severity and 
duration of asthma (Bousquet et al, 1996). 
Specific proteoglycans and glycosaminoglycans of the extracellular matrix influence 
tissue biomechanics, fluid balance and cellular function. In the airway wall of patients with 
mild atopic and severe asthma excess deposition of decorin, lumican and biglycan, members 
of the family of small proteoglycans, and the large proteoglycan versican is observed (Huang 
et al, 1999; Roberts, 1995). Hyaluronan is also overexpressed (Vignola et al, 1998b; Roberts, 
1995). The levels of hyaluronan in bronchoalveolar lavage fluid were elevated in persistent 
asthma compared to intermittent disease or control subjects (Vignola et al, 1998b). 
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Smooth muscle 
The airway smooth muscle layer runs from the trachea to the smallest bronchioles (Ebina 
et al, 1990b). Marked thickening of the airway smooth muscle layer is one of the best known 
features of asthmatic remodeling (Kuwano et al, 1993; Ebina et al, 1993; Carroll et al, 1993; 
Ebina et al, 1990a; James et al, 1989). Some degree of heterogeneity of the smooth muscle 
thickening exists. The increased smooth muscle mass is either restricted to larger airways or 
more uniformly present along the entire course of the bronchial tree (Ebina et al, 1990a). 
When smooth muscle thickening is restricted to larger bronchi, hyperplasia of muscle cells 
appeared responsible for the increase. Hypertrophy of individual smooth muscle cells causes 
the thickening of smooth muscle over the entire tree (Ebina et al, 1993). Also extracellular 
matrix and connective tissue surrounding smooth muscle bundles can contribute substantially 
to the smooth muscle area (Thomson et al, 1996). In patients with fatal asthma the increase in 
peripheral smooth muscle area was far greater than in asthma patients who died from other 
causes (Carroll et al, 1993). Others did not find a correlation with the degree of asthma 
severity (Cho et al, 1996).  
 
Blood vessels 
In the airway submucosa a dense microvasculature network is embedded in fibrous 
tissue. Histological analysis of bronchial biopsies or resected tissue has revealed higher vessel 
counts in asthmatics compared to normal controls (Li and Wilson, 1997; Carroll et al, 1997; 
Kuwano et al, 1993). In bronchial biopsies the number of blood vessels per area tissue and 
the percent biopsy occupied by vessels was increased in patients with mild allergic asthma 
(Salvato, 2001; Li and Wilson, 1997). In cross sections of airways in autopsy specimens of 
patients who died from or with asthma (Carroll et al, 1997; Kuwano et al, 1993) and in 
broncial biopsies from mild-to-moderate asthmatic s (Chu et al, 2001) the vessels that were 
present were larger suggesting vascular engorgement (Carroll et al, 1997). Vessels may 
increase in number through proliferation of the vessel branches or elongation of the existing 
vessels (Wilson and Stewart, 1999). Microvascular enlargement may result from proliferation 
of endothelial cells resulting in new vessels that are larger than the original ones (Busse et al, 
1999). The number of vessels was correlated with the severity of the disease (Salvato, 2001; 
Orsida et al, 1999).  
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Mucous glands 
Mucus secretions that coat the lining of the airway to protect the epithelium are produced 
in submucosal glands and in secretory cells of the epithelium. In normal airways, mucous 
glands are distributed throughout the cartilaginous airways and goblet cells are the most 
prominent secretory cell type in the trachea and large airways. Excessive mucus production is 
observed in fatal asthma (Aikawa et al, 1992; Dunnill, 1960). This hypersecretion of mucus 
into the asthmatic airway lumen is caused by submucosal gland hypertrophy and/or goblet 
cell hyperplasia. Morphometric analysis of airways in fatal asthma revealed an enlarged mass 
of mucous gland compared to normal subjects as a result of hypertrophy of the gland cells 
(Cho et al, 1996; Carroll et al, 1993; Aikawa et al, 1992). Whether the increase in number of 
mucous glands is correlated with asthma severity is debated (Cho et al, 1996; Carroll et al, 
1996; Carroll et al, 1993; Aikawa et al, 1992). In the epithelium a higher number of goblet cells 
is observed in mild as well as in moderate and severe asthmatics (Ordonez et al, 2001; 
Shimura et al, 1996; Laitinen et al, 1993; Aikawa et al, 1992). As a result of this increase in 
goblet cell number, mucin stores in the airway epithelium were higher in asthmatic compared 
to healthy control subjects (Ordonez et al, 2001). 
 
2.2. Airway wall thickening 
These various structural alterations can contribute to the overall thickening of the airway 
wall as observed in asthmatics (Kuwano et al, 1993; Carroll et al, 1993; Saetta et al, 1991). In 
fatal asthma a thickened airway wall was found in airways of all sizes and the difference was 
most pronounced in small airways (Carroll et al, 1993). In non-fatal asthma only the overall 
thickness of small airways is increased compared to controls. This increase is smaller 
compared to fatal asthma (Kuwano et al, 1993; Carroll et al, 1993). Measurements of airway 
wall thickness via high-resolution computed tomography (HRCT) scans confirm the 
observations of autopsy studies (Kasahara et al, 2002; Awadh et al, 1998; Paganin et al, 1996; 
Okazawa et al, 1996; Boulet et al, 1995). HRCT scanning revealed wall thickening in 16-92% 
of the asthmatic patients (Little et al, 2002; Brown et al, 2001; Niimi et al, 2000b; Carr et al, 
1998; Park et al, 1997; Paganin et al, 1996). HRCT showed that in mild asthmatics, increases 
in airway size are limited to airways under 6 mm, while in severe asthmatics differences can be 
seen in all airways except the largest (Awadh et al, 1998; Boulet et al, 1995). Also small 
airways (2-4 mm diameter) showed the greatest difference between normal and asthmatics on 
HRCT (Okazawa et al, 1996). Kasahara et al (2002) showed that sub-basement membrane 
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thickness measured in bronchial biopsy specimens correlated with whole airway wall 
thickness assessed via HRCT. 
Within the airway wall, three areas are defined: the inner wall, the outer wall and the 
smooth muscle layer (figure 2). The inner wall comprises the area between the basement 
membrane and the outer borders of the airway smooth muscle. The outer airway wall is 
limited by the outer boundary of the smooth muscle and the outer adventitia (Bai et al, 1994). 
Besides the above described increase in the smooth muscle area an increase in the thickness 
of the inner and outer airway wall has been described in both fatal and non-fatal asthma 
(Kuwano et al, 1993; Carroll et al, 1993; James et al, 1989). 
 
 
 
 
 
 
Figure 2. Schematic representation of the different areas in the airway wall. A distinction is made 
between the inner airway wall, the outer airway wall and the smooth muscle layer. The inner wall 
comprises the basement membrane, the lamina propria and the airway smooth muscle. The outer airway 
wall consists of the adventitia. 
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3. Pathogenesis of airway remodeling  
 
3.1. The inflammatory basis of asthma 
Asthma is a disease that results from complex interactions between a variety of 
environmental factors acting on a background of genetic predisposition and it is characterized 
by a specific form of airway inflammation. The inflammation is orchestrated predominantly 
by T helper-2 (Th-2) cells and involves a variety of cells such as eosinophils and mast cells. 
Structural airway cells also contribute to the inflammatory events. A range of cytokines and 
chemokines mediates interactions between the various cell types. Activated inflammatory cells 
release a variety of pro-inflammatory mediators, resulting in morphologic features of 
inflammation in the airway wall. 
Evidence that inflammation is a component of asthma was initially derived from findings 
in fatal asthma. Autopsy studies showed airway walls infiltrated with eosinophils, neutrophils 
and mast cells in patients who died from asthma. More recently, biopsy studies showed that 
even in mild asthmatics substantial inflammation is present in the wall. The inflammatory 
changes occur in central as well as in peripheral airways and vary with the severity of the 
disease (Moore et al, 2001; Hamid and Minshall, 2000; Kraft, 1999; Haley et al, 1998; Vignola 
et al, 1998b; Hamid et al, 1997; Kraft et al, 1996; Ferguson and Wong, 1989). Further 
evidence for an inflammatory response in asthma is the presence of cytokines and 
chemotactic chemokines that mediate inflammation in bronchoalveolar-lavage fluid or 
pulmonary secretions (Chung and Barnes, 1999). 
The tissue infiltration of inflammatory cells may involve both the recruitment of cells 
from the blood stream and proliferation of their progenitors in the submucosa. Increased 
survival of these cells in asthma is influenced by the micro -environment within the airway wall 
and might result from the interaction of inflammatory cells with other cell types and with 
cytokines and growth factors (Chung and Barnes, 1999; Luster, 1998). 
In asthmatics, allergen inhalation results in an acute inflammatory response characterized 
by vascular leakage, mucus hypersecretion, epithelial shedding and widespread airway 
narrowing. At the same time, through release of mediators, cytokines, chemokines and growth 
factors, the inflammatory infiltrate persists in the airway wall and causes structural tissue 
damage to it. Enhanced survival of cells and the resulting tissue damage can contribute to 
airway wall remodeling (Bratton and Fadok, 1999).  
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3.2. Inflammatory and structural cells involved in remodeling 
The inflammatory process underlying asthma results from the interaction of various cell 
types (Busse and Lemanske, Jr., 2001). Inflammatory cells such as eosinophils, activated T-
cells, mast cells and macrophages and structural tissue cells in cluding epithelial cells, 
fibroblasts and smooth muscle cells can play an important effector role in the remodeling 
process in the asthmatic airway through the release of mediators, cytokines and chemokines 
(Chung and Barnes, 1999).  
 
Eosinophils 
Eosinophils participate in the allergic inflammatory response in airways of mild-to 
moderate asthmatics. The number of eosinophils are increased in peripheral blood, sputum, 
BAL fluid and bronchial tissue of patients with asthma and their numbers have been claimed 
to correlate positively with the severity of the disease (Louis et al, 2000; Chanez et al, 1999; 
Vignola et al, 1998b; Bradley et al, 1991; Bousquet et al, 1990). The migration of eosinophils 
from the circulation to the airway mucosa is stimulated by cytokines such as IL-5 and CC-
chemokines such as eotaxin and RANTES of which the local concentration is increased in 
airways of asthmatic subjects(Hamid and Minshall, 2000; Wardlaw et al, 2000; Wardlaw, 
1999; Luster, 1998; Berkman et al, 1996; Sedgwick et al, 1991). Eosinophils contribute to 
their own survival by releasing several cytokines including GMCSF, IL-3 and IL-5 
(Rothenberg, 1998). 
Initially eosinophils were thought to be involved in the acute inflammatory process in the 
asthmatic airway through the release of toxic granule proteins and other mediators such as 
leukotrienes (LTC4 and LTD4) or platelet activating factor. During the late-phase inflammatory 
reaction after allergen challenge eosinophils are recruited to the airway mucosa where they 
become activated (Rossi et al, 1991; de Monchy et al, 1985). Once activated, products from 
the eosinophils contract the airway smooth muscle, increase vascular permeability and induce 
airway hyperresponsiveness (Rabe et al, 1994; Leff, 1994; Collins et al, 1993). The cytotoxic 
eosinophil granule products such as major basic protein and eosinophilic cationic protein 
seem to contribute to the denudation of the epithelium (Trautmann et al, 2002; Gleich et al, 
1993). 
Recent findings also indicate that eosinophils may be active in the airway remodeling 
process in asthmatics. Possible mechanisms include the release of growth factors such as 
transforming growth factor-ß (TGF-ß) and other profibrogenic cytokines such as IL-11. 
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TGF-ß possesses the ability to directly affect growth of different cell types and to regulate the 
synthesis of matrix components (Cohen et al, 1997; Minshall et al, 1997). Transforming 
growth factor-ß expression in asthmatic airways correlated with the degree of subepithelial 
fibrosis (Ohno et al, 1996) and TGF-ß (Minshall et al, 1997) expression was located 
predominantly in fibroblasts and eosinophils. Interleukin-11 which is able to induce structural 
changes (Leng and Elias, 1997) is also expressed in the airway wall of asthmatics (Minshall et 
al, 2000). Again, eosinophils are also considered the prime source of matrix 
metalloproteinases (MMPs) that are involved in the degradation of extracellular matrix (Dahlen 
et al, 1999; Ohno et al, 1997).  
The selective action of IL-5 in several stages of eosinophil development supports an 
important role for this cytokine in asthma (Chung and Barnes, 1999). Thus, indirectly IL-5 
might also be important in the process of airway remodeling. In vivo models have shown that 
selective suppression of eosinophils by anti IL-5 reduced subepithelial fibrosis in mice (Blyth 
et al, 2000).   
 
T-lymphocytes 
T-cells have been linked with subepithelial fibrosis based on the association between 
CD4/CD8 ratio in the airway wall and the thickness of the lamina reticularis in asthmatics 
(Laprise et al, 1999). Whether T-lymphocytes can cause directly tissue damage and alter the 
airway structure is debated. Indirectly they can contribute to the pathogenesis of airway 
remodeling by the recruitment and activation of inflammatory cells in asthma. Th2-cells in the 
airways are activated by inhaled allergen processed by antigen-presenting cells (Robinson et 
al, 1992). In turn, the T-cells proliferate and produce a wide range of cytokines, such as IL-4, 
IL-5, IL-9, IL-13 and GM-CSF which are relevant to asthma pathogenesis and play a central 
role in the initiation and amplification of the inflammatory response (Ying et al, 1997; 
Robinson et al, 1993a; Robinson et al, 1993b). 
 
Mast cells 
Mast cells have an important function in the regulation of allergic inflammatory processes 
in asthmatic airways. Mast cell numbers are increased in the airway tissue of asthmatics 
concomitantly with local recruitment and activation of Th2-cells (Amin et al, 2000; Laitinen et 
al, 1993). Mast cells are activated in asthmatics predominantly via the allergen-specific IgE 
receptor (Yssel et al, 1998). Upon activation they release cytokines and mediators involved in 
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recruitment and survival of inflammatory cells (Bingham, III and Austen, 2000; Kobayashi et 
al, 1998; Bradding et al, 1994). In analogy to its role in other fibrotic diseases, the mast cell 
may play an important role in the remodeling process of the lamina propria of asthmatic 
airways by releasing proteases, proteoglycans, histamine and cytokines including tumor 
necrosis factor-a (TNF-a) (Hart, 2001; Sommerhoff, 2001; Okuda, 1999; Cairns, 1998; 
Inoue et al, 1996; Chanez et al, 1993). The positive correlation that has been found between 
the thickness of the tenascin and laminin layer beneath the epithelium and mast cell numbers in 
atopic asthmatics could be an indication for this role (Amin et al, 2000). 
 
Macrophages 
Macrophages have a central role in host defense against infection and in inflammatory 
processes. Activated macrophages have the potential to secrete a wide variety of products, 
many of which have the capacity to injure normal structures, leading to tissue repair and 
remodeling. Macrophages are present in the airway inflammatory infiltrate of asthmatic patients 
and a significant correlation is observed between their activation and the severity of asthma 
(Kelly et al, 1988). Macrophages can regulate the airway inflammation in asthma through 
release of enzymes, eicosanoids, PAF, oxygen free radicals and cytokines (Henderson, Jr., 
1991). In asthma, macrophages can also participate in tissue repair and remodeling by 
releasing fibrogenic mediators (TGF-ß, PDGF-ß and endothelin) (Chanez et al, 1996; Vignola 
et al, 1996; Taylor et al, 1994) and proteolytic enzymes (MMP-9) and their tissue inhibitors 
(TIMP-1) involved in extracellular matrix turnover (Kelly et al, 2000; Mautino et al, 1999; 
Vignola et al, 1998c; Mautino et al, 1997). 
 
Epithelial cells 
Epithelial cells are metabolically extremely active, and have been postulated to contribute 
to a large extent to the remodeling process (Holgate et al, 1999). The epithelium in asthmatics 
is injured via exogenous factors such as viruses, inhaled pollutants and allergens but also by 
endogenous factors including proteolytic enzymes released by activated mast cells and 
eosinophils (Holtzman et al, 2002). The respiratory epithelium is also a target of the 
inflammatory attack by T-cells (Trautmann et al, 2002). Following injury, normal epithelium 
releases a wide spectrum of molecules that participate in the repair process. It has been 
hypothesized that in asthma these mechanisms have become disregulated resulting in 
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sustained production by the epithelial cells of cytokines and growth factors that are relevant to 
the ongoing inflammatory response and to airway remodeling in asthma (Holgate, 1998). 
 
Fibroblasts 
Fibroblasts are involved in the deposition of collagen, reticular and elastic fibers, 
proteoglycans and glycoproteins in the extracellular matrix within the airway wall. A range of 
cytokines and growth factors regulates their biological activity. In asthmatic airways, 
fibroblasts may also play a key role in the inflammatory and the remodeling processes.  
A layer of myofibroblasts located immediately beneath the basement membrane has 
attracted particular interest. After allergen challenge their number is increased and their number 
correlates strongly with the depth of the collagen layer in the lamina reticularis of asthmatic 
airways suggesting that these cells are responsible for the deposition of the increased amounts 
of collagen beneath the epithelium (Gizycki et al, 1997; Brewster et al, 1990). These 
myofibroblasts lie in close interaction with the epithelial cells, forming a functional unit (the so-
called epithelial-mesenchymal trophic unit). The close spatial relationship between the 
epithelium and the myofibroblasts indicates a high level of organization between the two layers 
(Holgate et al, 2000). After allergen challenge, epithelial cells stimulated collagen type I and III 
synthesis by lung myofibroblasts (Hastie et al, 2002; Morishima et al, 2001). The injured and 
repairing epithelium releases growth factors such as TGF-ß and epidermal growth factor. In 
response to these mediators the fibroblasts in the asthmatic airway wall express a more 
differentiated and responsive phenotype of fibroblasts (Zhang et al, 1999; Dube et al, 1998). 
This bi-directional communication between repairing epithelium and the lining myofibroblasts 
result in a chronic imbalance of matrix synthesis and remodeling (Hastie et al, 2002; 
Morishima et al, 2001; Holgate et al, 2000).  
 
Smooth muscle cells 
Smooth muscle cells have recently been implicated as inflammatory cells in asthma 
because they exhibit also synthetic and secretory potential besides their contractile and 
mitogenic responses (Chung and Barnes, 1999; John et al, 1997). They can participate in the 
chronic inflammation by releasing proinflammatory cytokines involved in the chemoattractant 
activity for eosinophils, T-cells and macrophages (Chung and Barnes, 1999). Smooth muscle 
also have the potential to produce matrix proteins and orchestrate key events in the process of 
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chronic airway remodeling (Coutts et al, 2001; Johnson et al, 2000; Hirst, 1996; Black et al, 
1996). 
 
3.3. Interdependence of inflammation and remodeling  
Asthma is characterized by a persistent inflammation in the lower airways (Hamid and 
Minshall, 2000; Vignola et al, 1998b; Laitinen et al, 1993). However a persistent inflammation 
is not seen in all atopic individuals (Bradley et al, 1991). The mechanisms that account for this 
persistence of inflammation in the lower airways remain largely unknown. 
Remodeling in the airway wall might contribute in this respect. Components of the 
extracellular matrix can interact profoundly with inflammatory cells and influence the 
persistence and progression of the inflammatory response (Goldring and Warner, 1997; 
Roman, 1996). Extracellular matrix proteins can affect migration, proliferation, differentiation 
and activation state of inflammatory cells and influence their survival (Zhang and Phan, 1999; 
Meerschaert et al, 1999; Vignola et al, 1999; Lavens et al, 1996; Neeley et al, 1994; Anwar et 
al, 1993). Moreover some extracellular proteins can serve as a reservoir for growth factors 
(Redington et al, 1998; Ruoslahti and Yamaguchi, 1991). Changes in the extracellular matrix 
components could therefore influence the nature or persistence of the inflammatory process 
in the airways. 
Remodeling is usually considered to be a consequence of inflammation. Conversely, it 
has also been claimed that airway remodeling as a result of epithelial injury might develop prior 
to inflammatory changes in the airway wall. Injured and repairing bronchial epithelial cells 
might contribute directly to the remodeling processes through increased production of 
proliferative and fibrogenic growth factors (Holgate et al, 2000) which then activates the 
myofibroblasts (Puddicombe et al, 2000). Upon activation myofibroblasts not only produce 
extracellular matrix proteins but also mediators that can amplify the signals of structural 
changes throughout the airway wall (Zhang et al, 1999). These inherent abnormalities result in 
more pronounced structural alterations that subsequently can firmly anchor inflammation in 
the lower airways (Holgate et al, 2000).  
It appears that airway inflammation and remodeling are interdependent processes that 
clearly influence the clinical long-term evolution of asthma. Modulation of the extracellular 
matrix components by remodeling could therefore influence the nature or persistence of the 
inflammatory process and contribute to its chronicity within the asthmatic airway wall. There 
are however few hard data in this respect. 
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4. Functional consequences of airway remodeling 
 
Airway remodeling could have important clinical impact in asthmatics. The functional 
consequences of airway remodeling have mainly been related to the altered airway function 
characteristic for asthmatics. Airway mechanics may be changed because of quantitative 
changes in the airway wall compartments and/or by changes in the biochemical composition 
or material properties of the various constituents of the airway wall. Airway remodeling may 
contribute to bronchial hyperresponsiveness, loss of airway distensibility and accelerated 
decline in FEV1 in asthmatics.  
 
4.1. Non-specific bronchial hyperresponsiveness 
Airway hyperresponsiveness to non-specific stimuli (i.e. histamine, methacholine or cold 
air) is one of the defining characteristics of asthma and is usually expressed as the dose of 
bronchoconstrictor (e.g. methacholine) causing a 20% fall in FEV1 from baseline 
(PC20FEV1). Non-specific airway hyperresponsiveness refers to an increase in the ease in 
degree of airway narrowing in response to a wide range of bronchoconstrictor stimuli (Sterk 
et al, 1993). In asthmatics this airway hyperresponsiveness is persistent even in periods of 
symptomatic remission and after optimal therapy (Boulet et al, 2000). It is thought that 
chronic airway inflammation and airway remodeling are critical factors in the development of 
airway hyperresponsiveness (James et al, 1989). Non-specific airway hyperresponsiveness has 
been correlated with inflammatory cells in the airways (Boulet et al, 2000; Laprise et al, 1999; 
Chetta et al, 1996; Ohashi et al, 1992; Bradley et al, 1991), epithelial injury (Oddera et al, 1996; 
Cho et al, 1996; Jeffery et al, 1989; Laitinen et al, 1985), and features of airway remodeling 
(Boulet et al, 2000; Laprise et al, 1999; Boulet et al, 1997; Chetta et al, 1996; Bramley et al, 
1994). However, not all studies have found an association between inflammation or structural 
changes and the PC20FEV1 of asthmatic patients (Lozewicz et al, 1990) implying that altered 
smooth muscle behavior might also be involved (Chu et al, 1998; Crimi et al, 1998). 
In asthmatic subjects, mediators (histamine, LT, PAF or proteases) released  by 
inflammatory cells that are recruited to the airways after allergen inhalation can alter the 
contractility of airway smooth muscle and induce airway hyperresponsiveness (Crimi et al, 
2001; Oddera et al, 1998). The direct role of inflammatory cells however not fully accounts 
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for the chronicity of the altered airway mechanics in persistent asthma. Indeed, increased 
airway responsiveness was observed in the absence of demonstrable inflammatory infiltrates in 
the airway lumen or mucosa (Crimi et al, 1998). Hence, the hypothesis that airway 
inflammation can affect airway hyperresponsiveness indirectly through its active role in the 
restructuring of the airway wall. 
How structural airway changes can result in increased airway narrowing and airway 
hyperresponsiveness is debated. Different research groups have developed computer models 
to predict the functional significance of altered airway dimensions and physical behavior on 
airway resistance and airway hyperresponsiveness. Changes in thickness of airway wall 
compartments could have profound effects on airway function (figure 3). When smooth 
muscle shortens it has to deform the tissue between the smooth muscle layer and the lumen 
into folds. Thickening of the inner wall in asthma has only little effect on baseline airway 
resistance but can enhance the airway narrowing produced by smooth muscle shortening 
resulting in exaggerated increase of airway resistance (Wiggs et al, 1992; James et al, 1989; 
Moreno et al, 1986). It was also predicted that swelling of the inner airway wall after allergen 
provocation in asthma could result in airway hyperresponsiveness (James et al, 1989). The 
increased airway resistance can be further enhanced when intraluminal airway mucus 
secretions are present (Postma and Kerstjens, 1998). Outer airway wall adventitial thickening 
could also affect airway responsiveness. When airway smooth muscle contraction is initiated, 
shortening occurs until the stress in the surrounding parenchyma prevents further shortening 
and narrowing. An increase in the outer wall thickness could theoretically reduce the tethering 
effect of the parenchyma on the airway and therefore reduce the afterload on the bronchial 
smooth muscle (figure 4). As a result smooth muscle could shorten more for a given force 
generation (Macklem, 1996; Pare and Bai, 1995; Lambert et al, 1994). The third compartment 
of the asthmatic airway wall that could alter airway responsiveness is the amount of airway 
smooth muscle. The increase in airway smooth muscle mass in asthma can have a simple 
geometric effect on airway narrowing, much like the effect of thickening of the submucosal 
region of the airway wall. It can also amplify the effect of smooth muscle shortening and 
enhance airway narrowing. The increased area of airway smooth muscle can also increase the 
force-generating ability and allow the smooth muscle to shorten more against the elastic loads 
provided by the lung parenchyma and again can result in a larger airway narrowing (Postma 
and Kerstjens, 1998; Pare et al, 1997). Maximal airway narrowing can be largely enhanced 
both by an increase in the smooth muscle layer and changes in the adventitial structure, 
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leading to a loss of elastic parenchymal recoil on contracting airway smooth muscle 
(Macklem, 1996; Lambert et al, 1993).  
Changes in the stiffness of the airway wall areas due to biochemical changes of the tissue 
can also affect airway behavior in asthmatics. The mechanical effects of collagen deposition 
results from an altered size and composition of the collagen bundles in the subepithelial layer. 
Increased collagen fibril density and thickening of this layer as observed in asthmatics (Carroll 
et al, 2000) could increase the stiffness of the inner layer of the airway wall in comparison with 
the surrounding submucosa. It was calculated that subepithelial thickening might reduce the 
number of folds that forms when airway smooth muscle shortens. This then would favor 
airway narrowing compared to a larger number of thin folds in contracting normal airways 
(Wiggs et al, 1997). Also extracellular matrix protein changes in the submucosa may 
contribute to airway hyperresponsiveness in asthmatics. The functional consequences of 
proteoglycan deposition in the airway wall are unknown but hydrated proteoglycan may 
contribute to an increased thickness of the submucosa in asthmatics and thus possibly also in 
airway hyperresponsiveness (Kuwano et al, 1993). Degradation of elastin and matrix proteins 
that form tethers between the submucosa and the airway smooth muscle may decrease the 
load internal to airway smooth muscle and increase deformability of the airway (Bousquet et 
al, 1996). This also has been postulated to induce increased smooth muscle contractility in 
asthma (Bramley et al, 1994).  
 
 
 
Figure 3. Increase in airway wall area enhances smooth muscle contraction. The normal airway has an 
inner wall area of 20%. When 30% airway smooth muscle (ASM) shortening occurs, the resistance (R) 
of the airway wall increases from 1 to 7.6. When inner wall area is 40%, baseline resistance is slightly 
 Review of the Literature 24
increased (R=1.8). However, with a thicker airway wall, 30% smooth muscle shortening increases 
resistance to 80 times baseline (Bosken et al, 1990). 
 
  
Figure 4. Influence of outer airway wall thickening on smooth muscle contraction. The normal airway 
has a resistance (R) of 1. When airway smooth muscle (ASM) contraction is stimulated, shortening 
occurs until the stress of the surrounding parenchyma prevents further shortening. When the outer airway 
wall is thickened the stress in the surrounding parenchyma decreases and a greater smooth muscle 
shortening is possible (Pare and Bai, 1995). 
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Based on these theoretical assumptions it is clear that changes in compartments of the 
airway wall have the capacity to influence airway function in asthma. However, it is not clear 
whether they are indeed applicable in chronic asthma. Methodological problems hamper the 
evaluation of correlations between parameters of remodeling and airway hyperresponsiveness. 
Histological assessment of remodeling in asthmatic subjects is limited to the evaluation of the 
thickness of the subepithelial fibrosis in bronchial biopsies from central airways. It is 
unknown how well this correlates with other elements of the remodeling process. Results 
from studies that have correlated PC20FEV1 with the thickness of subepithelial fibrosis are 
conflicting. Although in some studies, a correlation was found between the PC20FEV1 and 
the thickness of the subepithelial collagen layer (Niimi et al, 2000c; Laprise et al, 1999; Chetta 
et al, 1997; Boulet et al, 1997) this was not confirmed by others (Boulet et al, 2000; Chu et al, 
1998; Saetta et al, 1992). Similarly, studies using HRCT scans have not consistently shown a 
correlation between the PC20FEV1 and the airway wall thickness at the level of the intermediary 
bronchus (Niimi et al, 2000a; Carr et al, 1998; Boulet et al, 1995). In a human experimental 
setting the allergen-induced increase of airway responsiveness that was observed in asthmatic 
patients did not correlate with indices of airway edema (Peebles et al, 2001). These results 
again contradict the theoretical models predicting that airway hyperresponsiveness in asthma 
might be a result of airway wall edema.  
Some have even observed a negative relationship between airway responsiveness and 
subepithelial thickening (Milanese et al, 2001). This finding is in keeping with the theoretical 
prediction that increased collagen deposition tends to increase airway wall stiffness, thus 
providing additional internal load on contracting airway smooth muscle and protecting 
against instead of enhancing airway narrowing (Seow et al, 2000; Lambert et al, 1994; 
Lambert, 1991). Alterations in extracellular matrix proteins within the airway wall and more 
specifically around the smooth muscle layer and between smooth muscle cells could have the 
effect of banding and interfere with smooth muscle contractions, again resulting in limited 
narrowing (Meiss, 1999; Bramley et al, 1995).  
In addition, the above mentioned morphometric analysis fails to take into account airway 
smooth muscle dynamics. The contractile properties of airway smooth muscle are also altered 
in asthma. The maximal capacity and velocity of shortening is larger in airway smooth muscle 
from patients with asthma than those from healthy subjects (Stephens et al, 1998). Moreover, 
passive sensitization of airway smooth muscle by serum from atopic individuals resulted in 
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enhanced contractile responses in vitro (Wohlsen et al, 2001; Schmidt et al, 2000; Watson et 
al, 1997). 
These theories and observations illustrate that airway hyperresponsiveness in asthma is 
not uniquely related to airway inflammation or structural airway changes but results from an 
interaction between complex and multiple mechanisms that regulate narrowing of the airway 
wall (Brusasco et al, 1998). 
 
4.2. Irreversible component of the airways obstruction 
It has long been recognized that reversible airflow limitation is one of the unique features 
of asthma. A majority of asthmatic patients show a complete reversibility of airflow limitation 
and become symptom-free, even when initially they had moderate to severe asthma 
(Panhuysen et al, 1997). However, despite apparently optimal therapy a significant degree of 
airflow obstruction may persist in some asthmatic patients, both children and adults (Ulrik 
and Backer, 1999; Backman et al, 1997; Boulet et al, 1994). The irreversible airflow limitation 
seem to develop more commonly in patients with severe asthma and in middle-aged and older 
adults with asthma (Ulrik and Backer, 1999; Panhuysen et al, 1997). The phenomenon has 
also been described in asymptomatic patients (Ferguson, 1988).  
An indication of the irreversible changes in the histology of asthmatic airways is the 
accelerated decline in FEV1. Longitudinal studies have shown that in patients with asthma the 
decline in FEV1 is steeper compared to those without asthma (Lange et al, 1998; Ulrik and 
Lange, 1994; Peat et al, 1987). The effect of asthma is variable and not all subjects with 
asthma have accelerated rates of decline. The rate of decline has been reported to be larger in 
patients with intrinsic asthma than in atopic asthma, (ten Brinke et al, 2001; Ulrik et al, 1992) 
however this relation was not always found (Peat et al, 1987). The decline in lung function is 
further accelerated by regular smoking (Lange et al, 1998; Peat et al, 1987). A relation was 
observed between airway hyperresponsiveness and rate of decline in FEV1 (Peat et al, 1987) 
but this also was not invariably confirmed (Ulrik and Backer, 1999). 
Airway remodeling, especially the irreversible fibrotic change in the airway wall is thought 
to contribute to the irreversible impairment of FEV1 in asthma (Ward et al, 2001; Boulet et al, 
2000; Reed, 1999). Although somewhat debated, it was recently shown that longer duration 
of asthma is associated with progressive remodeling of the airway wall. These changes 
included a progressive increase in airway smooth muscle volume and a greater reduction in 
airway lumen (Bai et al, 2000). This study thus provided a basis for understanding the 
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exaggerated decline in FEV1 reported in individuals with asthma, especially in the older 
asthmatic patients. In asthma, studies of moderately severe asthmatic patients also have found 
some loss of elastic recoil and lung elasticity (Zapletal et al, 1993; McCarthy and Sigurdson, 
1980). These findings were thought to result from airway remodeling because increased 
bronchial wall rigidity can reduce airway distensibility (Johns et al, 2000; Wilson et al, 1993). 
Further evidence in this respect is given recently by showing a correlation between decreased 
airway distensibility and the increase in sub-basement membrane thickening in asthmatic 
subjects (Ward et al, 2001). 
There are however no prospective studies showing that structural changes, pulmonary 
function parameters and indices of inflammation are related longitudinally. Therefore the long-
term evolution of lung function in asthma and airway remodeling needs to be further 
examined. 
 
 
5. In vivo experimental models of airway remodeling 
 
In vivo experimental models in which aspects of the asthma pathology are replicated are 
necessary and useful to assess the contribution of particular mediators and cells to the 
development of airway remodeling and its functional consequences. Further insight into the 
pathogenic events leading to remodeled airways is clearly required. More information is 
needed on which mediators, mediator-mediator interactions, cell-cell interactions, signal 
transduction pathways and effector mechanisms are responsible for these biologic processes. 
Also a further evaluation of the impact of these structural changes on airway function is 
necessary. This implies that the animal model should display not only morphological 
characteristics of remodeling but also a degree of airway hyperresponsiveness comparable to 
human asthma.  
The ideal animal model in which these morphological and physiological requirements are 
combined does not yet exist. Animal models displaying naturally occurring asthma-like 
syndromes are nearly inexistent. Two animal species, horses and cats can develop disease 
profiles that resemble human asthma. Horses develop airway obstruction after exposure to 
mold but the airway histology is different from asthma and resembles more bronchiolitis 
(Derksen et al, 1985). The only species that seems to spontaneously develop an airway 
disorder that bears similarities to asthma, both functionally and histologically, are cats. 
 Review of the Literature 28
Sensitization followed by repeated exposure to Ascaris has been shown to increase airway 
responsiveness in conjunction with histological changes such as peribronchial eosinophil 
infiltration, an extensive increase in smooth muscle mass and submucosal gland mass. The 
overall airway wall thickness was not increased (Padrid et al, 1995). However the cat has not 
gained widespread acceptance as an experimental animal. 
The vast majority of animal models of allergic airway inflammation have been 
experimentally induced in small rodents, mice and rats in particular. This choice of animal 
species is in part dictated by economical and ecological considerations, but mainly 
attributable to the huge range of immunological tools available in mice. The development of 
monoclonal antibodies and more recently gene deletion technology allows to effectively 
neutralize a given mediator or cell, thus allowing to establish its functional importance in the 
disease process (Kips and Pauwels, 1997). To date, the majority of airway remodeling studies 
in rat and mice have been conducted in previously characterized animal models of airway 
hyperresponsiveness. The advantage of these models of airway hyperresponsiveness is that 
they allow us to study the relationship between inflammatory and structural changes on one 
hand and physiologic abnormalities on the other (Fernandes et al, 2001). 
 
5.1. Rat models of airway remodeling 
Rat models have received considerable attention during recent decades. Experimental 
data suggest that some features of human asthma including pathological changes can be 
duplicated in rats. Most studies on airway remodeling were conducted in the Brown Norway 
species after chronic allergen challenge. Brown Norway rats produce IgE as the major 
anaphylactic antibody and they exhibit both early and late responses to antigen. They are a 
popular model of allergic bronchoconstriction. Sprague-Dawley rats were also used in a few 
airway remodeling studies using especially non-allergic substances.  
 
Chronic antigen challenge 
In a series of studies, Brown Norway rats were sensitized and exposed to a number of 
inhalation challenges with ovalbumin (OA) (Salmon et al, 1999; Du et al, 1996; Wang et al, 
1993; Sapienza et al, 1991; Bellofiore and Martin, 1988). An increase in airway responsiveness 
was observed in those animals that developed an early response to OA inhalation (Sapienza et 
al, 1991; Bellofiore and Martin, 1988). The increase in airway responsiveness in some of the 
animals persisted for up to 17 days after the last exposure (Bellofiore and Martin, 1988). The 
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altered airway behavior in these rats was not accompanied by a clear eosinophil influx into the 
airways, nor altered airway wall thickness but with an increased thickness of the smooth 
muscle layer attributed to smooth muscle cell hyperplasia (Panettieri, Jr. et al, 1998; Sapienza 
et al, 1991). Others have reported increased numbers of replicating cells in airway epithelium 
and in the airway smooth muscle layer after repeated OA exposure (Salmon et al, 1999). In 
this report increased subepithelial collagen deposition and mucus secretion was observed 
along with a significant recruitment of eosinophils and lymphocytes to the airways (Salmon et 
al, 1999).  
In addition to OA, the occupational allergen trimellitic anhydride (TMA) has also been 
used to induce airway remodeling in Brown Norway rats (Cui et al, 1999). Sensitization and 
repeated exposure to TMA conjugated to rat serum albumin resulted in enhanced bronchial 
responsiveness that was accompanied by an increased thickness of smooth muscle, an 
increase in narrowing of the small airways and goblet-cell hyperplasia but without a persistent 
airway eosinophilia (Cui et al, 1999; Cui et al, 1997). 
 
Non-antigenic inhaled substances 
A number of models were able to induce aspects of remodeling in rats after exposure to 
non-specific irritants. Chronic exposure of Sprague-Dawley rats to SO2 resulted in airway 
hyperresponsiveness, accompanied by epithelial changes and increased thickness of the 
airway smooth muscle layer (Long et al, 1997; Shore et al, 1995). In developing Sprague-
Dawley rats, chronic hyperoxia exposure resulted in an increased epithelial and airway smooth 
muscle layer thickness and increased airway wall thickening that correlated with airway 
hyperresponsiveness (Hershenson et al, 1992a; Hershenson et al, 1992b). These rats also 
exhibited abnormally increased DNA synthesis in both the bronchiolar epithelium and smooth 
muscle layer (Hershenson et al, 1994). Intratracheal instillation of vanadiumpentoxide induced 
airway wall remodeling in Sprague-Dawley rats including airway smooth muscle thickening, 
mucus cell metaplasia, and airway fibrosis. Myofibroblasts were the principal proliferating cell 
type that contributed to the progression of the airway fibrosis (Bonner et al, 2000).  
 
5.2. Mouse models of airway remodeling 
The use of the mouse model of airway inflammation and airway hyperresponsiveness is 
becoming more widespread. Mouse models present numerous advantages when compared 
with other animal species as they offer the opportunity to explore mechanisms of allergic 
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reactions in view of the availability of numerous immunologic reagents and molecular 
histological probes that far exceeds those of other species. Murine models have provided 
fundamental information regarding the role of IgE and T lymphocyte cytokines in the 
pathogenesis of airway inflammation that underlies asthma.  
 
Antigen -induced structural airway changes 
The majority of the currently developed murine models have focused on acute 
inflammatory changes (Kips and Pauwels, 1997). However, in a few models, the effect of 
more prolonged allergen exposure has been evaluated. Blyth and coworkers reported that 
repeated intratracheal instillation of OA induced peribronchial eosinophilia and goblet cell 
hyperplasia in BALB/c mice (Blyth et al, 1996). Repeated challenges also resulted in fibrosis 
in the reticular layer beneath the basement membrane (Blyth et al, 1996). In another animal 
experiment, prolonged allergen exposure of sensitized and challenged BALB/c mice resulted 
in goblet cell hyperplasia and airway fibrosis but suppressed airway hyperresponsiveness and 
reduced the number of peribronchial eosinophils (Sakai et al, 2001). Temelkovski and 
coworkers reported that repeated exposure of BALB/c mice to low dose antigen over 6 to 8 
weeks induced goblet cell hyperplasia as an early characteristic of airway remodeling followed 
by epithelial thickening and subepithelial fibrosis. Allergen sensitization and exposure resulted 
in a peribronchial accumulation of mainly mononuclear cells and in an increased sensitivity to 
methacholine (Temelkovski et al, 1998). Interleukin-5 gene knockouts showed no 
inflammatory changes or airway hyperresponsiveness while structural changes remained 
present after OA exposure. It was therefore suggested that the structural alterations in these 
BALB/c mice were not simply a consequence of the inflammation and did not correlate 
directly with the airway hyperresponsiveness (Foster et al, 2000). Repeated intranasal OA 
challenge of sensitized BALB/c mice during 12 weeks induced airway eosinophilia, airway 
hyperresponsiveness and evidence of airway remodeling, including subepithelial collagen 
deposition and an increase in a-smooth muscle actin positive cells in the airway wall. The 
changes persisted for at least two weeks after the last exposure (Inman et al, 1999). Recently, 
increased levels of cellular fibronectin in BAL and epithelial proliferation were observed after 
repeated OA challenges in sensitized BALB/c and C57BL/6 mice (Trifilieff et al, 2001). These 
parameters were used to indicate the presence of airway remodeling in these mice. The 
changes were accompanied with inflammatory alterations and airway hyperreactivity (Trifilieff 
et al, 2000). In contrast to the findings by Foster et al (2000), this model showed that 
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infiltration with eosinophils in the airways is a key event in the initiation of structural changes 
that may lead to a further remodeling process. In this study it was also shown that IL-5 did 
not affect the remodeling process directly but only via its mediator function on eosinophils 
(Trifilieff et al, 2001).  
More recently, a model of allergic airway remodelin g was described after sensitization 
and repeated challenge with Aspergillus fumigatus. Intratracheal introduction of A. fumigatus 
spores or conidia into the airways of sensitized mice resulted in a persistent airway 
hyperresponsiveness, goblet cell hyperplasia and subepithelial fibrosis (Hogaboam et al, 
2000). 
 
Non antigen -induced models of airway remodeling in genetically manipulated mice 
Overexpression of cytokines in murine airway epithelium, using transgene technology 
has been reported to induce structural airway changes. Overexpression of IL-6 and IL-11, 
two members of the IL-6-type cytokine family resulted in peribronchial fibrosis with the 
accumulation of myofibroblasts (Tang et al, 1996; DiCosmo et al, 1995). Interleukin-6 did 
not induce smooth muscle cell proliferation and did not induce airway hyperresponsiveness 
(DiCosmo et al, 1995). Interleukin -11 overexpression was accompanied by an increase in true 
airway smooth muscle mass. Despite similar histological changes IL-11 transgenic mice were 
hyperresponsive, whereas IL-6 transgene animals were hyporesponsive (Tang et al, 1996). Of 
note is that the airway caliber of IL-11 transgene mice was reduced, when compared to IL-6 
transgenes (Kuhn, III et al, 2000). This difference in airway caliber probably accounts for the 
airway hyperresponsiveness, and illustrates once more that histological analysis on its own is 
insufficient to evaluate the full impact of airway remodeling in asthma.  
Others have reported some degree of subepithelial fibrosis in addition to eosinophil 
accumulation in transgenic animals expressing Th2-type cytokines. Overexpression of IL-13 
generates a complex phenotype that includes eosinophilic and mononuclear inflammation, 
subepithelial airway fibrosis, airway obstruction and airway hyperresponsiveness on 
methacholine challenge (Zhu et al, 1999). Increased amounts of IL-5 and IL-9 has also been 
demonstrated to cause eosinophilia and airway fibrosis (Temann et al, 1998; Lee et al, 1997). 
These models obviously are of interest, illustrating the potential effect of high concentration of 
a given cytokine in inducing structural airway changes. However, they do not address the role 
of physiological concentrations of endogenously released cytokines in the pathogenesis of 
the remodeling process. 
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6. Conclusion 
 
In conclusion, the airway wall in asthma shows convincing signs of remodeling. 
However, it remains largely unclear how the remodeling process is initiated and to what extent 
these structural changes contribute to the abnormal airway physiology observed in 
asthmatics. Moreover, methodological restrictions limit a full evaluation of all histological 
changes in the airway wall and thus limit the investigation on the relation between the 
remodeling process and the resulting airway physiology. Data derived from representative in 
vivo animal models could therefore add valuable information. Most models developed to date 
display only transient, acute inflammatory airway changes. To study the relation between 
airway remodeling and physiology animal models need to be developed that also display the 
chronicity of the inflammation and the structural changes in the airway wall, characteristic of 
asthma. 
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The overall aim of this study was to develop an in vivo animal model that displays 
characteristics of allergen-induced airway remodeling. The rat model has several advantages. 
Rats are easy to house and are readily available. They are of sufficient size to allow for easy 
instrumentation and reliable lung function measurements. The strain chosen, Brown Norway 
rats, are known to produce specific IgE and develop an acute airway inflammation in 
response to active immunization and allergen challenge. A single allergen challenge in 
immunized Brown Norway rats also causes an increase in bronchial hyperresponsiveness. 
Mouse models are particularly interesting because of the wealth of immunologic tools and the 
range of knockout mice that are available. Different inbred mouse strains develop 
immunologic, inflammatory and smooth muscle responses when actively immunized and 
exposed to allergen. Moreover, the existence of different inbred mouse strains allows 
assessing the importance of genetic differences in the remodeling process. 
 
The specific aims of our study were: 
 
1. To develop an in vivo animal model in rat and in mice that mimics the chronic nature 
of the asthmatic airway inflammation and the development of structural airway 
changes. 
2. To relate the allergen-induced structural changes to airway behavior. 
3. To evaluate whether smooth muscle contractions, independent from allergen-induced 
airway inflammation, can contribute to the remodeling process. 
4. To evaluate whether the susceptibility of the airways to allergen-induced structural 
changes is age dependent. 
5. To evaluate if there is a difference in the remodeling process between species with 
distinct genetically determined immunologic and smooth muscle responses to 
allergen sensitization and exposure. 
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1. Respiratory measurements  
 
Overall, three techniques exist for the assessment of airway mechanics in rodents (Drazen 
et al, 1999; Amdur and Mead, 1958). In the first, the physical properties of the lungs or 
airways are assessed after their removal from the host. An example for this technique is the 
measurement of contractions in isolated airway segments. The second set of techniques 
requires anesthesia and instrumentation of the animal to allow the recording of airway 
mechanics. We have used this approach to measure pulmonary resistance in the rat. In the 
third technique neither anesthesia nor airway instrumentation is required. This has been used 
to assess airway function in mice. 
  
1.1. Respiratory measurements in rats  
Lung resistance (RL) was used as a parameter of airway tone. As described by Amdur 
and Mead (1958), the mechanical properties of the lung in rodents can be obtained by relating 
tidal volume and flow rate to intrapleural pressure at specific time points during the respiratory 
cycle. Intrapleural pressure can be divid ed into a flow-resistive and elastic component. The 
flow-resistive component is related to resistance to flow of gas in lungs and airways and to 
viscous resistance of lung tissue, whereas the elastic component is related to elastic recoil of 
the lung. At points of equal volume during the respiratory cycle, the elastic forces must be 
approximately equal and the pressure change between two such points must relate chiefly to 
resistance to flow in lungs and airways (figure 1A). The pressure change is related to  the 
associated flow change to give a measure of the flow resistance of the lungs and airways. This 
method gives a value that represents the average inspiratory and expiratory resistance near 
peak inspiratory and expiratory flows. Therefore RL = ? P/?V (figure 1A). RL not only 
measures airway resistance, but also the viscous resistance of lung tissue. Using a 
plethysmographic technique in tracheostomized animals, it has however been shown that in 
rats, RL is nearly identical to airway resistance (Raw) (Johanson and Pierce, 1971). In rats, 
therefore RL is therefore considered to be a parameter of mainly airway resistance.  
 
RL is derived from data of tidal volume (V), air flow (V) and transpulmonary pressure 
(Ppt) measured at the outlet of an intratracheal cannula. Therefore rats are anaesthetized by the 
intraperitoneal injection of pentobarbital (60 mg/kg; Sanofi, Libourne, France). The trachea is 
cannulated with a Teflon cannula (35 mm long and 1.67 mm internal diameter [I.D.]). The 
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femoral artery is cannulated with a polyethylene catheter (1.77 mm I.D., 2.80 mm outer 
diameter; Intramedic; Clay Adams, Parsippany, NJ) to monitor blood pressure and heart rate 
with a pressure transducer (Celesco Transducer Products, Canoga Park, CA) throughout the 
experiment. A polyethylene catheter was inserted in the external jugular vein for administration 
of intravenous drugs and fluids (figure 1B). Animals were placed on a heating pad (37°C), 
were connected with a Palmer animal respirator (BioScience, Sheerness, UK), and were 
ventilated with oxygen-enriched air at a rate of 75 strokes/min and a stroke volume of 2 to 2.5 
ml. Animals were injected with pancuronium bromide (Organon Teknika, Boxtel, the 
Netherlands), at 0.2 mg/kg body weight to interrupt spontaneous respiratory movements. The 
animals’ arterial blood gases were measured after 10 min of ventilation, and the stroke volume 
was adapted to keep pH, pO2 and pCO2 within the normal ranges. 
 
A  B 
 
 
 
 
Figure 1. A. Method of measuring pulmonary flow resistance. At a point of equal volume during the 
respiratory cycle, the elastic forces are approximately equal and the pressure change between two such 
points relate chiefly to resistance to the flow sensitive component (Amdur and Mead, 1958). B. 
Schematic representation of the experimental setup used for the measurement of respiratory mechanics in 
rats. Ppt, transpulmonary pressure; V, airflow; V, volume; RL, lung resistance. 
  
 
 
The animals’ transpulmonary pressure (Ppt) was measured with a differential pressure 
transducer (Celesco Transducer Products), of which one end was attached to an air-filled 
catheter inserted into the pleural cavity and the other end was attached to a catheter connected 
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to a sideport of the outlet of the tracheal cannula. The airflow at the outlet of the intratracheal 
cannula was measured with a pneumotachograph (Type 00000; Fleisch, Geneva, 
Switzerland). The tidal volume (VT) was obtained by integration of the flow. RL was 
continuously calculated from VT, airflow, and Ppt (PRS800; Mumed, London, UK). 
Carbachol (carbamoylcholine hydrochloride; Merck, Darmstadt, Germany) was nebulized 
with an ultrasonic nebulizer (Model 2511; Pulmo-Sonic, DeVilbiss Co., Somerset, PA). The 
mean particle size of the aerosol was 3.8 µm and the output was 1.0 ml/min. The aerosol was 
led into the inspiratory tube of the respiratory pump. Increasing concentrations of carbachol 
were administered over a period of 30 s at 5 min intervals, allowing RL to return to baseline 
between administrations of each concentration. Carbachol-induced bronchoconstriction was 
measured as the percent increase in RL, comparing the peak of the reaction with baseline RL.  
 
1.2. Assessment of airway function in mice 
In mice, airway function is assessed in awake animals using a whole-body 
plethysmograph system (Buxco; Buxco Electronics, Troy, NY). In barometric 
plethysmography, unrestrained animals are placed in a chamber (figure 2) and the pressure 
fluctuations that occur during a ventilatory cycle are monitored (figure 3) (Hamelmann et al, 
1997). The major advantage of this technique is that this method does not require the use of 
anesthetic agents or surgical preparation and therefore allows studying the same mouse on 
different occasions. 
The basic idea in barometric plethysmography is that during inspiration, tidal air is 
warmed and heated up as it enters the thorax and the pressure change associated with this 
change is mirrored in the pressure within the chamber. With few assumptions, the time of 
inspiration and expiration can be accurately assessed. Using this approach an empiric 
parameter ‘enhanced pause’ (Penh) is defined based on the respiratory pattern observed in  
unrestrained mice (Hamelmann et al, 1997). The expiratory period is divided in two phases: an 
early relaxation phase and a later phase (figure 3). A respiratory pause is defined by Pause = 
(Te – Tr)/Tr where Te is time of expiration and Tr is time required for the area under the 
chamber pressure-time curve during expiration to decrease to 36% of its total value. 
Hamelmann and coworkers (1997) noted that when breathing was unobstructed, the 
plethysmographic pressure signal during inspiration and expiration had equal deflections, 
whereas when breathing was obstructed, the expiratory pressure deflection was greater than 
was the inspiratory pressure deflection. Thus, they defined the parameter Penh as Penh = 
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[(Te-Tr)/Tr] x (PEP/PIP) where PEP is peak expiratory pressure, and PIP is peak inspiratory 
pressure (figure 3). Penh reflects changes in the waveform of the box pressure signal from 
both inspiration and expiration (PIP, PEP) and combines it with the timing comparison of 
early and late expiration (Pause). Hamelmann and coworkers (1997) demonstrated that the 
changes in Penh reflected the changes in RL during bronchoconstriction induced by 
aerosolized methacholine and an increase in Penh was an index of airway obstruction in mice 
that were sensitized and challenged with allergen. 
 
 
 
 
Figure 2. Schematic diagram of the whole-body plethysmograph. (A) Main chamber containing the 
mouse (A); (B) reference chamber; (C) pressure transducer connected to analyzer and (D) 
pneumotachograph. (1) Main inlet for aerosol closed by valve; (2) inlet for bias flow with four-way 
stopcock and (3) outlet for aerosol with four-way stopcock (Hamelmann et al, 1997). 
 
Before performing readings, the system was calibrated by rapid injection of 1 ml air.  
Pressure differences between the main chamber of the whole-body plethysmograph 
containing the awake mouse and a reference chamber (this is the box pressure signal) were 
recorded using the software BioSystem XA (version 157; Buxco). This pressure signal is 
caused by volume and resultant pressure changes in the main chamber during the respiratory 
cycle of the animal. A pneumotachograph with defined resistance in the wall of the main 
chamber acts as a low-pass filter and allows thermal compensation (figure 2). For each 
mouse, data of Penh were recorded at baseline, and after exposure to PBS or increasing 
concentrations of methacholine (2 – 81 mg/ml). The solutions were nebulized through an inlet 
of the main chamber during 1 min. Readings were taken during 5 min after each nebulization. 
Between readings Penh value returned to baseline. Recordings of every 10 breaths are 
extrapolated to define the respiratory rate in breaths per minute. 
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Figure 3. Schematic figure of a box pressure wave in inspiration (down) and expiration (up) explaining 
the computation of the parameters by whole-body plethysmography. Ti, inspiratory time (s), time from 
start of inspiration to end of inspiration; Te, expiratory time (s), time from end of inspiration to start of 
next inspiration; PIP, peak inspiratory pressure (ml/s), maximal negative box pressure occurring in one 
breath; PEP, peak expiratory pressure (ml/s), maximal positive box pressure occurring in one breath; Tr, 
relaxation time (s), time of the pressure decay to 36% of the total box pressure during expiration 
(Hamelmann et al, 1997). 
 
 
2. Morphometric measurements 
 
In the airway wall the length of the basement membrane is relatively constant despite 
passive changes in lung volume and changes in airway dimensions caused by smooth muscle 
contraction (James et al, 1989; James et al, 1988; James et al, 1987). This observation 
provides a mechanism by which airway size can be accurately assessed regardless of the state 
of inflation of the lung and the degree of bronchoconstriction.  
The airway can be divided into different layers that have a distinct composition. 
Quantification of these layers is important because different pathophysiologic processes may 
result in specific thickening of one of the compartments without thickening of the others. 
Also the mechanisms by which each layer may be thickened could be different and the 
functional consequences of thickening of individual layers are different. To quantify the 
subdivisions in the bronchial wall the standardized nomenclature for the morphometric 
measurements of the airway wall described by Bai et al (1994) was used in this study. 
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2.1. Nomenclature for quantifying subdivisions of the bronchial wall 
Figure 4 shows an idealized schematic cross section of a small cartilage-free airway in a 
contracted state. The following abbreviations are used to define the different compartments of 
the airway wall (Bai et al, 1994).  
 
Pbm  perimeter basement membrane 
Pmo   perimeter outer muscle (outer border of smooth muscle) 
Po   outer perimeter (outer border of the adventitia) 
Abm, Amo, Ao areas enclosed by the defined perimeters 
WA  wall area 
WAi  inner wall area (Amo – Abm) 
WAo  outer wall area (Ao  – Amo) 
WAt  total wall area (Ao – Abm) 
WAm  smooth muscle area  
 
Areas denoted Abm, Ai and Ao include the luminal area, whereas wall areas denoted WAi, 
WAo, WAt and WAm represent tissue area only. 
 
 
 
Figure 4. Schematic diagram of an airway in a constricted state. Dl and Ds, long and short diameters, 
respectively of outer border of smooth muscle perimeter. WAi and WAo , inner and adventitial wall areas, 
respectively; Po  and Ao, outer airway perimeter and area, respectively; Pmo and Amo, outer muscle 
perimeter and area respectively; Pbm and Abm, perimeter basement membrane respectively. The dashed 
line on the bronchus indicates the path to be traced in measuring Po. (Bai et al, 1994). 
 
 
2.2. Morphometric analysis of airways in rats and mice 
For the morphometric analysis of airways, lungs were fixed with 4% paraformaldehyde 
via the trachea cannula. The lungs were removed and slices from different lobes were 
embedded in paraffin and cut in 2 µm-thick sections. Measurements of morphometrical 
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parameters are made on all airways observed in the stained lung sections. These airways are 
cut in transverse section and free of branching. A transverse section is defined as one in 
which there is an approximately constant thickness of the airway wall around the entire airway 
and has a ratio of minimal I.D. to maximal I.D. greater than 0.5 (figure 4). The morphometric 
measurements were made with a Zeiss Axiophot microscope or on the digital representation 
of the airways via a computerized image analysis system (KS400; Zeiss, Oberkochen, 
Germany). 
In rats the following morphometrical parameters (Bai et al, 1994) were marked manually 
on the airways: Pbm, Pmo and Po (figure 5A); the areas defined by these parameters (Abm, 
Amo and Ao) and the length of Pbm are assessed via the computerized systems. The 
following parameters were calculated based on the measured values: the total bronchial wall 
area (WAt = Ao - Abm), the inner wall area (WAi = Amo - Abm) and the outer wall area (WAo 
= Ao - Amo). The area of smooth muscle (WAm) was measured by specifically tracing 
around the smooth muscle bundles. In mice, the following parameters were determined: Pbm, 
the area defined by the basement membrane (Abm) and the area defined by the total adventitial 
perimeter (Ao). The total bronchial wall area (WAt) was calculated (WAt = Ao - Abm) (figure 
5B). 
 
2.3. Assessment of extracellular matrix protein deposition in the airway wall 
To assess the deposition of extracellular matrix proteins in the airway wall two 
computerized image analysis systems were used in the experiments: the software system 
KS400 (Zeiss) and the system LEICA Q500MC (Leic a Cambridge, Cambridge, UK). The 
basic principle for the quantification of protein deposition in the airway wall is the same for 
both image analysis systems. 
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A 
 
B 
 
Figure 5. Morphological parameters assessed in rats (A) and mice (B). A. In rats the following 
parameters are shown Pbm (black line), WAi (red lines), WAo  (blue lines) and WAt (red and blue lines) 
(hematoxylin and eosin stained section, magnification 200x). B. In mice the parameters Pbm (green line) 
and WAt (area between green and pink line) are shown (Congo Red stained section, magnification 400x). 
Pbm = perimeter basement membrane, WAi = inner wall area, WAo = outer wall area and WAt = total 
wall area.  
 
 
 
Figure 6. Assessment of extracellular matrix protein deposition in an airway wall. The small insert 
shows the area covered by the red-stained collagen fibers for a part of the airway wall. This area was 
determined by the software KS400 (Zeiss) (Sirius Red stained section, magnification 200x). 
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A camera sampled the image of the stained sections and generated an electronic signal 
proportional to the intensity of illumination, which was then digitized into picture elements or 
pixels. The digital representation of the airways cut in transverse sections was analyzed with 
the software. Each pixel in a color image is divided into three color components (hue, 
saturation, and intensity). The threshold for each color component for the specific stain of the 
extracellular matrix protein (red or brown for total collagen stain with Sirius red or protein 
staining via immunohistochemistry, respectively) was defined and kept constant throughout 
the analysis. The area covered by the stain was determined by the software (figure 6). The 
borders of the different compartments of the airway wall were marked manually and the 
software analyzed the amount of protein deposited in these regions.  
 
 
3. References 
 
Amdur MO and Mead J. Mechanics of respiration in anaesthetized guinea pigs. Am J Physiol 
1958, 192:364-368. 
Bai A, Eidelman DH, Hogg JC, James AL, Lambert RK, Ludwig MS, Martin J, McDonald 
DM, Mitzner WA, Okazawa M, Pack RJ, Pare PD, Schellenberg RR, Tiddens HA, Wagner 
EM and Yager D. Proposed nomenclature for quantifying subdivisions of the bronchial wall. 
J Appl Physiol 1994, 77:1011-1014. 
Drazen JM, Finn PW and De Sanctis GT. Mouse models of airway responsiveness: 
physiological basis of observed outcomes and analysis of selected examples using these 
outcome indicators. Annu Rev Physiol 1999, 61:593-625. 
Hamelmann E, Schwarze J, Takeda K, Oshiba A, Larsen GL, Irvin CG and Gelfand EW. 
Noninvasive measurement of airway responsiveness in allergic mice using barometric 
plethysmography. Am J Respir Crit Care Med 1997, 156:766-775. 
James AL, Hogg JC, Dunn LA and Pare PD. The use of the internal perimeter to compare 
airway size and to calculate smooth muscle shortening. Am Rev Respir Dis 1988, 138:136-
139. 
James AL, Pare PD and Hogg JC. The mechanisms of airway narrowing in asthma. Am Rev 
Respir Dis 1989, 139:242-246. 
James AL, Pare PD, Moreno RH and Hogg JC. Quantitative measurement of smooth muscle 
shortening in isolated pig trachea. J Appl Physiol 1987, 63:1360-1365. 
Johanson WG and Pierce AK. A noninvasive technique for measurement of airway 
conductance in small animals. J Appl Physiol 1971, 30:146-150. 
 List of Publications 69
 
 
 
 
 
 
 
LIST OF PUBLICATIONS 
  
 Prolonged Allergen Exposure in Sensitized Rats 71
 
 
 
 
 
CHAPTER I 
 
 
PROLONGED ALLERGEN EXPOSURE INDUCES STRUCTURAL 
AIRWAY CHANGES IN SENSITIZED RATS 
 
 
 
Els Palmans, Johan C. Kips and Romain A. Pauwels  
 
American Journal of Respiratory and Critical Care Medicine 2000, 161:627-635 
 
 
 
 Prolonged Allergen Exposure in Sensitized Rats 73
1. Abstract 
 
The pathogenesis and functional consequences of airway remodeling in asthma remain 
to be fully established. In the present study we evaluated the effect of prolonged allergen 
exposure on airway function and structure in rats. Sensitized Brown Norway rats were 
repeatedly exposed for periods of 2, 4 or 12 wk to aerosolized ovalbumin (OA) or 
phosphate-buffered saline (PBS). OA exposure induced a persistent increase in OA-specific 
serum IgE and in the number of peribronchial eosinophils. After 2 wk of OA exposure, 
airway histology revealed goblet-cell hyperplasia, an increase in bromodeoxyuridine-positive 
cells in airway epithelium, increased fibronectin deposition, and a thickening of the airway 
inner wall area. This coincided with airway hyperresponsiveness (AHR) to aerosolized 
carbachol. After OA exposure for 12 wk increased fibronectin (p<0.05 versus PBS) and 
collagen deposition (p<0.05 versus PBS) were observed in the submucosa. After 12 wk of 
exposure, neither total nor inner wall area or airway responsiveness to carbachol were any 
longer significantly different from those of PBS-exposed animals. In conclusion, prolonged 
OA exposure in rats induces structural airway changes that bear similarities to airway 
remodeling in asthma. The study further indicates that depending on the extent and 
distribution of the remodeling, changes in the extracellular matrix can enhance or protect 
against AHR. 
 
 
2. Introduction 
 
Airway morphology in asthma not only displays characteristics of an acute inflammatory 
process, but also structural changes. These include goblet-cell hyperplasia; changes in 
extracellular matrix (ECM) composition, with increased subepithelial deposition of collagens 
I, III, and V, fibronectin, and tenascin; and neovascularisation and smooth-muscle-cell 
hyperplasia and/or hypertrophy (Ebina et al, 1993; Jeffery et al, 1989; Laitinen et al, 1997; Li 
and Wilson, 1997; Roche et al, 1989; Takizawa, 1972). These structural changes are 
considered to play an important role in the pathophysiology of bronchial 
hyperresponsiveness, the functional hallmark of asthma (James et al, 1989; Lambert et al, 
1993; Macklem, 1996). The remodeling process that produces these changes is thought to 
result from the combination of chronic, repetitive injury to the airway wall, and the ensuing 
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tissue repair process. A variety of proinflammatory mediators, enzymes, cytokines, and 
growth factors have been implicated in the pathophysiology of airway remodeling (Cairns 
and Walls, 1996; Cohen et al, 1997; Cohen et al, 1995; Glassberg et al, 1994; Hirst, 1996; 
McKay et al, 1998; Panettieri et al, 1990; Stewart et al, 1995; Vignola et al, 1998); however, 
both the pathogenesis and the functional consequences of such remodeling must be further 
established. 
In vivo animal models might provide interesting information in this respect. We and 
others have previously shown that exposure to aerosolized allergen in Brown Norway (BN) 
rats results in eosinophilic airway inflammation, IgE production, and an increase in airway 
responsiveness (Bellofiore and Martin, 1988; Elwood et al, 1991; Haczku et al, 1994; Kips et 
al, 1992; Sapienza et al, 1991). However, in these models, airway remodeling was either not 
assessed or was revealed to be quite limited (Sapienza et al, 1991). The aim of the present 
study was to evaluate whether longer exposure of sensitized animals to inhaled allergen could 
result in more pronounced structural airway changes. 
 
 
3. Methods 
 
3.1. Animals 
Specific pathogen-free, male BN rats were obtained from Harlan CPB (Zeist, the 
Netherlands). They were housed in the animal research facilities of the Department of 
Respiratory Diseases of the University Hospital, Gent, for 1 to 3 wk before testing, and 
received food and water ad libidum. The rats were aged 2 to 5 months and weighed between 
250 and 350 g at the time of testing. 
 
3.2. Immunization procedures and exposure  
All animals were actively sensitized by the intraperitoneal injection of 1 mg of ovalbumin 
(OA) (Grade III; Sigma Chemical Co., Poole, UK) together with 200 µg Al(OH)3 in 0.5 ml 
0.9% NaCl on the first day of the study (Day 0). Different groups of rats (each group 
containing eight to 10 animals) were treated as follows: (1) Intraperitoneal injection of 1 mg 
OA and 200 µg Al(OH)3 in 0.5 ml 0.9% NaCl on Day 7, followed from Day 14 to 28 by 
thrice weekly exposure to aerosolized OA or PBS (2 wk). (2) Intraperitoneal injection of 1 mg 
OA and 200 µg Al(OH)3 in 0.5 ml 0.9% NaCl on Day 7, followed from Day 14 to 42 by 
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thrice weekly exposure to aerosolized OA or PBS (4 wk). (3) Thrice weekly exposure to 
aerosolized OA or PBS from Days 14 to 98 (12 wk).  
The aerosol was generated with an ultrasonic nebulizer (Sirius Nova; Carl Heyer GmbH, 
Bad Ems, Germany) and was drawn into an exposure chamber containing awake animals. 
The output of the nebulizer was 3 ml/min and the median particle size was 3.2 µm according 
to specifications by the manufacturer. The concentration of OA in the nebulizer was 1% 
(wt/vol), and the duration of exposure was 30 min. Control animals were exposed to 
aerosolized, sterile phosphate-buffered saline (PBS). 
 
3.3. Measurement of bronchial responsiveness 
At 24 h after the last exposure to OA or PBS, rats were anaesthetized by the 
intraperitoneal injection of 60 mg/kg pentobarbital (Sanofi, Libourne, France). The trachea 
was cannulated with a Teflon cannula (35 mm long and 1.67 mm internal diameter [I.D.]). The 
femoral artery was cannulated with a polyethylene catheter (1.77 mm I.D., 2.80 mm outer 
diameter; Intramedic; Clay Adams, Parsippany, NJ) to monitor blood pressure and heart rate 
with a pressure transducer (Celesco Transducer Products Inc., Canoga Park, CA) 
throughout the experiment. A polyethylene catheter was inserted in the external jugular vein for 
administration of intravenous drugs and fluids. 
Animals were placed on a heating pad (37°C), were connected with a Palmer animal 
respirator (BioScience, Sheerness, UK), and were ventilated with oxygen-enriched air at a rate 
of 75 strokes/min and a stroke volume of 2 to 2.5 ml. Animals were injected with 
pancuronium bromide (Organon Teknika B.V., Boxtel, the Netherlands), at 0.2 mg/kg body 
weight to interrupt spontaneous respiratory movements. The animals’ arterial blood gases 
were measured after 10 min of ventilation, and the stroke volume was adapted to keep pH, 
pO2 and pCO2 within the normal ranges. 
The animals’ transpulmonary pressure (Ppt) was measured with a differential pressure 
transducer (Celesco Transducer Products), of which one end was attached to an air-filled 
catheter inserted into the pleural cavity and the other end was attached to a catheter connected 
to a sideport of the outlet of the tracheal cannula. The airflow at the outlet of the intratracheal 
cannula was measured with a pneumotachograph (Type 00000; Fleisch, Geneva, 
Switzerland). The tidal volume (VT) was obtained by integration of the flow. Lung resistance 
(RL) was continuously calculated from VT, air flow, and Ppt (PRS800; Mumed, London, 
UK). 
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Carbachol (carbamoylcholine hydrochloride; Merck, Darmstadt, Germany) was 
nebulized with an ultrasonic nebulizer (Model 2511; Pulmo-Sonic, DeVilbiss Co., Somerset, 
PA). The mean particle size of the aerosol was 3.8 µm and the output was 1.0 ml/min. The 
aerosol was led into the inspiratory tube of the respiratory pump. Increasing concentrations of 
carbachol were administered over a period of 30 s at 5 min intervals, allowing RL to return to 
baseline between administrations of each concentration. Carbachol-induced 
bronchoconstriction was measured as the percent increase in RL, comparing the peak of the 
reaction with baseline RL.  
 
3.4. Bronchoalveolar lavage  
After determination of the bronchial responsiveness, lungs were lavaged via the tracheal 
cannula with six volumes of 6 ml each of Hank’s balanced salt solution (HBSS), free of 
ionized calc ium and magnesium and supplemented with 0.05 mM sodium EDTA. Lavage 
fluid was recovered by gentle manual aspiration with a syringe. The lavage fluid was 
centrifuged and the cell pellet was washed in HBSS and incubated for 7 min in 1 ml of NH4Cl 
to remove red blood cells. The cell pellet was then washed twice and resuspended in 1 ml 
HBSS. Total numbers of leukocytes in the bronchoalveolar lavage fluid (BALF) were 
determined with a Coulter counter (Coulter Electronics Ltd, Harpeneden, UK). A differential 
cell count was performed on cytocentrifuged preparations (Cytospin 2; Shandon Ltd, 
Runcorn, UK) stained with May-Grünwald-Giemsa, and was based on standard 
morphological criteria of at least 300 cells. 
 
3.5. Histological analysis of lung tissue 
After being lavaged, lungs were fixed with 4% paraformaldehyde via the trachea cannula. 
The lungs were removed and slices from different lobes were embedded in paraffin and cut in 
2 µm-thick sections. Histological changes were evaluated on sections stained with 
hematoxylin and eosin (H&E). Additionally, Congo Red and Sirius Red stains were 
performed for specific assessment of eosinophil number and collagen deposition 
respectively. 
 
3.6. Immunohistochemical staining for fibronectin  
The detection of fibronectin was done out as previo usly described (Casscells et al, 
1990) with a slight modification. Sections were deparaffinized, rehydrated, and incubated in 
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3% H2O2 in methanol for 10 min at room temperature to block endogenous peroxidase 
activity. The sections were then washed with 0.25% Brij 35 (Merck) in Tris -buffered saline 
(TBS) (0.15M NaCl, 0.01M Tris-HCl; pH 7.4), incubated in 0.4% pepsin (Sigma Chemical) 
in 0.01N HCl at 37°C for 15 min, and rinsed with TBS. Nonspecific binding sites were 
blocked with 1% blocking reagent (Boehringer Mannheim GmbH, Mannheim, Germany) in 
PBS for 30 min. Excess reagent was removed and the sections were incubated for 1 h with 
goat antirat fibronectin antibody (Calbiochem-Novabiochem GmbH, Bad Soden, Germany) 
at a dilution of 1:800 in TBS. After incubation with the primary antibody, the sections were 
rinsed with 0.25% Brij 35 in TBS (pH 7.4) and incubated for 30 min with biotinylated rabbit 
antigoat IgG (DAKO A/S, Glostrup, Denmark) diluted 1:200 in TBS (pH 7.4). The primary 
antibody-secondary antibody complex was detected by incubating the sections for 30 min 
with streptavidin -biotinylated horseradish peroxidase complex (Nycomed Amersham Plc. 
Buckinghamshire, UK) diluted 1:200 in TBS (pH 7.4). The chromogenic substrate for the 
peroxidase was 3,3’-diaminobenzidine (DAB) (DAKO), giving a brown reaction product. 
Sections were counterstained with hematoxylin and mounted in Paramount. Two control 
procedures were performed for fibronectin detection: (1) normal goat serum was substituted 
for the primary antibody; and (2) goat antirat fibronectin antibody (diluted 1:800) was 
adsorbed overnight at 4°C with 100 µg fibronectin, and the supernatant of the antibody-
fibronectin complex was substituted for the primary antibody. 
 
3.7. Cell proliferation in the airways 
To detect proliferating cells in lung tissue, animals were injected intraperitoneally twice 
weekly from Day 14 onward with bromodeoxyuridine (BrdU) (20 mg/kg) (Nycomed 
Amersham). BrdU is a thymidine analogue and is incorporated during the S phase of the cell 
cycle. BrdU was detected immunohistochemically in 2 µm sections that were deparaffinized 
and rehydrated. Endogenous peroxidase activity was blocked with 3% H2O2 in methanol for 
10 min, after which the sections were incubated at 37°C for 15 min in 0.1% trypsin (Sigma 
Chemical), rinsed in tap water, and incubated for a further 15 min at 37°C with 2M HCl. 
Nonspecific binding sites were blocked with 5% normal sheep serum (NSS) for 30 min. 
Excess reagent was removed and the sections were incubated for 2 h with mouse anti-BrdU 
antibody (Nycomed Amersham) diluted 1:75 in 1% NSS. After incubation with the primary 
antibody, the sections were rinsed with TBS (pH 7.5) and incubated for 30 min with 
biotinylated sheep antimouse IgG (Nycomed Amersham) diluted 1:200 in TBS (pH 7.5). The 
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primary antibody-secondary antib ody complex was detected by incubating the sections for 
30 min with streptavidin-biotinylated horseradish peroxidase complex (Nycomed Amersham) 
diluted 1:200 in TBS (pH 7.5). The sections were then incubated for 10 min with DAB, 
rinsed in tap water and counterstained with hematoxylin. As a negative control 1% NSS was 
substituted for the primary antibody. Sections of the duodenum were used as a positive 
control.  
 
3.8. Morphometric analysis of the airways 
H&E-stained tissue sections were examined light-microscopically, and morphometric 
measurements were made with a Zeiss Axiophot microscope (Zeiss, Oberkochen, Germany) 
at magnifications between x200 and x400. For each treatment group, four stained lung 
sections from six to 10 rats each were analyzed. The following morphometric parameters (as 
previously described by Bai et al 1994) were measured in all airways cut in reasonable cross- 
sections (defined by a ratio of minimal I.D. to maximal I.D. greater than 0.5): the length of the 
basement membrane of the epithelium (Pbm), the perimeter of the outer boundary of the 
smooth muscle (Pmo) and the outer adventitial perimeter (Po); the areas defined by these 
parameters (Abm, Amo and Ao) and the area of smooth muscle (WAm). The following 
parameters were calculated based on the measured values: the total bronchial wall area (WAt = 
Ao - Abm), the inner wall area (WAi = Amo - Abm) and the outer wall area (WAo = Ao - Amo). 
Furthermore, the number of epithelial cells, the number of BrdU-positive cells, and the 
number of goblet cells along the basement membrane were counted. The total number of 
eosinophils and the number of BrdU-stained smooth muscle cells in the bronchial wall were 
determined. 
Deposition of collagen and fibronectin was examined by light microscopy, and 
quantitative measurements of each were made with a computerized image analysis system 
(LEICA Q500MC; Leica Cambridge Ltd., Cambridge, UK). A camera sampled the image of 
the stained sections and generated an electronic signal proportional to the intensity of 
illumination, which was then digitized into picture elements or pixels. The digital representation 
of the airways was analyzed with Qwin software (Leica Cambridge). Each pixel in a color 
image was divided into three color components (hue, saturation, and intensity). The threshold 
for each color component for the red stain of collagen and the brown stain of fibronectin was 
defined and kept constant throughout the analysis. In different fields around an airway, the 
area covered by the stain was determined by the software, and its value was calculated. For 
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each experimental group, three lung sections from 10 rats each, stained for collagen, were 
examined. Fibronectin deposition was measured in three lung sections from five rats exposed 
to OA or PBS for 2 or 12 wk. The amount of protein deposited in the various components 
of the total airway wall was measured for all airways cut in reasonable cross-sections.  
 
3.9. Measurement of OA-specific IgE 
OA-specific IgE was measured with an enzyme-linked immunosorbent assay (ELISA). 
Blood was obtained by cardiac puncture at the end of the exposure period. Serum was 
added to OA (Grade V; Sigma Chemical) -coated microwell plates, and OA-specific IgE was 
detected with mouse antirat IgE antibody (H. Bazin; Experimental Immunology Unit, 
Brussels, Belgium) followed by horseradish peroxidase-conjugated goat antimouse 
immunoglobulins (DAKO). After addition of the substrate (o-phenylenediamine 
dihydrochloride; Sigma Chemical) plates were read in a plate reader (Titertek Multiskan MCC; 
Flow Laboratories, Irvine, Scotland) at 492 nm. The results are expressed in nanograms 
ovalbumin bound to IgE per milliliter of serum.     
 
3.10. Data analysis  
Reported values are expressed as mean ± SEM. For measurements of bronchial 
responsiveness, cumulative dose-response curves for the changes in RL with increasing doses 
of carbachol were constructed. The changes in RL were expressed as percent increases in RL. 
The concentration of carbachol causing a 50% increase in baseline RL (PC50RL) was 
calculated by log-linear interpolation of the dose-response curve. The cumulative dose-
response curves were compared through analysis of variance (ANOVA). PC50RL values, 
cellular composition of the BALF, OA-specific IgE, BrdU- positive cells and goblet cells in 
the epithelium, and peribronchial eosinophils for the different experimental groups were 
compared through the Kruskal-Wallis test for multiple comparisons. When significant 
differences were observed, pairwise comparisons were made, using a Mann-Whitney U-test 
with Bonferroni’s corrections. 
For analysis of the morphometric measurements and the measurements of collagen and 
fibronectin deposition, the data for the rats in a particular experimental group were pooled, 
and the values of WAt, WAi, WAo, area of collagen deposition (WC), and area of fibronectin 
deposition (WF) were normalized to Pbm. Thereafter, the airways were divided into three 
categories according to the length of their basement membrane, as previously described by 
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Sapienza (Sapienza et al, 1991)): Pbm £ 1 mm (small), Pbm > 1 mm and £ 2 mm (medium) 
and Pbm > 2 mm (large). To ensure that a similar range of airway sizes was being compared, 
we compared the frequency distribution of Pbm for the PBS and OA experimental group for 
each category of airways, using the Kolmogorov-Smirnov test. The mean values of WAt, 
WAi, WAo, WC, and WF normalized to Pbm for each category of airways were compared 
for the experimental groups through an unpaired t-test. Values of p<0.05 were regarded as 
significant. 
 
 
4. Results  
 
4.1. Airway responsiveness 
A 2-wk exposure to aerosolized OA induced an increase in  airway responsiveness to 
inhaled carbachol as compared with PBS-exposed animals. This was reflected by a 
significant leftward shift of the dose-response curve (ANOVA, p<0.05) (Figure 1) and a 
significant decrease in the PC50RL for carbachol (p<0.01) (Table 1). More prolonged 
exposure to OA resulted in a loss of airway hyperresponsiveness. After 4 wk of OA 
exposure, the PC50RL and dose-response curve for carbachol were no longer significantly 
different from those of control animals (Table 1). The PC50RL for rats exposed to OA for 12 
wk was significantly greater than that of control animals (Table 1), although the dose-response 
curve for these animals was not significantly different from that of control animals (Figure 1). 
The dose-response curves for carbachol of control animals exposed for 2, 4, or 12 wk to 
PBS were not significantly different from one another. A leftward shift of the dose-response 
curves for animals exposed to OA for 2 wk was observed as compared with the curves for 
animals exposed to OA for 4 and 12 wk (ANOVA, p<0.05). No significant difference was 
found in the dose-response curves for animals exposed to OA for 4 and 12 wk. 
 
 
TABLE 1 
EFFECT OF REPEATED OA EXPOSURE ON AIRWAY RESPONSIVENESS TO 
CARBACHOL AND ON OA-SPECIFIC IGE LEVELS IN THE SERUM* 
 PC50RL carbachol IgE serum 
 (mg/ml) (µg IgE/ml serum) 
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Treatment 2 wk 4 wk 12 wk 2 wk 4 wk 12 wk 
PBS 1.73±0.25 1.86±0.45 0.86±0.13 1.48±0.60 1.66±0.80 1.42±0.53 
OA 0.83±0.16‡ 2.75±0.89 ll 1.18±0.33† 9.24±1.70§ 15.87±1.4 § # 13.94±1.52
§ 
¶ 
*n = 10 for all groups  
† p < 0.05, ‡ p < 0.01 and § p < 0.001, versus PBS 
ll p < 0.05, ¶ p < 0.01, OA versus OA 2 weeks  
# p < 0.001 OA versus OA 4 weeks 
 
 
Figure 1. Bronchial responsiveness to aerosolized carbachol in sensitized BN rats exposed for (A) 2 wk, 
(B) 4 wk, and (C) 12 wk to OA (closed squares) and PBS (open squares) (n = 10 for each group) 
(ANOVA for OA versus PBS, 2 wk, p<0.05). 
 
 
4.2. OA-specific IgE 
Serum levels of OA-specific IgE were consistently increased in sensitized rats exposed to 
OA for 2, 4, and 12 wk as compared with those of control animals (Table 1). Peak levels of 
OA-specific IgE were reached after 4 wk of OA exposure (Table 1). 
 
4.3. BALF 
Total cell counts were significantly increased in BALF obtained from OA-exposed 
animals (Table 2). The to tal cell number increased at up to 4 wk and remained stable 
afterwards. OA-exposed groups also had significantly greater numbers of eosinophils and 
neutrophils in their BALF than did controls. The number of eosinophils was not significantly 
different at 2, 4, or 12 wk, whereas the number of neutrophils increased further at 4 and 12 wk 
(Table 2).  
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4.4. Histology 
Inflammatory cell infiltrates, including eosinophils, were observed in the peribronchial 
area of sensitized and OA-exposed BN rats (Figure 2). After 2 wk of OA exposure, the 
number of eosinophils around the airways was significantly increased compared to control 
animals (Table 3). The number of infiltrating eosinophils remained increased after 4 and 12 wk 
of OA exposure (Table 3). 
Light-microscopic analysis did not reveal epithelial desquamation in any of the BN rats. 
The ratio of goblet cells to epithelial cells was increased in all sensitized and antigen-exposed 
rats (Table 3). The maximal increase in goblet cells was observed after 2 wk of exposure. The 
number of BrdU-positive cells in the epithelium was measured in sensitized rats exposed to 
PBS or OA during 2 or 4 wk. An increase in proliferating epithelial cells was observed after 2 
wk (6.0±1.5 BrdU-positive cells/mm Pbm [mean±SEM] versus 1.9±0.6 BrdU-positive 
cells/mm Pbm  in PBS-exposed animals; p < 0.05) and 4 wk (11.1±0.9 BrdU-positive 
cells/mm Pbm versus 2.3±0.9 BrdU-positive cells/mm Pbm in PBS-exposed animals; p < 
0.001) of OA exposure. No BrdU-positive cells were found in the airway smooth muscle. 
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Figure 2. Airway sections of sensitized BN rats exposed to PBS (A) and OA (B) for 2 wk (Congo Red; 
original magnification x400). 
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TABLE 3 
NUMBER OF GOBLET CELLS IN EPITHELIUM AND NUMBER OF AIRWAY-
WALL EOSINOPHILS AFTER REPEATED OVALBUMIN EXPOSURE 
 Peribronchial eosinophils Goblet cells 
 (cells/mm2 total airway wall) (% goblet cells/epithelial cells) 
Treatment 2 wk 4 wk 12 wk 2 wk 4 wk 12 wk 
PBS 254±49 125±33 124±57 4.8±2.2 1.7±0.6 1.5±0.3  
OA 664±68‡ 728±84‡ 746±161‡ 11.3±1.4* 6.1±1.1† 9,6 ±1.1 ‡ 
* p < 0.05, † p < 0.01 and ‡ p < 0.001 versus PBS 
 
 
4.5. Morphometric measurements  
For the morphometric measurements, a mean of 54 airways (range: 45 to 68) per 
experimental group were analyzed. The average number of airways analyzed within each 
category (large, medium, and small) was 20 (range: 12 to 33). The total airway wall area of 
small, medium, and large airways was increased in sensitized rats exposed to OA for 2 wk, as 
compared with the areas in control animals (Figure 3). This increase disappeared upon 
prolonged exposure. Similarly, inner wall area of small and large airways increased 
significantly in rats exposed to OA for 2 wk, but not for 4 or 12 wk (Figure 3). As compared 
with that of control animals, the outer wall area was increased in small (p<0.001), medium 
(p<0.01), and large (p<0.05) airways after 2 wk of OA exposure, and in small (p<0.01), and 
medium (p<0.05) airways after 4 wk of OA exposure (data not shown). The area of the 
smooth-muscle layer around the airways did not change after OA exposure.  
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Figure 3. Effect of exposure to OA (solid bars) or PBS (open bars) for 2 wk (A and B), 4 wk (C and D), 
and 12 wk (E and F) on WAt (A, C, and E) and WAi (B, D, and F) in small, medium, and large airways. 
 
 
4.6. Fibronectin and collagen deposition 
Fibronectin deposition was analyzed in a mean of 59 airways (range: 53 to 63) per 
experimental group, and collagen deposition was analyzed in a mean of 43 airways (range: 39 
to 51) per experimental group. The average number of airways studied for fibronectin 
deposition in each category was 20 (range: 13 to 25), and the average number studied for 
collagen was 21 (range: 11 to 20). At 2 wk, increased fibronectin deposition was observed in 
large and medium airways of OA-exposed animals. This was further increased after 12 wk 
exposure (Figures 4 and 5). Fibronectin was deposited in the outer airway wall adjacent to the 
smooth-muscle layer (Figure 4). Large airways of rats exposed to OA for 12 wk also showed 
increased fibronectin deposition in the inner airway wall (p<0.01) (data not shown). The 
amount of collagen was increased in large airways of animals exposed to OA for 4 and 12 wk 
(Figure 6). After 4 wk, an increased amount of collagen was deposited in the outer airway wall 
(p<0.05) (data not shown); after 12 wk, an increase was observed in the inner (Figure 6) as 
well as in the outer airway wall (p<0.01) (data not shown).  
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Figure 4. Airway sections of sensitized BN rats exposed to PBS (A and C) and OA (B and D), stained 
for fibronectin after an exposure period of 2 wk (A and B) and 12 wk (C and D) (hematoxylin 
counterstain; original magnification x400). 
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Figure 5. Effect of exposure to OA (solid bars) or PBS (open bars) for 2 wk (A and B) and 12 wk (C 
and D) on the amount of fibronectin deposited in the total airway wall (WFt) (A and C) and in the outer 
airway wall (WFo) (B and D) of small, medium, and large sized airways. 
 
 
 
Figure 6. Effect of exposure to OA (solid bars) or PBS (open bars) for 2 wk (A and B), 4 wk (C and D), 
and 12 wk (E and F) on the amount of collagen deposition in the total airway wall (WCt) (A, C and E) and 
in the inner airway wall (WCi) (B, D and F) of small, medium, and large airways. 
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5. Discussion 
 
Airway remodeling encompasses the structural changes observed in asthmatic airways. 
The pathophysiology of remodeling and its effect on airway physiology remain to be fully 
established. In vivo animal models might provide useful information in this respect. However, 
most of the currently developed animal models of allergic airway inflammation have been 
restricted to acute inflammatory changes following relatively short periods of allergen 
exposure. In the present study we investigated the effect of more prolonged OA exposure on 
the airways of sensitized BN rats. In addition to producing an increase in OA-specific IgE and 
persistent eosinophilic airway inflammation, repeated exposure to aerosolized OA over a 
period of up to 12 wk also resulted in greater structural airway changes. These included 
goblet-cell hyperplasia, increased mitogenic activity in the epithelium, and changes in ECM 
components in the form of increased collagen and fibronectin deposition. The dynamics of 
these structural changes are clearly different, since goblet-cell hyperplasia and fibronectin 
deposition could be observed from 2 wk of exposure onward, whereas increased collagen 
deposition occurred only after more prolonged exposure. Other models have also shown 
goblet-cell hyperplasia after relative short exposure periods (Blyth et al, 1996; Temelkovski et 
al, 1998). However, to the best of our knowledge, ours is the first model to show increased 
mucosal collagen deposition following repeated allergen exposure, thus mimicking the 
subepithelial fibrosis from increased deposition of collagen I, III and V observed in human 
asthma (Laitinen et al, 1997; Roche et al, 1989). 
Airway remodeling is thought to have a profound effect on airway responsiveness. 
Different mathematical models describe the potential effect of structural changes on the 
function of asthmatic airways (James et al, 1989; Lambert et al, 1993; Macklem, 1996). 
Thickness of the inner airway wall, smooth-muscle mass, and adventitial structure are 
considered to be the main determinants in the airway response to a bronchoconstrictor 
stimulus (Moreno et al, 1986). Increased airway wall thickness has little effect on baseline 
resistance, but enhances the effect of a given smooth-muscle contraction, following 
Poiseuille’s law for laminar flow, thus contributing to increased airway sensitivity (Moreno et 
al, 1986). It has been shown in rats that changes in pulmonary resistance after methacholine 
inhalation are mainly due to changes at the large airway level (Sapienza et al, 1991). In our 
model an increase in inner wall area at the large airway level was observed only in rats exposed 
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to aerosolized OA for 2 wk. The observed leftward shift of the dose-response curve of RL for 
aerosolized carbachol could therefore result from this increase in inner airway wall thickness. 
Increased smooth-muscle mass around the airways could also contribute to bronchial 
hyperresponsiveness (Macklem, 1996). Our model showed no changes in the smooth muscle 
layer, either by morphometric analysis or BrdU incorporation at 2 and 4 wk. This factor is 
therefore unlikely to have contributed to the altered airway behavior in our model. This 
contrasts with previous findings in BN rats of an increase in smooth-muscle thickness and 
smooth-muscle proliferation following repeated allergen exposure (Panettieri, Jr. et al, 1998; 
Sapienza et al, 1991). These divergent observations can at least be partly explained by 
differences in the substrains of BN rats (BN/RyHsd versus BN/SSN Hsd) and in the 
sensitization and exposure protocols used in these studies and our own.  
Another element that could affect airway responsiveness are changes in the composition 
of the ECM in the airways. It has been calculated that subepithelial collagen deposition in 
asthmatic airways can influence the buckling pattern of the airway mucosa when the airway 
narrows (Wiggs et al, 1997). A smaller number of folds result in an enhanced increase in 
intraluminal pressure. In addition, changes in the ECM of the adventitial layer, in combination 
with fluid fluxes during smooth-muscle contraction, can reduce elastic recoil exerted on the 
airways by the lung parenchyma, thus contributing to AHR (Macklem, 1996). Conversely, 
increased collagen deposition could increase airway wall stiffness, thus opposing against 
narrowing of the airway wall (Lambert et al, 1994), and increased collagen deposition within 
and around the smooth-muscle layer can interfere with smooth-muscle contraction, thus again 
limiting airway narrowing (Bramley et al, 1995). In the present model, a small increase in 
fibronectin deposition around the smooth-muscle layer was observed after a 2-wk exposure 
period. At 12 wk this was far more pronounced. Increased deposition of collagen was 
observed after 4 wk, but especially after 12 wk exposure. This coincided with a gradual 
reduction in the airway wall thickness, whereas the AHR observed after 2 wk waned and 
turned into hyporesponsiveness at 12 wk.  
It has to be borne in mind that the ECM does not merely constitute a biologically 
inactive framework within tissues, but consists of a highly regulated network of proteins and 
proteoglycans that interact profoundly with inflammatory cells and other structural tissue 
components (Raghow, 1994). Among its many effects, fibronectin binds to a5b1 integrins 
on the surfaces of cells, thus not only influencing cell trafficking, but also affecting cell 
function and survival (Zhang et al, 1995). During tissue regeneration, fibronectin production 
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precedes collagen synthesis (Welch et al, 1990). The ongoing inflammation observed in the 
airways of rats after prolonged  OA exposure might induce a repair process in which the ECM 
is regenerated. Changes in the deposition of fibronectin starts after 2 wk, but the increase in 
collagen content of the airway wall is observed only after a longer exposure period. 
Fibronectin attaches collagen fibers to the elastin framework and to fibroblasts, mediating 
contraction of collagen by fibroblasts (LeviSchaffer et al, 1999). The more pronounced 
increase in fibronectin deposition around the airway smooth-muscle layer after 12 wk, in 
combination with increased collagen deposition in the outer airway wall, could therefore result 
in a tighter adhesion between lung parenchyma and the outer airway wall and prevent fluid 
fluxes into the adventitium during smooth-muscle contraction. The changes of collagen 
composition in the inner airway wall after 12 wk could also increase the stiffness of the airway 
wall (Lambert et al, 1994).  These observations suggest that increasing airway wall stiffness, 
reducing airway wall thickness, enhancing elastic recoil, and changes in the ECM both within 
and around the smooth-muscle layer might constitute an attempt to oppose against bronchial 
hyperresponsiveness. 
The present model also adds to previous rat models showing that the presence of 
eosinophils per se in the airway tissue is insufficient to cause AHR (Haczku et al, 1994; Kips 
et al, 1992). The influx of eosinophils in and around the airways persists with prolonged 
allergen exposure, as does IgE synthesis, yet the increase in airway responsiveness 
progressively declines. This illustrates that the loss of bronchial hyperresponsiveness is 
probably not due to immunological tolerance, but is related to the development of 
compensatory mechanisms, the loss of which could contribute to the persistent bronchial 
hyperresponsiveness observed in human asthma. 
In conclusion, we have described an in vivo rat model that displays characteristics of 
airway remodeling. We postulate that the increase in airway responsiveness is due to increased 
thickness of the inner airway wall of the large airways. Prolonged exposure results in scarring 
of the airway wall, with a reduction in airway wall thickness and a loss of AHR. These 
observations suggest that, depending on the extent and distribution of airway wall fibrosis, 
airway remodeling might oppose, rather than enhance AHR. 
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1. Abstract 
 
Increased or altered collagen deposition in the airway wall is one of the characteristics of 
airway remodeling in asthma. The mechanisms underlying this increase, and its functional 
consequences remain to be further established. Representative in vivo animal models might be 
useful in this respect. In the present study we characterized collagen deposition after 
prolonged allergen exposure in the airway wall of Brown Norway rats. Sensitized rats were 
repeatedly exposed to ovalbumin (OA) or phosphate-buffered saline (PBS) during 2 and 12 
weeks. The deposition of collagen type I, III, IV, V and VI was not altered in animals 
exposed to OA for 2 weeks. After 12 weeks of OA exposure, more collagen type I was 
deposited in the inner and outer airway wall (p < 0.01 versus PBS) and more type V and VI 
collagen were observed in the outer airway wall (p < 0.05 versus PBS). At 12 weeks the 
number of vessels, identified via type IV collagen staining was not increased, but the total 
vessel area was (p < 0.05 versus PBS). In conclusion, prolonged allergen exposure in 
sensitized rats is associated with enhanced deposition of type I, V and VI collagens and 
increased vascularity. 
 
 
2. Introduction 
 
Different extracellular matrix (ECM) proteins have been identified throughout the airway 
wall. The basement membrane (BM) underneath the airway epithelium consists of type IV 
collagen, proteoglycans, laminin, and fibronectin (Roche et al, 1989). Beneath this BM the 
ECM of normal airways is composed of collagens type I, III and V, elastins, proteoglycans, 
fibronectin and laminins. The major fibrillar components of the matrix, type I and III collagen 
and elastin, are the primary determinants of the mechanical properties of airways (Campa et al, 
1993).  
The asthmatic airway wall displays structural changes including sub-basement membrane 
thickening, altered submucosal ECM deposition and neovascularization (Bousquet et al, 
1996; Lee et al, 1999; Li and Wilson, 1997; Roche et al, 1989; Wilson and Li, 1997). The 
thic kened layer beneath the BM comprises predominantly types I, III, and V collagen together 
with fibronectin and tenascin (Laitinen et al, 1997; Roche et al, 1989). Moreover, increased 
deposition of collagen type III, V and VI has also been observed in the bronchial submucosa 
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in chronic asthmatics (Lee et al, 1999; Wilson and Li, 1997). Others have observed the 
presence of increased amounts of fragmented elastin fibers under the epithelium (Bousquet et 
al, 1996). Both the pathogenesis and the functional consequences of these ECM changes in 
asthmatic airways remain uncertain.  
An appropriate in vivo  animal model could provide useful information in this respect. 
We have previously described that prolonged allergen exposure induced structural changes in 
the airways of sensitized Brown Norway (BN) rats (Palmans et al, 2000). In these animals 
exposure to allergen for up to 3 months resulted in an increased amount of collagen and 
fibronectin in the large airways (Palmans et al, 2000). We now further characterized the 
increased collagen deposition by evaluating the amount of different collagen types in the 
airway wall of sensitized rats exposed to allergen for 14 days and 3 months. 
 
 
3. Methods 
 
3.1. Sensitization and exposure of animals  
Male BN rats (Harlan CPB; Zeist, the Netherlands) were sensitized and exposed to 
allergen as previously described (Palmans et al, 2000). In brief, all animals were sensitized by 
the intraperitoneal (ip) injection of 1 mg ovalbumin (OA) (Sigma Chemical Co., Poole, UK) 
and 200 µg Al(OH)3 on day 0. One group of animals (n=5) was boosted with 1 mg OA and 
200 µg Al(OH)3 ip on day 7 and exposed from day 14 to day 28 to aerosolized 1% OA 
thrice weekly (2 weeks). A second group of animals (n=5) was similarly exposed to 
aerosolized 1% OA from days 14 to 98 (12 weeks). Control animals (n=5 per group) were 
exposed to sterile phosphate-buffered saline (PBS). 
 
3.2. Lung histology 
Twenty-four hours after the last aerosol exposure rats were anaesthetized (60 mg/kg 
pentobarbital [Sanofi, Libourne, France], ip) and the trachea was cannulated. Following 
lavage, lungs were fixed with 4% paraformaldehyde via the tracheal canulla. Lung sections 
were processed for immunohistochemistry and for Congo Red staining. The total number of 
peribronchial eosinophils was determined on Congo Red stained sections (Palmans et al, 
2000). 
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3.3. Immunohistochemical staining of type I, III, IV, V and VI collagen 
Type I collagen was stained with a polyclonal goat anti-type I collagen in lung tissue 
embedded in Technovit 8100 (Heraeus Kulzer GmbH, Wehrheim, Germany) according to 
the manufacturers instructions. The other collagen types were detected in paraffin embedded 
tissue. Sections of 2 µm were pre-treated with H2O2 to block endogenous peroxidase activity 
and 0.1% trypsin (Sigma Chemical) in 0.1% CaCl2 (pH 7.8) at 37°C. The sections were 
rinsed in distilled water and subsequently incubated with normal rabbit serum (NRS) for 1h 
and with the primary polyclonal antibody (Southern Biotechnology Associates Inc., 
Birmingham, AL) diluted in 1% NRS as follows: goat anti-type I collagen (1:20), goat anti-
type III collagen (1:100), goat anti-type IV collagen (1:50), goat anti-type V collagen (1:50) 
and goat anti-type VI collagen (1:300). The sections were washed and incubated with 
biotinylated rabbit anti-goat IgG (DAKO A/S, Glostrup, Denmark) diluted 1:200. The 
primary antibody-secondary antibody complex was detected with the streptavidin-
biotinylated horseradish peroxidase complex (Nycomed Amersham Plc., Buckinghamshire, 
UK) diluted 1:200. Peroxidase activity was developed in diaminobenzidine (DAB) (DAKO) 
giving a brown reaction product. Sections were counterstained with hematoxylin. Rat skin 
was used as a positive control for the different collagen types. The primary antibody was 
substituted with normal goat serum as a negative control.  
 
3.4. Quantification of collagen deposition 
The deposition of the different types of collagen was examined by light microscopy and 
quantitative measurements were performed using a computerized image analysis system (Leica 
Q500MC; Leica Cambridge Ltd., Cambridge, UK) as previously described (Palmans et al, 
2000). For each experimental group three lung sections per animal were examined. The 
amount of the specific collagen deposited in the different compartments of the airway wall 
was measured in all large airways (length of BM [Pbm] greater than 2 mm) cut in reasonable 
cross sections (defined by a ratio of minimal to maximal internal diameter greater than 0.5). 
The different compartments of the airway wall are the total wall defined by the BM and the 
outer adventitia; the inner wall defined by the BM and the outer boundary of the smooth 
muscle; and the outer wall defined by the outer boundary of the smooth muscle and the outer 
adventitia. The borders of these compartments were marked manually and the software 
analyzed the amount of specific collagen deposited in these regions. 
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3.5. Measurement of vessel area 
Vessels were identified by the staining of their BM with type IV collagen. With the image 
analysis system (Leica Q500MC) the vessel area in the airway wall of large airways was 
measured on the sections used for type IV collagen quantification. The vessel area is defined 
by all the structures internal to the vessel BM and was calculated by the software Qwin. The 
total amount of vessels in the total airway wall was counted. 
 
3.6. Data analysis  
Reported values are expressed as mean ± standard error of the mean (SEM). The data of 
collagen deposition, vessel area and vessel number of all sections in one experimental group 
were pooled. Each quantification was performed in a mean of 16 large airways (range 12 to 
25) per experimental group. Values of the area of collagen deposition in total, inner and outer 
airway wall (WCt, WCi and WCo respectively) were normalized to Pbm. The vessel area was 
normalized to the total wall area (WAt) and the number of vessels was divided by WAt to 
obtain the amount of vessels per square mm. The frequency distribution of Pbm  for the PBS 
and OA experimental group was compared using the Kolmogorov-Smirnov test to ensure the 
comparison of a similar range of airway sizes. Mean values of WCt, WCi and WCo, the vessel 
area and the amount of vessels per square mm were compared between the OA- and PBS-
exposed animals in one experiment by an unpaired t-test. Spearman’s rank correlation 
coefficient was used to examine the correlation between the amount of collagen deposited in 
the airway wall and the number of peribronchial eosinophils. P-values less than 0.05 were 
regarded as significant.  
 
 Collagen Deposition in Rat Airway Wall 105
4. Results  
 
4.1. Distribution of different collagen types 
Type I collagen was clearly present in the total airway wall and formed bundles parallel 
with the airway epithelium (figure 1A and B). Type III and type VI collagen were ubiquitous 
in the airway mucosa and adventitia and their deposition pattern was similar (figure 1C, G and 
H). Type V collagen was predominantly deposited in the outer airway wall close to the airway 
smooth muscle cells and the blood vessels (figure 1F). Type IV collagen was found in the 
basement membrane beneath the epithelium and surrounding blood vessels, and within 
smooth muscle bundles (figure 1E).  
The distribution pattern of the different types of collagen was similar in control animals 
and allergen exposed animals independent of the duration of the exposure (figure 1).  
 
4.2. Quantification of type I, III, V and VI collagen deposition 
The amount of the collagen subtypes deposited in the total, inner and outer airway wall 
of large airways did not differ between sensitized BN rats exposed to PBS or OA during 2 
weeks (data not shown). 
Quantitative changes in collagen types were observed in rats exposed to allergen during 
12 weeks. Type I and type VI collagen were increased in the total airway wall (p<0.001 versus 
PBS-exposed animals) (figure 2A and C). The increase in type I collagen was observed in the 
inner (p<0.01) as well as in the outer airway wall (p<0.001) (figure 2A) and the increase in 
type VI collagen was found mainly in the outer airway wall (p<0.001) (figure 2C). Although 
the amount of type V collagen in the total airway wall of OA- and PBS-exposed rats did not 
differ, more type V collagen was deposited in the outer airway wall of allergen exposed 
animals (p<0.05 versus PBS) (figure 2B). No difference was observed in the deposition of 
type III collagen between OA- and PBS-exposed rats (12.56±1.24 µm2/µm BM versus 
13.93±2.33). 
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Figure 1. Photomicrographs of type-specific collagen staining in large airways of BN rats exposed 
during 12 weeks (counterstain hematoxilyn, magnification x400). Type I collagen in airways of rats 
exposed to OA (A) or PBS (B). Type III collagen (C), type IV collagen (E) and type V collagen (F) in 
OA-exposed rats. Type VI collagen in animals exposed to OA (G) or PBS (H). A representative negative 
control for the collagen staining (D). 
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Figure 2. Deposition of (A) type I, (B) V and (C) VI collagen in the total, inner and outer airway wall of 
sensitized rats exposed to ovalbumin (solid bars) or PBS (open bars) during 12 weeks. 
 
 
The amount of type I collagen present in the airway wall correlated with the number of 
peribronchial eosinophils in rats exposed during 12 weeks (rs = 0.72, p<0.05) (figure 3). 
Deposition of type VI collagen was also related to the number of eosinophils in the airway 
wall (rs = 0.86, p<0.01) (data not shown).  The amount of type V collagen in the airway wall 
did not correlate with the number of eosinophils.  
 
 
 
Figure 3. Correlation between the 
amount of type I collagen deposited 
in the airway wall and the number of 
peribronchial eosinophils in BN rats 
exposed during 12 weeks. Open 
circles represents data from rats 
exposed to PBS; closed circles 
represent data from OA-exposed 
animals. 
 
 
 
 
4.3. Basement membrane type IV collagen 
No differences were observed in the amount of type IV collagen deposited in the airway 
wall of rats exposed to OA during 2 and 12 weeks (1.51±0.21 µm2/µm BM versus 1.33±0.4 
in PBS-exposed animals). Also no difference was seen in the amount of vessels per area of 
the bronchial wall. After 2 weeks the airways of OA-exposed animals contained 265 ± 27 
vessels per mm2 compared to 332 ± 20 vessels per mm2 in PBS exposed rats. After 12 weeks 
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318 ± 13 vessels per mm2 were counted in the OA group compared to 288 ± 31 vessels per 
mm2 in the PBS group. The vessel area normalized to WAt was increased in animals exposed 
to OA during 12 weeks (figure 4) compared to PBS-exposed animals (p<0.05).  
 
 
 
Figure 4. The effect of ovalbumin 
(solid bars) or PBS (open bars) 
exposure during 2 weeks and 12 
weeks on the vascularity in large 
airways. 
 
 
 
 
 
 
5. Discussion 
 
The purpose of this study was to characterize changes in collagen deposition in the large 
airway walls of sensitized BN rats repeatedly exposed to allergen (Palmans et al, 2000). The 
results indicate that these airways contained increased amounts of collagen types I, V and VI 
after 12 weeks of allergen exposure. An increase of all three collagen types was observed in 
the outer airway wall; collagen type I was also deposited in the inner wall. No differences were 
observed in the deposition of type III and type IV collagen. Vascular perfusion was increased 
after 12 weeks of OA exposure.  
Two aspects of changes in the collagen composition in the airway wall that have been 
linked to chronic asthma are the thickened lamina reticularis and increased deposition of 
collagen in the submucosa (Lee et al, 1999; Wilson and Li, 1997). The information obtained 
from endobronchial biopsy studies relates mainly to the composition of the area beneath the 
basal lamina. In the asthmatic airway the reticular layer represents an area of irregularly 
distributed fibrosis. This collagenous matrix band beneath the BM contains increased 
amounts of the fibrillar collagens type I, III and V but also of fibronectin and tenascin 
(Laitinen et al, 1997; Roche et al, 1989; Wilson and Li, 1997). In the present model the 
increase in type I collagen in this area is most prominent. Although the thickness of the lamina 
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reticularis is increased in bronchial biopsies from asthmatic when compared to normal 
subjects (Jeffery et al, 1989; Roche et al, 1989) the significance of this subepithelial fibrosis 
remains unclear. In some studies no relation was found between the thickening and the 
severity, duration or etiology of asthma (Chu et al, 1998; Jeffery et al, 1989; Milanese et al, 
2001). Others confirmed thickening of the matrix band beneath the BM in atopic, but not in 
non-atopic asthma (Amin et al, 2000), and reported a correlation with the severity but not with 
the duration of asthma (Boulet et al, 1997; Chetta et al, 1997). 
Far less data are available on the distribution of collagen in the submucosa and the 
adventitial area. Wilson and colleagues (Wilson and Li, 1997) observed increased amounts of 
type III and type V collagen in the submucosa of asthmatic airways and Lee and colleagues 
(Lee et al, 1999) found an increase in type VI collagen in the submucosa of asthmatics. These 
findings have not been invariably confirmed, as others did not observe increased amounts of 
total collagen nor increased deposition of type I and III collagen in asthmatic subjects (Chu et 
al, 1998). In the present study repeated allergen challenge was shown to induce increased 
deposition of collagen I, V and VI in the outer airway wall. This area corresponds to the 
adventitial tissue between the cartilage and/or the smooth muscle layer. In normal airways, the 
adventitia consists mainly of fibrous tis sue and blood vessels but to the best of our 
knowledge data on collagen deposition in the adventitia of the asthmatic airways are not 
available. It is therefore unclear whether subepithelial fibrosis serves as a marker of changes 
such as ECM protein deposition throughout the submucosa and the adventitia, as has been 
suggested (Bradding et al, 1997). Therefore we cannot ascertain that the changes observed in 
this study are consistent with those in human asthma. 
Data on vascular changes within the airway wall of asthmatics are also sparse. Recent 
reports illustrate an increase of vessels and vascularity in the airway wall of asthmatics (Kuhn 
et al, 1989; Orsida et al, 2001; Skalli et al, 1986). In patients with fatal asthma the number of 
large blood vessels was increased compared to control subjects in large but not in smaller 
airways (Carroll et al, 1997). Similarly, the total area occupied by the blood vessels in the 
airway submucosa was not different between asthmatics and control subjects (Carroll et al, 
1997). In the present model, blood vessels were identified by immunostaining for collagen 
type IV which is the major collagen subtype present in the vascular BM. Using this approach, 
we could not identify an increase in the total amount of vessels per square mm. However, in 
line with the data by Li and Wilson an increase in the total area of the mucosa occupied by 
blood vessels was found. 
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The mechanisms underlying the allergen induced increased collagen deposition in this 
model remain to be further elucidated. Collagen formation is part of tissue repair response to 
injury, in an attempt at tissue regeneration. When this repair process is dysregulated and 
prolonged, it may result in progressive fibrosis with its specific changes (Busse et al, 1999). 
Different types of collagen seem to be produced at various stages in the regeneration process. 
The production of ECM in airways of rats repeatedly exposed to allergen resembles the 
process of tissue regeneration in which fibronectin precedes collagen deposition forming a 
provisional ECM (Welch et al, 1990). Previously we have shown that changes in the 
fibronectin deposition start after 2 weeks, but the increase in collagen content and 
composition of the airway wall is observed only after a longer exposure period (Palmans et al, 
2000). Moreover collagen type I and V are usually considered to reflect fully established 
fibrotic lesions, occurring at a later stage during the regeneration process (Martin et al, 1985; 
McAnulty and Laurent, 1995). The main sources of collagen probably are fibroblasts and/or 
myofibroblasts responding to a wide range of stimuli including various growth factors such 
as transforming growth factor-b , insulin like growth factor or platelet derived growth factor 
(Hoshino et al, 1998; Zhang et al, 1999). These factors can in turn be released from different 
cell types, epithelial cells and eosinophils in particular (Ohno et al, 1995; Vignola et al, 1997; 
Zhang et al, 1999). Of note is the positive correlation between the amount of collagen type I 
and VI and the number of eosinophils in the airway wall of BN rats exposed during 12 weeks 
found in the present study. Whether the eosinophils express these growth factors is yet 
unknown.  
The increased and altered collagen deposition in the airway wall, observed in the current 
study could have important functional consequences. Mathematical models link airway 
remodeling to airway hyperresponsiveness (AHR) (James et al, 1989). Changes in the 
composition of the airway connective tissue can influence smooth muscle shortening 
(McFawn and Mitchell, 1997) and depending on the extent and location of the altered ECM 
deposition these might protect against instead of enhancing airway responsiveness to 
bronchoconstrictor stimuli (Lambert et al, 1994; Milanese et al, 2001; Seow et al, 2000). In 
the initial study we observed that the loss of AHR in rats exposed to OA during 12 weeks 
was associated with an increase in total collagen in the total airway wall and fibronectin in the 
outer airway wall (Palmans et al, 2000). We suggested that tighter adhesion between lung 
parenchyma and the outer airway wall could influence the mechanical properties of the 
airways (Palmans et al, 2000). Type VI collagen microfibrils are known to form fibrillar 
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connections between other ECM components (Davidson, 1990). These fibers might thus 
function as a mechanical link between interstitial collagen fibrils and other matrix structures 
including basement membranes and elastin microfibrils (Keene et al, 1988). Type I collagen 
forms a relatively rigid  linear fibrillar network and could also increase the stiffness of the airway 
wall (Raghow, 1994). The increase of both collagen type I and VI in the OA-exposed rats 
might therefore increase rigidity of the airway wall and thus oppose against instead of induce 
AHR.  
These observations stress the importance of including all structural changes that occur 
throughout the airway wall, when evaluating the functional role of remodeling. To date, in 
man, this analysis has been limited to subepithelial collagen deposition, relating the extent of 
collagen type I and III deposition to an increase as opposed to a decrease in airway 
responsiveness. The causal relationship between both however is not known. The present 
model cautions against relating one single aspect of the structural alterations to airway 
function, without taking into account the potential contribution of co-existing alterations. 
In conclusion, the increased collagen type I, V and VI deposition in the airway wall of 
sensitized rats exposed to allergen during 12 weeks might result from repeatedly induced 
tissue repair processes in response to the persistent presence of inflammatory cells. The 
different collagens may increase the rigidity and stiffness of the airway wall and thus prevent 
AHR.  
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1. Abstract 
 
Remodeling of the extracellular matrix (ECM) in the airway wall is one of the 
characteristics of asthma. Although it is suggested that alterations of the ECM proteins result 
from the chronic inflammation present in the asthmatic airway wall, mechanical stress 
associated with bronchoconstriction might also stimulate and amplify deposition of ECM 
proteins in airway wall. The aim of the present study was therefore to examine whether the 
structure of the airway wall of rats is altered after repeated induction of bronchoconstriction. 
Brown Norway rats were injected daily with carbachol during two weeks. The carbachol 
administrations resulted in constricted airways as shown by the increase of lung resistance. 
Control animals received phosphate-buffered saline. After the treatment period, no 
inflammation was present in the airways of carbachol-treated rats. Also, the composition of 
the ECM proteins in the mucosa and adventitia or the airway wall dimensions did not change 
after exaggerated smooth muscle constriction. Airway function was similar in carbachol-
treated and control animals. We concluded that bronchoconstriction in se did not alter the 
airway structure in rats.  
 
 
2. Introduction 
 
The airways of chronic asthmatic patients display structural changes including a 
thickened layer beneath the basement membrane that comprises predominantly collagen type 
I, III and VI together with fibronectin and tenascin (Laitinen et al, 1997; Roche et al, 1989) 
and increased deposition of collagen type III, V and VI in the bronchial submucosa (Lee et 
al, 1999; Wilson and Li, 1997). Other characteristics of this so-called airway remodeling in 
asthma are mucus cell hyperplasia, smooth muscle hypertrophy or hyperplasia and 
neovascularization (Ebina et al, 1993; Jeffery et al, 1989; Li and Wilson, 1997). Airway 
remodeling may contribute to airway hyperresponsiveness, the functional hallmark of 
asthmatics (James et al, 1989).   
It is generally thought that the increased amount of extracellular matrix proteins is 
produced by myofibroblast in response to inflammation in the airway wall (Brewster et al, 
1990; Zhang et al,  1999). However, an alternative hypothesis for the pathogenesis of the 
altered deposition of ECM proteins and other structural airway changes has been proposed. It 
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is believed that the remodeling of the ECM and possibly also of other airway structures is not 
only controlled by cellular responses but also by mechanical stress in the airway wall 
(Chiquet, 1999). During bronchoconstriction the airway wall is subjected to abnormal 
physical forces that might deform the shape of structural cells (Wirtz and Dobbs, 2000). In 
vitro studies that mimic facets of the fibrotic response in asthmatic airways have shown that 
shape deformations can stimulate cells to modify their phenotype and alter their production of 
ECM proteins (Ressler et al, 2000; Swartz et al, 2001; Xu et al, 1999). 
In a rat model that we developed to investigate the pathogenesis and functional 
consequences of remodeling in asthmatic airways, allergen sensitization and exposure during 
3 months resulted in increased deposition of collagen and fibronectin in the walls of large 
airways (Palmans et al, 2000). We suggested that the altered production of ECM proteins was 
caused by the ongoing inflammation present in the airways of the rats (Palmans et al, 2000). 
Since mechanical stress that is imposed on the structural cells of the airway wall during 
bronchoconstriction might itself induce the deposition of ECM proteins we evaluated the 
structure of the airway wall in BN rats after repeated smooth muscle contractions induced by 
treatment with carbachol.  
 
 
3. Methods 
 
3.1. Animals and study protocol 
In specific pathogen-free, male BN rats (Harlan CPB, Zeist, the Netherlands) (n=10) 
bronchoconstriction was induced once daily during 14 days by intraperitoneal (i.p.) injection 
of carbachol (carbamylcholinehydrochloride; Merck, Darmstadt, Germany) (1 mg/kg body 
weight) (CARBACHOL). This dose was shown to increase baseline lung resistance (RL) with 
380%. Control animals (n=9) were injected i.p. with phosphate-buffered saline (PBS) 
(CONTROL).  
 
3.2. Outcome measures  
On day 15, 24 hours after receiving carbachol or PBS, the rats were anaesthetized [60 
mg/kg pentobarbital (Sanofi, Libourne, France), i.p.]. Airway responsiveness to increasing 
concentrations (0.1 – 10 mg/ml) of aerosolized carbachol was assessed as previously 
described (Palmans et al, 2000). Dose-response curves for the change in lung resistance (RL), 
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expressed as the change from baseline, were constructed. The concentration of carbachol 
causing a 100% increase in baseline RL (PC100RL) was calculated via log-linear interpolation of 
the dose-response curve.  
Immediately after measuring airway responsiveness, bronchoalveolar lavage was 
performed (Palmans et al, 2000). 
 
3.3. Histology 
Histological analysis was performed on 4% paraformaldehyde fixed lung tissue. 
Histological and inflammatory changes were evaluated on sections stained with hematoxylin-
eosin (H&E) and Congo Red. Morphometric measurements were performed using a Zeiss 
Axiophot microscope (Zeiss, Oberkochen, Germany) on 23 (CARBACHOL) to 24 
(CONTROL) large airways. Total bronchial wall area (WAt), inner wall area (WAi) and outer 
wall area (WAo) were normalized to the length of basement membrane (Pbm) (Palmans et al, 
2000). 
Collagen deposition in the airway wall was assessed on lung sections stained with Sirius-
Red. Quantitative measurements were performed using a computerized image analysis system 
(LEICA Q500MC; Leica Cambridge Ltd., Cambridge, UK) on 20 (CONTROL) to 21 
(CARBACHOL) large airways. The area of the total, inner and outer airway wall stained for 
collagen (WCt, WCi and WCo respectively) is expressed per µm basement membrane 
(Palmans et al, 2000).  
 
3.4. Data analysis  
Reported values are expressed as mean ± standard error of the mean (SEM). The 
cumulative dose-response curves were compared through analysis of variance (ANOVA). 
PC100RL values and cellular composition of BAL fluid of the CARBACHOL and 
CONTROL group were compared using a Mann-Whitney U-test. 
For the analysis of the morphometry and collagen deposition, the data of the different 
rats in each group were pooled together. The mean values of WAt, WAi, WAo, WCt, WCi and  
WCo were analyzed between the experimental groups by an unpaired t-test. P-values less than 
0.05 were regarded as significant. 
 
4. Results  
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Repeated i.p. injections with carbachol did not alter airway responsiveness to aerosolized 
carbachol of the BN rats. The dose-response curve of these animals was not significantly 
different with those of the control animals (Figure 1). Also, no change was observed in 
PC100RL for carbachol (2.16 ± 0.45 mg/ml carbachol versus 1.90 ± 0.24 mg/ml carbachol in 
PBS treated animals). 
 
 
Figure 1. Bronchial responsiveness to 
aerosolized carbachol of BN rats after 
repeated i.p. injections of carbachol 
(CARBACHOL, closed squares) or PBS 
(CONTROL, open squares).  
 
 
 
 
 
 
In the airways of the BN rats no inflammatory abnormalities were observed after repeated 
carbachol injections. The total amount of cells in BAL fluid was similar in carbachol- and 
PBS-treated animals. The distribution of macrophages, eosinophils, lymphocytes and 
neutrophils in BAL fluid was not altered after carbachol-induced bronchoconstriction (Table 
1). No peribronchial inflammatory infiltrate was observed in both experimental groups (data 
not shown).  
 
 
TABLE 1 
TOTAL NUMBER AND DISTRIBUTION OF WHITE BLOOD CELLS IN BRONCHO-
ALVEOLAR LAVAGE FLUID AFTER REPEATED BRONCHOCONSTRICTION 
 Total Cells Monocytes Eosinophils Neutrophils Lymphocytes 
Treatment (x 103) (%) (%) (%) (%) 
CONTROL 370.8±77.1  94.70±0.68 0.91±0.22 1.58±0.32 2.80±0.62 
CARBACHOL 303.1±32.4  96.56±0.62 0.33±0.13 0.96±0.15 2.14±0.58 
Histological evaluation of the lung tissue of carbachol and control rats did not reveal 
structural changes within the airway wall. The epithelial layer had a normal appearance with no 
signs of desquamation. The size of the different compartments in the airway wall was not 
0.01 0.1 1 10 100
0
100
200
300
400
concentration carbachol (mg/ml)
%
 in
cr
ea
se
 in
 R
L
 Airway Structure after Repeated Bronchoconstriction 121
affected by carbachol treatment. Total airway wall area of the carbachol-treated group did not 
change compared to control animals. Also inner and outer airway wall areas were similar in 
rats treated with carbachol and control animals (figure 2A). Deposition of collagen in the 
airway wall was not altered in rats injected with carbachol. Similar amounts of collagen were 
present in inner and outer airway wall of carbachol- and PBS-injected BN rats (figure 2B).  
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Figure 2. Effect of repeated carbachol injections (solid bars) or PBS injections (open bars) on (A) the 
total, inner and outer airway wall area and (B) on the deposition of collagen in the total, inner or outer 
airway wall of large-sized airways. 
 
 
 
5. Discussion 
 
The main purpose of this study was to evaluate if repeated airway smooth muscle 
contractions in se could induce the development of structural changes in the airway wall. 
Exaggerated bronchoconstriction was repeatedly induced in BN rats via i.p. injections of 
carbachol. Neither inflammatory nor structural alterations were observed in the airway wall of 
these animals compared to control rats. Airway responsiveness to nebulized carbachol did 
not change.  
The administration of carbachol clearly increased RL as a result of the airway constriction 
in the rats. Previously it was shown that the mucosa as well as the adventitia deformed during 
bronchoconstriction induced by carbachol (James et al, 1988; Sasaki et al, 1996). The 
present study in the BN rats thus gave us a tool to evaluate in vivo  structural airway changes 
that might have originated from repeated bronchoconstriction.  
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Airway smooth muscle shortening changes the architecture of the airway wall and results 
in increased physical forces on the different wall compartments (Mitchell, 1997). In the lung, 
physical forces can influence its structure, function and metabolism (Riley et al, 1990). 
Asthma is characterized by exaggerated narrowing in response to a bronchoconstrictor agent 
defined as bronchial hyperresponsiveness (James et al, 1989). The mechanical stress on the 
tissue and cells of the asthmatic airway is therefore elevated compared to normal subjects 
(Wiggs et al, 1997). Although it is known that in response to mechanical stress cells can 
increase their production of ECM proteins, we did not observe higher amounts of collagen in 
repeatedly constricted airway walls. Most information on the influence of mechanical stress 
on cellular ECM turnover however is derived from in vitro models (Kolpakov et al, 1995; 
Swartz et al, 2001; Xu et al, 1999). These experiments describe the increased production of 
several ECM proteins in cell cultures containing airway epithelial cells and fibroblasts (Xu et al, 
1999) or pulmonary vascular smooth muscle cells (Kolpakov et al, 1995) in response to 
physical forces such as elongation or stretch. Airway epithelial cells subjected to 
transmembrane pressure released growth factors associated with remodeling in asthma 
(Ressler et al, 2000) and fibroblast co-cultured with these epithelial cells increased their 
production of fibronectin and collagen types III and V (Swartz et al, 2001). The mechanical 
stress sensed by cells in vitro and in vivo  might however be different. How mechanical forces 
can be sensed by cells and converted into biochemical signals is not known, but it has been 
suggested that stress signals can be transmitted from ECM to cells via an ECM-integrin-
cytoskeleton complex (Ingber, 1997). Organ structures are complex with a variety of cell 
types and a variety of forces exposed to these cells. The complexity of the interactions 
cannot be fully mimicked  in cell cultures and this might explain the difference between our in 
vivo study and results obtained via in vitro models. 
Our experiments show that mechanical stress alone in the absence of inflammation is 
insufficient to induce structural airway changes. This contrasts with in vitro data in which 
remodeling responses are induced in mechanically stressed cells without the presence of other 
inflammatory cells (Swartz et al, 2001). Previously we showed that BN rats could develop 
alterations in epithelium and ECM proteins of the airway wall in response to sensitization and 
repeated allergen exposure. The structural alterations appeared after 2 weeks of exposure and 
were associated with peribronchial inflammation and airway hyperresponsiveness (Palmans et 
al, 2000). Moreover, the remodeling in the airway wall was prevented by anti-inflammatory 
treatment (Vanacker et al, 2001). Since allergen-induced structural changes were induced after 
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2 weeks, the period of challenge with carbachol was judged to be sufficient to evaluate the 
effect of repeated bronchoconstriction on ECM protein production.  
In conclusion, we showed that in BN rats repeated bronchoconstriction over 2 weeks 
did not alter the structure of the airway wall.  
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1. Abstract 
 
The mechanisms responsible for the development of airway remodeling in asthma are not 
well understood. In the present study we evaluated to what extent differences in immune and 
inflammatory responses can influence the remodeling process in airways. We therefore 
compared structural airway changes after prolonged allergen exposure in two genetically 
distinct mouse strains. BALB/c and C57BL/6 mice were sensitized and exposed to 
ovalbumin (OA) and phosphate-buffered saline (PBS) for 2 to 9 weeks. After 2 weeks of OA 
exposure, the allergic response was more pronounced in BALB/c and the number of BALF 
eosinophils was higher in C57BL/6 mice. The number of peribronchial eosinophils and 
goblet cells were equally increased in both BALB/c and C57BL/6 mice. BALB/c, but not 
C57BL/6 showed an increase in airway wall thickness and airway hyperresponsiveness 
(AHR) to methacholine (p<0.005 versus PBS). Upon further allergen exposure, peribronchial 
eosinophilia disappeared in both mice strains and AHR was abolished in BALB/c. The 
number of goblet cells remained elevated and collagen deposition in the airway wall was 
increased (p<0.005 versus PBS) in OA-exposed BALB/c and C57BL/6. Also airway wall 
thickness remained increased in both mouse strains after longer OA exposure. In conclusion, 
these data indicate that despite different inflammatory responses to prolonged allergen 
exposure, BALB/c as well as C57BL/6 mice displayed comparable structural airway changes. 
 
 
2. Introduction 
 
Asthmatic airways display, in addition to signs of an acute inflammatory process, more 
structural alterations coined airway remodeling (Bousquet et al, 2000). Remodeling is thought 
to have important consequences on airway behavior in asthma (Pare and Bai, 1995). The 
pathophysiology of the remodeling process is largely unknown but it is thought to result 
from inappropriate attempts at tissue repair in response to inflammation (Kips and Pauwels, 
1999; Vignola et al, 2000). To what extent remodeling develops uniformly in all asthmatic 
patients also is unclear. The limited data currently available indicate a substantial degree of 
variability between remodeled asthmatic airways (Amin et al, 2000; Carroll and James, 2001). 
Moreover, remodeling of the airways is not necessarily clinically demonstrated in all asthmatic 
patients (Bousquet et al, 2000). Several studies of familial aggregation have suggested a 
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genetic etiology for each of asthma, atopy, and bronchial hyperresponsiveness and it is likely 
that several or many genes, as well as interactions with environmental factors, are involved 
(Clarke et al, 2000; Sandford and Pare, 2000). However, the importance of genetic alterations 
in the development of allergen-induced remodeling remains unknown.  
In vivo mouse models might help to understand the pathogenesis of airway remodeling 
and its functional implicatio ns in asthma. In view of the well characterized genetic differences 
in immunological and smooth muscle responses to allergen exposure between inbred mouse 
strains (Brewer et al, 1999; Duguet et al, 2000; Takeda et al, 2001; Zhang et al, 1997), murine 
models can also address the impact of genetic differences on the remodeling process.  
In the present study we compared to what extent differences in the immune and 
inflammatory responses can influence the remodeling process in airways of mice. We 
compared allergen induced airway inflammation and remodeling in two genetically distinct 
mouse strains.  
 
 
3. Methods 
 
3.1. Immunization and exposure of animals 
Male C57BL/6 and BALB/c mice aged 6 to 8 weeks (Harlan CPB; Zeist, the 
Netherlands) were actively sensitized by the intraperitoneal injection of 10 µg ovalbumin (OA) 
(Grade III; Sigma Chemical Co., Poole, Dorset, UK) absorbed to 1 mg Al(OH)3  0.9% NaCl 
on day 0 and day 7. From day 14 on all animals were exposed three times per week for 2, 6 
and 9 weeks to aerosolized OA (1% wt/vol) or phosphate-buffered saline (PBS) (Palmans et 
al, 2000). Group sizes varied from 6 to 12. 
 
3.2. Outcome measures 
Assessment of airway responsiveness 
Twenty-four hours after the last aerosol exposure, airway responsiveness to 
methacholine was assessed in awake animals using a whole body plethysmograph system 
(Buxco; Buxco Electronics Inc., Troy, NY). Before performing readings, the system was 
calibrated by rapid injection of 1 ml air. Pressure differences between the main chamber 
containing awake mice and a reference chamber were recorded using the software BioSystem 
XA (version 157; Buxco). This pressure signal is caused by flow changes in the main box 
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during the respiratory cycle of the animal. The value of ‘enhanced pause’ (Penh) is used to 
monitor airway function (Hamelmann et al, 1997). Penh = [(Te-Tr)/Tr] x (PEP/PIP) where Te 
is expiratory time (s), Tr is relaxation time or time of the pressure decay to 36% of total box 
pressure during expiration, PEP is peak expiratory pressure (ml/s), and PIP is peak inspiratory 
pressure (ml/s).  
For each mouse, data of Penh were recorded at baseline, and after exposure to PBS or 
increasing concentrations of methacholine (2 – 81 mg/ml). The solutions were nebulized 
through an inlet of the main chamber during 1 min. Readings were taken during 5 min after 
each nebulization. Between readings Penh value returned to baseline. 
 
Bronchoalveolar lavage 
After assessment of airway responsiveness the animals were anesthetized intraperitoneal 
with 60 mg/kg pentobarbital (Sanofi, Libourne, France) and bronchoalveolar lavage (BAL) 
was performed with 4 ml Hanks’ balanced salt solution for total and differential cell count. 
 
OA-specific IgE 
Blood was collected by cardiac puncture for the measurement of OA-specific IgE with 
ELISA as previously described (Kips et al, 1995). 
 
Histological analysis of lung tissu e 
Following lavage, lungs were fixed with 4% paraformaldehyde and slices from all lobes 
were embedded in paraffin for histological analysis. Sections of 2 µm were stained with Sirius 
Red, Periodic Acid Shiff (PAS) and Congo Red.  
 
Quantitative measurements in the airway wall 
For each animal quantitative measurements were performed in all airways with a length of 
basement membrane (Pbm) greater than 1000 µm and cut in reasonable cross sections (ratio 
of minimal to maximal internal diameter greater than 0.5). Measurements were performed on 
the digital representation of the airways via a computerized image analysis system (KS400; 
Zeiss, Oberkochen, Germany). 
Airway morphometry and collagen deposition were measured in Sirius Red-stained 
sections. Morphometrical parameters (Bai et al, 1994) were marked manually on the digital 
representation of the airway: Pbm, the area defined by the basement membrane (Abm) and the 
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area defined by the total adventitial perimeter (Ao). The total bronchial wall area (WAt) was 
calculated (WAt = Ao - Abm) and was normalized to the squared length of basement 
membrane. For the quantification of collagen deposition, the area in the airway wall covered 
by the stain was determined by the software (KS400; Zeiss) and its value calculated (Palmans 
et al, 2000). The area of collagen deposition (WCt) was normalized to Pbm. Goblet cells were 
quantified in PAS-stained sections and expressed as the number of goblet cells per mm Pbm. 
Peribronchial infiltration with eosinophils was evaluated in lung sections stained with Congo 
Red and expressed as total number of eosinophils per mm² WAt. 
 
3.3. Data analysis  
Reported values are expressed as mean ± standard error of the mean (SEM). Data of 
quantitative measurements in the airway wall of different mice in one experimental group were 
pooled together. Mean values of WAt and WCt were compared between experimental groups 
using one-way analysis of variance (ANOVA) with post-hoc (LSD and Scheffé) tests. For 
bronchial responsiveness, cumulative dose-response curves were constructed for changes in 
Penh after increasing doses of methacholine. Changes in Penh are expressed as percentage 
increase of maximum Penh following methacholine challenge compared to the average Penh 
after PBS-exposure (Analyst 1.29; Buxco). Dose-response curves of Penh were compared 
using ANOVA. The concentration of methacholine causing a 250% increase in baseline Penh 
(PC250Penh) was calculated by log-linear interpolation of the dose-response curve. Mean 
values of cellular composition of BAL fluid, goblet cells, peribronchial eosinophils, 
PC250Penh and OA-specific IgE of different groups were compared through the Kruskal-
Wallis test for multiple comparisons. When significant differences were observed, pairwise 
comparisons were made, using the Mann-Whitney U-test with Bonferroni’s corrections. P-
values less than 0.05 were considered significant. 
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4. Results 
 
4.1. Airway inflammation  
Bronchoalveolar lavage fluid (BALF) 
Over time the total number of cells increased in both mouse strains (Table 1). Ovalbumin 
exposure altered the total amount of white blood cells in BALF of C57BL/6 mice and the 
composition of the BALF in both inbred mouse strains (Table 1). The total cellularity of 
BALF recovered from OA-exposed BALB/c was not significantly different from control 
animals. However, throughout the experimental period, the BALF of these OA-exposed 
BALB/c mice contained increased numbers of eosinophils and lymphocytes (p<0.05 versus 
PBS) (Table 1), but not of macrophages and neutrophils (data not shown). The number of 
eosinophils and lymphocytes slightly decreased after OA exposure of 6 weeks and longer 
(p<0.05 versus 2 weeks). When compared to BALB/c, OA exposure during 2 weeks 
resulted in a greater influx of total white blood cells in BALF of C57BL/6 mice (p<0.05). 
This increase was also reflected in increased numbers of eosinophils and lymphocytes in the 
C57BL/6 mice (Table 1). The differences between BALB/c and C57BL/6 mice observed at 2 
weeks were no longer present after a longer exposure period during which the numbers of 
total cells, eosinophils and lymphocytes returned to baseline.  
 
Airway eosinophilia 
Both inbred mouse strains developed a peribronchial infiltrate that contained increased 
numbers of eosinophils after repeated OA-exposure (Table 2). In contrast to the findings in 
BALF, the number of peribronchial eosinophils was similar in BALB/c and C57BL/6 mice 
(Table 2). After 2 weeks of allergen exposure the increase in number of eosinophils was 
maximal (p<0.001 versus PBS). Prolonged exposure resulted in decreased amounts of 
peribronchial eosinophils in both allergen exposed and control animals, albeit that the 
difference between both groups remained significant until 9 weeks in BALB/c (p<0.05 versus 
PBS) and 6 weeks in C57BL/6 (p<0.001 versus PBS).  
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4.2. Goblet cells  
Ovalbumin exposure induced goblet cell hyperplasia in both inbred mouse strains 
(p<0.001 versus PBS) (Table 2). In BALB/c mice a maximal increase in goblet cells was 
observed after 2 weeks of OA-exposure (p<0.001 versus PBS). Moreover, the number of 
goblet cells after more prolonged allergen exposure was lower compared to OA-exposed 
BALB/c during 2 weeks (p<0.001). Also in OA-exposed C57BL/6 mice goblet cell 
hyperplasia was significantly smaller after a period of 6 weeks (p<0.005 versus 2 weeks). At 
no time point any difference was observed in the number of goblet cells between allergen-
exposed mice of both  strains. In contrast to PBS-exposed BALB/c mice, the number of 
goblet cells increased in control C57BL/6 when exposed for a longer period (p<0.05 versus 
2 weeks PBS). 
 
 
4.3. Morphometry and collagen deposition 
Morphometry 
After prolonged allergen exposure both mouse strains showed an increased in total wall 
area of large-sized airways (figure 1A and 1B). In BALB/c mice the increase was already 
observed after 2 weeks of OA exposure and was similar after the different allergen exposure 
periods (figure 1A). The airway wall of C57BL/6 mice was thickened in animals exposed to 
OA from 6 weeks onwards (figure 1B). Within PBS- and OA-exposed C57BL/6 groups no 
difference was observed between 2 and 6 weeks but the airway wall of both control and OA-
exposed C57BL/6 mice increased upon further exposure (figure 1B). A difference between 
control as well as between OA-exposed BALB/c and C57BL/6 mice was only observed at 9 
weeks (p<0.01) (figure 1A and 1B).  
 
Collagen 
Ovalbumin exposure increased the total amount of collagen in the airway wall (figure 2A 
and 2B). This change was observed after 6 weeks OA exposure in both mouse strains. Only 
in BALB/c mice the increased amount of collagen was also present after further allergen 
exposure (figure 2A). In contrast to BALB/c, in which the amount of collagen was similar in 
the different OA-exposed groups or in the different control groups (figure 2A), C57BL/6 
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showed a change in collagen content over time in both PBS- and OA-exposed mice (figure 
2B).  
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Figure 1. Effect of sensitization and prolonged allergen exposure to OA (solid bars) or PBS (open bars) 
on airway wall area of (A) BALB/c or (B) C57BL/6 mice for 2, 6 or 9 weeks.  
 
 
 
A. BALB/c
2 weeks 6 weeks 9 weeks
0
5
10
15
20
p<0.001 p<0.05
exposure period
µm
² c
ol
la
ge
n/
µm
 P
bm
B. C57BL/6
2 weeks 6 weeks 9 weeks
0
5
10
15
20
p<0.001
p<0.005
p<0.05
exposure period
µm
² c
ol
la
ge
n/
µm
P
bm
 
Figure 2. Effect of sensitization and prolonged allergen exposure to OA (solid bars) or PBS (open bars) 
on amount of collagen in the airway wall of (A) BALB/c or (B) C57BL/6 mice for 2, 6 or 9 weeks.  
 
 
4.4. Airway responsiveness 
BALB/c mice developed a significant increase in airway responsiveness to inhaled 
methacholine after 2 weeks OA exposure (ANOVA p<0.005 versus PBS) (figure 3A). After a 
longer exposure period the airway responsiveness of OA-exposed BALB/c mice returned to 
baseline responsiveness (figure 3B). The airway responses of C57BL/6 exposed to OA for 
the different periods were not changed compared to control animals (figure 3C and 3D). 
Overall, C57BL/6 were less responsive to methacholine than BALB/c mice. At 2 weeks 
the concentration of methacholine that caused a 250% increase in Penh from baseline in 
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allergen-exposed C57BL/6 was 17.40±5.92 mg/ml methacholine versus 4.69±1.81 mg/ml 
methacholine in BALB/c mice (p<0.05). Results for both the other exposure periods were 
similar (data not shown).  
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Figure 3. Airway responsiveness to nebulized methacholine in sensitized BALB/c (A and B) and 
C57BL/6 (C and D) exposed to OA (closed squares) and PBS (open squares) during 2 weeks (A and C) 
and 6 weeks (B and D) (ANOVA OA versus PBS at 2 weeks: p<0.005). 
 
 
4.5. OA-specific IgE 
OA-specific IgE levels in serum of BALB/c and C57BL/6 mice were significantly 
increased after repeated OA exposure (Table 3). After 2 weeks of allergen exposure the levels 
of OA-specific IgE were similar in both mouse strains. Extending the exposure period 
resulted in BALB/c but not in C57BL/6 mice, in a further increase of OA-specific IgE serum 
levels in both OA-exposed and control animals (Table 3). When compared to BALB/c, 
C57BL/6 mice had also lower levels of OA-specific IgE in PBS-exposed animals.  
 
 TABLE 3 
 OA-SPECIFIC IGE-SERUM LEVELS AFTER SENSITIZATION 
 AND OA-EXPOSURE OF BALB/C AND C57BL/6 MICE 
 Airway Wall Changes in Inbred Mouse Strains 137
         
   OA-specific IgE (U/ml) 
 Treatment   BALB/c C57BL/6 
     
 
2 weeks PBS 7.60±1.02ll 2.22±0.55 
 
 OA 41.75±5.28† 33.50±7.19† 
     
 6 weeks PBS 29.11±2.54
§ ll 6.38±1.80 
 
 OA 96.30±10.67† ‡ 49.18±9.00* 
     
 9 weeks PBS 23.00±1.90
§ ll 3.43±1.14 
 
  OA 102.20±10.63† § ll 21.83±4.01* 
 * p<0.05, † p<0.005 OA versus PBS  
 ‡ p<0.05, § p<0.005 6 and 9 weeks versus 2 weeks  
 ll p<0.01 BALB/c versus C57BL/6   
 
 
 
5. Discussion 
 
Repeated allergen exposure in sensitized BALB/c and C57BL/6 mice induced in 
addition to IgE synthesis and eosinophil influx around the airways, more structural alterations 
including goblet cell hyperplasia and increased collagen deposition. These changes resulted in 
an increase of airway wall thickness and affected airway behavior to methacholine. 
The present study confirms that the genetic background of mice has an impact on 
immunological responses and inflammatory responses in BALF after allergen exposure. As 
previously reported a similar protocol for OA sensitization and challenges resulted in BALB/c 
in relative higher levels of IgE and in a lower amount of cells in the BALF compared to 
C57BL/6 mice (Brewer et al, 1999; Herz et al, 1998; Takeda et al, 2001; Zhang et al, 1997). 
Despite these differences between BALB/c and C57BL/6 mice, both inbred strains displayed 
a similar degree of goblet cell hyperplasia and collagen deposition after sensitization and 
allergen exposure. The development of these structural alterations in BALB/c and C57BL/6 
mice shows differences in kinetics. Goblet cell hyperplasia and increased airway wall 
thickness were observed after two weeks of allergen exposure. Collagen deposition could not 
be observed prior to OA exposure of 6 weeks. These observations correspond to findings in 
previous studies in BALB/c mice. Some describe a rapid onset of goblet cell hyperplasia in 
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response even to a single allergen challenge (Blyth et al, 1996; Haile et al, 1999). Others 
reported, using different sensitization protocols, the development of goblet cell hyperplasia 
and increased subepithelial collagen deposition. Again goblet cells hyperplasia preceded the 
alterations in collagen deposition (Blyth et al, 1996; Temelkovski et al, 1998). Far less data are 
available on airway remodeling in C57BL/6 and only few studies compared structural 
changes between both strains after sensitization and a single allergen challenge (Foster et al, 
1996; Trifilieff et al, 2000). Light microscopical analysis revealed that C57BL/6 exposed to 
OA showed changes in the structural integrity of the airway wall, thickening of the basement 
membrane region and smooth muscle band. However, these alterations were not quantified 
(Foster et al, 1996). Trifilieff et al evaluated the proliferative index of epithelium and the 
presence of cellular fibronectin in BALF as markers for airway remodeling in C57BL/6 and 
BALB/c mice. They found that BALB/c revealed more pronounced structural alterations 
compared to C57BL/6 after a single OA exposure (Trifilieff et al, 2000; Trifilieff et al, 2001).  
A potential cause of remodeling is the release of growth factors and cytokines from 
infiltrating eosinophils (Eickelberg et al, 1999; Minshall et al, 1997; Vignola et al, 1997). Of 
note is that in the current comparative study the intensity of eosinophilic infiltration of the 
airways was similar and that the number of peribronchial eosinophils decreased both in 
BALB/c and C57BL/6 when collagen deposition was increased. The presence of the 
eosinophils in the airways could have initiated the process of altered collagen synthesis 
(Minshall et al, 1997). The waning of peribronchial eosinophilia despite further allergen 
exposure seems similar to previous data. An acute-on-chronic allergic inflammation was 
observed in the airways of BALB/c mice after prolonged allergen exposure and the infiltrating 
cells in the lamina propria of intrapulmonary conducting airways consisted of lymphocytes, 
macrophages and plasma cells but not of eosinophils (Foster et al, 2000; Sakai et al, 2001; 
Temelkovski et al, 1998). A significantly increased but small amount of eosinophils was only 
observed in the epithelium of BALB/c mice exposed to allergen for 6 weeks (Foster et al, 
2000). A possible explanation for this observation is that chronically challenged BALB/c and 
C57BL/6 can develop antigenic tolerance characterized by loss of airway eosinophilia, shifts 
in the lymphocyte population in the airway and diminished IgE levels (McMenamin et al, 
1994; Sakai et al, 2001; Tsitoura et al, 2000; Yiamouyiannis et al, 1999). The persistent IgE 
production in OA-exposed mice would argue against tolerance development as being the 
only mechanism explaining the reduction in airway eosinophilia. 
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Airways of BALB/c mice were more sensitive to nebulized methacholine as compared to 
C57BL/6 mice. After a 2 week allergen exposure period, BALB/c but not C57BL/6 
developed airway hyperresponsiveness despite the influx of peribronchial eosinophils in both 
inbred strains. A significant genetic variability exists between inbred mouse strains in their 
development of enhanced bronchial responses  after airway antigen sensitization and exposure 
(Brewer et al, 1999; Wills-Karp and Ewart, 1997; Zhang et al, 1997). The finding that OA-
exposed C57BL/6 had similar airway responses compared to control animals is in contrast to 
previous data from our lab, using a similar sensitization and exposure protocol in C57BL/6 
mice but using a different parameter of airway caliber (Kips et al, 1995). This again illustrates 
one of the main weaknesses of murine models, namely the difficulty in reliably assessing 
airway caliber and lack of an invariably accepted gold standard lung function index (Kips et 
al, 2000). 
The evolution of airway hyperresponsiveness over time in BALB/c is somewhat similar 
to data obtained in BN rats (Palmans et al, 2000). In both models hyperresponsiveness wanes 
despite the persistent presence of eosinophils in the BN rats and to a lesser extent in BALB/c 
mice. The loss of hyperresponsiveness parallels the increased collagen deposition in the 
airway wall. It is tempting to speculate that the remodeling process might protects against 
airway hyperresponsiveness because increased collagen deposition could increase airway wall 
stiffness and oppose against extended narrowing of the airway wall (Lambert et al, 1994; 
Milanese et al, 2001; Seow et al, 2000). Although the increase in airway wall thickness could 
affect airway responses in OA-exposed BALB/c mice, enhanced collagen deposition in the 
airway wall might have compensated the increased wall thickness and contribute more to the 
loss in airway hyperresponsiveness observed after prolonged allergen exposure.  
In conclusion, the inbred mouse strains BALB/c and C57BL/6 showed different allergic, 
BALF inflammatory and airway responses after a similar allergen sensitization and exposure. 
Despite the different allergic response between BALB/c and C57BL/6 mice, both inbred mice 
strains developed similar structural airway changes. The mechanisms that predispose the 
inbred mouse strains to the development of the different allergic and functional responses did 
not affect the occurrence and magnitude of the remodeling process in the airways of these 
mice. 
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1. Abstract 
 
It remains to be fully established whether allergen-induced airway inflammation and 
remodeling are influenced by age. The aim of the present study was to compare allergen-
induced airway changes in young and adult rats. Brown Norway rats were sensitized at 4 
weeks of age (young) or 13 weeks of age (adult) and exposed to aerosolized ovalbumin (OA) 
or phosphate-buffered saline for 2 weeks. In both age groups OA exposure induced an 
increase in OA-specific Immunoglobulin E and in the number of peribronchial eosinophils. 
OA-challenged animals also developed an increase in total airway wall area, enhanced 
fibronectin deposition and goblet cell hyperplasia. Both inflammatory and structural 
alterations were more pronounced in the airways of young compared with adult OA-exposed 
rats. The number of peribronchial eosinophils was increased in young animals (685.4±75.0 
versus 389.9±37.8/mm² in adult rats; p<0.001). A higher degree of goblet cell hyperplasia 
was observed in young rats (65.37±4.68 versus 34.74±3.68/mm basement membrane in adult 
rats; p<0.001) and area of fibronectin deposition in the airway wall was higher in young 
compared with adult animals (5.08±0.46 versus 3.62±0.29 µm²/µm basement membrane; 
p<0.005). In conclusion, in young rats airways are more susceptible to allergen-induced 
inflammatory and structural airway changes. 
 
 
2. Introduction 
 
Asthma is an inflammatory disorder of the airways, and several studies have confirmed a 
similar type of inflammation in children and adults with asthma (Cai et al, 1998; Louis et al, 
2000; Twaddell et al, 1996). However, it is unknown whether developing airways in children 
are more prone to the development of allergic inflammation, nor has it been fully established 
whether a similar environmental exposure will induce a similar severity of airway inflammation 
in children and adults. Part of the inflammatory process in asthmatic airways consists of 
structural airway changes, the so-called airway remodeling. This is thought to result from 
attempts at repair in response to repetitive bouts of allergen-induced inflammation and tissue 
injury (Vignola et al, 2000b). Again, it is unknown whether developing airways in children are 
more susceptible to remodeling. This aspect would seem particularly relevant for the natural 
history of asthma as remodeling is thought to have important functional consequences on 
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lung function, contributing to loss of airway distensibility and bronchial hyperresponsivess 
(Boulet et al, 1997; Macklem, 1996). Both low baseline FEV1 and severe bronchial 
hyperresponsiveness are known risk factors for the persistence of asthma into adulthood 
(Grol et al, 1999; Palmer et al, 2001; Roorda et al, 1994).  
Representative in vivo  animal models might provide interesting information in this 
respect. We and others have previously shown that structural airway changes can be induced 
in Brown Norway (BN) rats after sensitization and chronic exposure to the allergen ovalbumin 
(OA) (Palmans et al, 2000; Salmon et al, 1999; Sapienza et al, 1991). In the present study we 
compared the allergen-induced airway changes in prepuberal and adult rats. The results 
indicate that sensitized rats exposed to allergen before they reach puberty develop more 
profound inflammatory and structural airway changes. 
 
 
3. Methods 
 
3.1. Immunization and exposure of animals 
Specific pathogen-free, male BN rats (Harlan CPB, Zeist, the Netherlands) were actively 
sensitized by intraperitoneal injection of OA (4 mg/kg body weight) (Grade III; Sigma, Poole, 
Dorset, UK) together with Al(OH)3 (800 µg/kg body weight) in 0.5 ml 0.9% NaCl on Day 0 
and Day 7. On Day 0 one group of rats (n=20) was 4 weeks of age (young rats) and another 
group of rats (n=19) was 13 weeks of age (adult rats). From Day 14 to Day 28 animals were 
exposed seven times to aerosolized OA or phosphate-buffered saline (PBS). 
 
3.2. Outcome measures  
On Day 29, 24 hours after the last exposure to OA or PBS, rats were weighed prior to 
instrumentation and anesthetized by intraperitoneal injection of 60 mg/kg pentobarbital 
(Sanofi, Libourne, France). Bronchoalveolar lavage (BAL) was performed for analysis of 
total and differential cell count; blood was collected for the measurement of OA-specific 
Immunoglobulin E (IgE). 
Histological analysis of lung tissue 
After lavage, lungs were fixed with 4% paraformaldehyde, slices from different lobes 
were embedded in paraffin and cut in 2-µm-thick sections. Histological changes were 
evaluated on sections stained with hematoxylin and eosin. In addition, Congo red was used 
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to determine the number of eosinophils in the bronchial wall and the number of goblet cells in 
epithelium was assessed in sections stained with periodic acid-Schiff reagent. Fibronectin was 
stained immunohistochemically. Details of the methodology used have been previously 
described (Palmans et al, 2000).  
 
Analysis of airway morphometry and fibronectin deposition  
Hematoxylin- and eosin-stained tissue sections were examined by light microscopy and 
morphometric measurements were performed in three sections per animal, using a Zeiss 
Axiophot microscope (Zeiss, Oberkochen, Germany) as previously describ ed (Palmans et al, 
2000). The perimeter of epithelial basement membrane (Pbm) and the total bronchial wall area 
(WAt) were measured in all large airways (Pbm > 2 mm) cut in reasonable cross-sections (ratio 
of minimal to maximal internal diameter greater than 0.5). Smooth muscle area (WAm) was 
measured by specifically tracing around the smooth muscle bundles.  
Fibronectin deposition was examined by light microscopy and quantitative 
measurements were performed using a computerized image analysis system (LEICA 
Q500MC; Leica Cambridge, Cambridge, UK). Fibronectin deposition was analyzed in three 
lung sections per rat as previously described (Palmans et al, 2000). The amount of protein 
deposited in the total airway wall (WFt) was measured for all large airways cut in reasonable 
cross-sections.  
 
3.3. Data analysis  
Reported values are expressed as mean ± standard error of the mean. The weight of 
young and adult rats was compared using a Mann-Whitney U-test. The cellular composition 
of the bronchoalveolar lavage fluid (BALF) and concentrations of OA-specific IgE in the 
serum of the different groups were compared via Kruskal-Wallis test for multiple 
comparisons. When significant differences were observed, pairwise comparisons were made 
by using a Mann-Whitney U-test with Bonferroni corrections. 
For analysis of morphometry and fibronectin deposition, the data of the different rats in 
each experimental group were pooled. Measurements were performed in a mean of 27 large 
airways (range, 24 to 32) for morphometry and in a mean of 23 large airways (range, 17 to 31) 
for quantification of the fibronectin. To ensure that a similar range of airway sizes was being 
compared, the frequency distribution of Pbm values between different experimental groups 
was compared by the Kolmogorov-Smirnov test. The mean values of WAt, WAm and WFt 
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were normalized to Pbm; the number of goblet cells per mm Pbm and number of eosinophils 
per square mm WAt were compared between the experimental groups, using one-way analysis 
of variance with post hoc (least significant difference and Scheffé) tests (p values less than 
0.05 were considered significant). 
 
 
4. Results  
 
4.1. Weight 
On Day 29, young rats reached a mean weight of 181.0±2.5 g, whereas adult rats 
weighed 266.6±5.5 g (p<0.001). 
 
4.2. OA-specific IgE 
Serum levels of OA-specific IgE were elevated in all sensitized rats exposed to OA 
compared with control animals (Table 1). The IgE levels of OA-exposed animals were not 
different when rats sensitized at 4 weeks were compared with the group of rats sensitized at 13 
weeks. Increased levels of OA-specific IgE were observed in adult control animals compared 
with young control animals (Table 1). 
 
4.3. Inflammatory cell infiltrate in BALF 
More cells were recovered in the BALF from all sensitized and OA-exposed animals 
compared with those exposed to PBS (Table 2). In young animals the amount of cells after 
OA exposure was twice the amount of BALF cells in control animals. In adult rats a 3-fold 
increase was observed in OA-exposed animals compared with control animals. Moreover, the 
total cellularity of OA-exposed rats immunized at 13 weeks was significantly increased 
compared  with OA-exposed rats sensitized at the age of 4 weeks (Table 2). The amount of 
macrophages, eosinophils, and neutrophils changed in both OA-exposed animal groups. In 
OA-exposed young animals a 3-fold increase in the number of eosinophils was observed 
compared with PBS-exposed rats ([500.0±121.5]x103 cells versus [182.4±74.0]x103 cells; 
p<0.05); in OA-exposed adult animals we observed a 10-fold increase of eosinophils 
([538.3±85.4]x103 cells versus [58.1±26.9]x103 cells in PBS-exposed rats; p<0.005). The 
total amount of BALF eosinophils was similar in both age groups ([500.0±121.5]x103 for 
young rats versus [538.3±85.4]x103 for adult rats). Total cellularity of BALF was not 
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different between both PBS-exposed control groups. However, the percentage of eosinophils 
was higher in control rats sensitized at 4 weeks compared with those sensitized at 13 weeks 
(Table 2). 
 
 
 TABLE 1 
OVALBUMIN-SPECIFIC IMMUNOGLOBULIN E LEVELS IN SERUM AFTER 
IMMUNIZATION AT DIFFERENT AGES AND REPEATED OA EXPOSURE 
 Age at immunization  OA-specific IgE 
 (weeks) Treatment (µg/ml) 
 4  PBS 1.083±0.194 
  OA 17.486±2.578
* 
 13  PBS 2.675±0.402† 
  OA 10.612±0.869* 
* p < 0.001, OA versus PBS 
† p < 0.001, PBS at age 13 weeks versus PBS at age 4 weeks 
 
 
4.4. Lung histology 
The difference in BALF composition was not reflected by histological analysis. 
Inflammatory infiltrates were observed in the peribronchial area of sensitized and OA-exposed 
animals. In addition to mononuclear cells, these infiltrates contained increased numbers of 
eosinophils. The number of eosinophils was higher around the bronchi of young rats. The 
number of peribronchial eosinophils was similar in both control groups (Table 3). 
There was no epithelial desquamation observed, but OA exposure resulted in goblet cell 
hyperplasia. The increase in goblet cells was more pronounced in OA-exposed animals 
immunized at 4 weeks. The number of goblet cells in young and adult control rats was not 
different (Table 3).  
 
 
TABLE 2 
TOTAL NUMBER OF WHITE BLOOD CELLS AND CELLULAR DISTRIBUTION IN 
BRONCHOALVEOLAR LAVAGE FLUID 
  Total cells Monocytes Eosinophils Neutrophils Lymphocytes 
Age* Treatment (x 106) (%) (%) (%) (%) 
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4 PBS 1.12±0.18 79.8±4.4  14.2±4.2 1.5±0.3  4.6±0.8 
weeks OA 2.36±0.41† 43.8±4.5 § 20.4±3.4† 29.3±4.4 ‡ 6.6±0.9 
13 PBS 3.54±0.95 94.7±0.7 ¶ 1.5±0.4 ** 0.4±0.2 ll 3.4±0.4 
weeks OA 12.18±2.0 † 
¶ 
57.5±5.3 § 4.5±0.5‡ ** 33.7±5.3 § 4.3±0.5 
 * Age = age at immunization 
† p < 0.05, ‡ p < 0.005 and § p < 0.001 OA versus PBS 
ll p < 0.05, and ¶ p < 0.005 and ** p < 0.001 age 13 weeks versus same treatment age 4 weeks  
 
  
 
 
TABLE 3 
NUMBER OF GOBLET CELLS IN THE EPITHELIUM AND NUMBER OF AIRWAY WALL 
EOSINOPHILS AFTER IMMUNIZATION AT DIFFERENT AGES AND REPEATED 
OVALBUMIN EXPOSURE 
Age at 
Immunization  Peribronchial eosinophils Goblet cells 
(weeks) Treatment (cells/mm2 airway wall area) (cells/mm basement membrane) 
4 PBS 34.30±5.45 287.2±35.7 
 OA 65.37±4.68† 685.4±75.0 † 
13  PBS 24.83±3.92 295.5±55.9 
 OA 34.74±3.68* § 389.9±37.8 * ‡ 
* p<0.05 and † p < 0.001 OA versus PBS 
‡ p<0.005 and § p<0.001 OA age 13 weeks versus OA age 4 weeks 
 
 
4.5. Fibronectin deposition 
Fibronectin deposition in large airways was significantly increased after 2 weeks of 
allergen exposure (5.08±0.46 versus 1.50±0.26 µm²/µm Pbm in young rats and 3.62±0.29 
versus 2.27±0.37 µm²/µm Pbm  in adult animals; p<0.001 and p<0.01 respectively) (Figure 
1A). The fibronectin deposition after allergen exposure in rats immunized at 4 weeks was 
higher compared with OA-exposed adult animals (p<0.005) (Figure 1A). The amount of 
fibronectin in control animals was similar in both age groups (Figure 1A). 
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4.6. Morphometry 
The total airway wall area was increased in OA-exposed adult animals compared with the 
control rats (94.04±11.53 versus 73.33±4.27 µm²/µm Pbm; p<0.05) (Figure 1B). In young 
animals, the difference in total wall area between control and OA-exposed rats showed a 
strong trend toward significance (92.89±5.93 versus 70.26±3.89 µm²/µm Pbm; p=0.056) 
(Figure 1B). No difference in airway wall thickness was observed between allergen-exposed 
rats of both age groups. There was no difference between age groups in airway wall thickness 
in control animals (Figure 1B). 
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Figure 1. Effect of age at immunization on fibronectin deposition in the airway wall (A) and airway wall 
area (B) in large airways after OA exposure (closed bars) versus PBS exposure (open bars) (* p<0.05 
versus PBS, + p<0.01 versus PBS, ++ p<0.001 versus PBS and § p<0.005 versus OA immunization at 4 
weeks). WAt = total bronchial wall area; Pbm = length of epithelial basement membrane. 
 
 
No difference in airway smooth muscle layer thickness was observed between control 
and OA-exposed adult rats (2.78±0.28 and 2.00±0.26 µm2/µm Pbm respectively). Although 
the thickness of the smooth muscle was increased in young animals compared with the adult 
animals (p<0.001) no difference was observed between PBS- and OA-exposed young rats 
(5.83±0.65 versus 4.14±0.55 µm2/µm Pbm). 
 
 
5. Discussion 
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The main purpose of this study was to evaluate the effect of age on the development of 
structural airway changes in BN rats after allergen sensitization and exposure. Synthesis of 
allergen-specific IgE was similar in both OA-exposed groups. However, in young animals 
sensitization and repeated exposure to aerosolized allergen resulted in the development of 
more pronounced acute inflammation reflected by increased peribronchial eosinophils as well 
as more structural alterations, including goblet cell hyperplasia and fibronectin deposition. 
Several elements could contribute to the different responses observed in young and adult 
BN rats. A first potentially confounding factor is a technical one. In view of the weight 
difference that we observed between young and adult rats, it is likely that the lung size in both 
groups was also different. We therefore cannot exclude the possibility that airways of slightly 
different generations are compared between both groups. However, we have previously 
shown that the extent of alterations in small, medium and large airways of sensitized BN rats 
after OA exposure was similar (Palmans et al, 2000). This indicates that allergen-induced 
airway changes are uniformly distributed throughout the bronchial tree and that comparison 
of airways in both age groups can provide valid data. In addition, an increased lung size 
could also result in a larger lung surface being sampled by the BAL procedure. Yet, as was 
also reported by Yagi et al(Yagi et al, 1997)), the total cell number in BALF was not different 
between young and adult rats. To us, these results indicate that lung size differences do not 
significantly influence the results obtained. 
Another element that needs to be considered is a possible difference in the immune 
response to sensitization in both age groups. It is known that experimental animals fail to 
develop helper T cell type 2-induced allergic responses at an older age (Yagi et al, 1997)(Ide 
et al, 1999; Smith et al, 2001). Throughout the age range chosen in the present study 
however, the immune response to inhaled allergen is helper T cell type 2 driven (Nelson et al, 
1994; Nelson and Holt, 1995). The observation that young and adult rats develop similar IgE 
serum levels is also an indirect argument that differences in the susceptibility of the airway 
mucosa rather than the immune response explain the observed results. 
The pathogenesis of remodeling remains to be established, but it is thought to result from 
attempts at tissue repair after bouts of repetitive injury caused by allergen inhalation (Vignola et 
al, 2000b). A characteristic feature of allergen-induced acute airway inflammation is the 
occurrence of airway eosinophilia. The present study indicates that for a same intensity of 
allergen exposure, the airways of young animals are infiltrated with larger numbers of 
eosinophils than those of adult rats. A previous study, using a different experimental protocol, 
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reported similar findings (Yagi et al, 1997). Comparative studies in human asthma are hardly 
available in this respect. The data available indicate that cellular composition of the airway 
inflammation in children resembles that observed in adult asthmatics (Cai et al, 1998; Louis et 
al, 2000; Twaddell et al, 1996). Similarly, analysis of induced sputum in asthmatic children 
showed, as in adults, an increase in the percentage of eosinophils (Cai et al, 1998; Twaddell et 
al, 1996). From the limited studies currently available, sputum eosinophilia in untreated 
asthmatic children also falls within a similar wide range compared with adults (Cai et al, 1998; 
Louis et al, 2000). To what extent this fully reflects tissue eosinophilia is, however, unknown 
(Grootendorst et al, 1997). Of note is that in the present study the difference in eosinophils in 
the airway wall between both age groups was not reflected in BALF counts.  
Airways in young rats develop a more pronounced remodeling as indicated by the 
number of goblet cells and fibronectin deposition. Biopsy studies have confirmed the 
presence of remodeling in airways of children (Cokugras et al, 2001; Cutz et al, 1978). A 
preliminary report even indicates that remodeling might be present prior to the development of 
asthma symptoms (Pohunek et al, 1997). This somewhat challenges the concept that 
remodeling results from inflammation, but raises the idea that eosinophilic airway inflammation 
and remodeling might be two independent processes (Pohunek et al, 1997). The present 
study confirms that remodeling is induced by allergen exposure, but obviously does not 
prove a causal role of the eosinophils in this process.  
The age-dependent difference between animals in terms of infiltrating inflammatory cells 
and structural changes is concordant with observations relating to other repair processes. 
During healing of cutaneous punch biopsies in humans the inflammatory response was 
delayed in adult compared with young subjects (Ashcroft et al, 1998). In vivo models of 
wound healing also showed that repair processes are associated with increased amounts of 
inflammatory cells in young compared with older animals (Ashcroft et al, 1997; Marcus et al, 
2000). In young rabbits excision of tissue in the ear resulted in a higher amount of proliferative 
cells in the healing dermis compared with old animals (Marcus et al, 2000). In mice, the 
inflammatory response to cutaneous incision wounds was less pronounced in older animals, 
as was the deposition of the extracellular matrix (ECM) components fibronectin and collagen 
type I and III (Ashcroft et al, 1997). 
That young animals develop more pronounced remodeling in response to allergen 
exposure could have profound implications. To date, the functional consequences of 
remodeling have been related mainly to altered airway behavior (Laprise et al, 1999). Although 
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it is generally assumed that remodeling contributes to bronchial hyperresponsiveness, it has 
been shown that depending on the exact extent and location, changes in ECM can also 
protect against bronchial hyperresponsiveness (Milanese et al, 2001; Palmans et al, 2000; 
Seow et al, 2000). We have previously reported that the degree of fibronectin deposition after 
exposing adult rats to OA for 12 weeks is three times higher than in animals exposed for 2 
weeks. This coincided with a change from airway hyperresponsiveness at 2 weeks to 
hyporesponsiveness after 12 weeks of exposure (Palmans et al, 2000). In the present study, 
we did not measure airway responsiveness. However, the difference between the intensity in 
fibronectin deposition is only 1.5. We would therefore speculate that this relatively limited 
difference is insufficient to significantly influence lung function.  
ECM proteins in the airway wall not only determine the structural integrity and 
mechanical properties of the airway wall, they can also interact with inflammatory cells 
(Roman, 1996). The components of the ECM can affect migration, proliferation, 
differentiation, and activation state of inflammatory cells and enhance their survival (Anwar et 
al, 1993; Lavens et al, 1996; Meerschaert et al, 1999b; Neeley et al, 1994; Zhang and Phan, 
1999). Modulation of the ECM by remodeling its structure can therefore affect the behavior 
of cells residing within it, and the changes of ECM composition could  have an important 
influence on the persistence of the allergic inflammation, anchoring it firmly within the airway 
wall. The matrix adhesion molecule fibronectin promotes recruitment and attachment of cells 
(Armstrong and Armstrong, 2000). As in the current model, asthmatic airways have increased 
levels of fibronectin (Meerschaert et al, 1999a; Roche et al, 1989). Fib ronectin is known to be 
released by proinflammatory cytokines and is thought to play an important role in epithelial 
repair (Vignola et al, 2000a). In addition, however, the presence of fibronectin in the ECM 
facilitates the adhesion of inflammatory cells and prolongs eosinophil survival (Meerschaert et 
al, 1999b). The more pronounced remodeling in response to allergen exposure at a young 
age might therefore increase the vulnerability of the lower airways to the development of a 
persistent allergic inflammation. This also fits with the observation that sensitization at young 
age increases the likelihood of developing asthma in adulthood compared with those who 
become sensitized later (Peat et al, 1990; Roorda et al, 1994; Sherrill et al, 1999). As 
remodeling promotes the ongoing inflammatory process, the current observations further 
strengthen the importance of avoiding stimuli that can induce remodeling in young children; 
this includes not only allergens, but also stimuli such as cigarette smoke (Rennard, 1999). 
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In vivo animal models obviously have limitations, one of which is to what extent the 
observations can be extrapolated to human asthma. However, the observations that allergen 
avoidance measures are far more effective at young age than in adults would seem to support 
the idea that the increased susceptibility to allergen induced airway changes observed in the 
present model might also apply in humans.  
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1. Introduction 
 
Airway remodeling encompasses a number of changes to the airway structure, found in 
asthma. This includes goblet cell hyperplasia, pseudo-thickening of the basement membrane 
due to subepithelial fibrosis, neovascularization, changes in composition of the extracellular 
matrix, and smooth muscle hyperplasia and/or hypertrophy (Chetta et al, 1997; Ebina et al, 
1993; Jeffery et al, 1989; Laitinen et al, 1997; Li and Wilson, 1997; Redington and Howarth, 
1997; Roche et al, 1989). What exactly causes these structural changes to occur is unclear. 
The amount of mediators present in asthmatic airways that can activate and induce or enhance 
proliferation of fibroblasts and smooth muscle cells is seemingly endless (Hirst, 1996; 
Minshall et al, 1997; Redington et al, 1997; Vignola et al, 1997), ranging from mediators such 
as leukotrienes, or proinflammatory cytokines including TNFa and IL-1ß, to a variety of 
growth factors. These can be divided in nonfibrinogenic mediators, such as GM-CSF, and 
fibrogenic ones, including epidermal growth factor (EGF), insulin -like growth factor (IGF), 
and transforming growth factor ß (TGF-ß). The exact functional importance of each of these 
mediators in the pathogenesis of remodeling is unknown. This is a first area to which data 
derived from in vivo models can contribute valuable information. 
A second element with regard to remodeling that needs to be further evaluated is the 
impact of these structural changes on airway function. It has been hypothesized, largely based 
on mathematical models, that the remodeling process underlies bronchial 
hyperresponsiveness (Pare and Bai, 1995). The two main determinants of bronchial 
hyperresponsiveness are hypersensitivity and hyperreactivity of the airways (Woolcock et al, 
1985). Hypersensitivity is reflected in a leftward shift of the dose-response curve toward a 
bronchoconstrictor agonist. This can be attributed, in adaptation of Poiseuille’s law, to 
thickening of the airway wall, especially the area inner to the smooth muscle layer (Lambert et 
al, 1993). Increased stiffness of the subepithelial layer could additionally contribute to this 
phenomenon, by influencing mucosal folding upon smooth muscle contraction (Wiggs et al, 
1997). Hyperreactivity of the airways is reflec ted by an increased slope of the dose-response 
curve of methacholine and exaggerated maximal airway narrowing (Macklem, 1996). This has 
been ascribed to an increase in airway smooth muscle mass and/or changes in the adventitial 
matrix, leading to a loss of elastic recoil on contracting airway smooth muscle (Lambert et al, 
1993; Macklem, 1996). These assumptions are based on superb mathematical models, but 
require further functional confirmation, an issue were in vivo animal models again can prove 
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very useful. This in turn implies that the animal model displays not only morphological 
characteristics of remodeling, but also a degree of airway hyperresponsiveness, comparable 
to human asthma, and that from a methodological point of view, airway responsiveness is 
measured in such a way that both sensitivity and reactivity of the airways can be assessed. 
When combining both these morphological and physiological requirements, it is quite clear 
that the ideal animal model of airway remodeling does not yet exist. An obvious disadvantage 
is that animal models displaying naturally occurring asthma-like syndromes are nearly 
inexistent. Horses are known to develop airway obstruction after exposure to mold but the 
airway histology is different from asthma, as it resembles more bronchiolitis (Derksen et al, 
1985).  
The only species that seems to spontaneously develop an airway disorder that bears 
similarities to asthma, both functionally and histologically, are cats. Sensitization followed by 
repeated exposure to Ascaris has been shown to increase airway responsiveness in 
conjunction with histological changes that mimic those observed in naturally occurring feline 
asthma. This includes goblet cell hyperplasia, eosinophil infiltration in the airway mucosa, and 
an increase in the thickness of the airway smooth muscle layer. The overall airway wall 
thickness was not increased (Padrid et al, 1995). However, the cat has not gained widespread 
acceptance as an animal model of asthma, and the vast majority of animal models of allergic 
airway inflammation have been experimentally induced in small rodents, mice in particular. 
This choice of animal species is in part dictated by economical and ecological 
considerations, but mainly attributable to the huge range of immunologic tools available in 
mice. The development of monoclonal antibodies and, more recently, gene deletion 
technology makes it possible to effectively neutralize a given mediator or cell, thus fully 
establishing its functional importance in the disease process (Kips and Pauwels, 1997). 
However, the degree of hyperresponsiveness obtained in most of the currently available 
models by no means compares to the generally far larger differences in airway responsiveness 
that exist between asthmatic and nonasthmatic individuals. This could relate at least in part to 
the pattern of airway inflammation induced in these models. In the murine models of allergic 
airway inflammation developed so far, only acute inflammatory changes have been induced, 
without any structural changes that might affect responsiveness to a larger degree. The 
distribution of the inflammation is also different from human asthma, concentrating not only 
in or around the airways, but frequently also including lung parenchymal, mainly perivascular, 
changes. Furthermore, in the vast majority of these currently available murine models, 
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sensitivity as opposed to reactivity of the airways has not been specifically evaluated. This is 
predominantly due to methodological problems. No ‘gold standard’ lung function test has 
been invariably accepted for small animal models, mice in particular. The indices used include 
lung resistance, based on the principles described by Amdur and Mead, overflow of 
insufflation pressure as described by Konzett and Rösler, sometimes expressed as the APTI 
(airway pressure over time index) or the penh value (Amdur and Mead, 1958; Hamelmann et 
al, 1997; Konzett and Rössler, 1940; Levitt and Mitzner, 1988). These various indices reflect 
to a variable and ill-defined degree the changes in airway sensitivity and reactivity. 
 
  
2. Rat models of airway remodeling  
 
Although as already explained, the ideal animal model of airway remodeling does not yet 
exist, the issue of structural airway changes has been addressed in a number of models. Most 
of these studies have been conducted in rats. In a series of studies conducted in Martin’s 
laboratory, Brown Norway (BN) rats were sensitized to ovalbumin on day 0, by injecting 1 
mg of ovalbumin + 200 mg Al(OH)3 subcutaneous, and 1 ml containing 6x10
9 Bordetella 
pertussis organisms intraperitoneally. The animals were then exposed to a number of 
inhalation challenges with ovalbumin, ranging from three to six, usually every 5 days, starting 
2 weeks after sensitization (Bellofiore and Martin, 1988; Du et al, 1996; Sapienza et al, 1991; 
Wang et al, 1993). This protocol led to an increase in airway responsiveness in those animals 
that developed an early response to ovalbumin inhalation, as judged by the dose of inhaled 
methacholine required to double baseline resistance (PD200RL) in animals ventilated via a 
tracheal cannula (Bellofiore and Martin, 1988). In one of these studies (Sapienza et al, 1991), 
the maximal increase in RL that could be achieved was measured, revealing no difference 
between ovalbumin-exposed and control animals. Noteworthy is that the increase in airway 
responsiveness in some of these animals persisted for up to 17 days after the sixth challenge. 
The altered airway behavior in these rats was not accompanied by a clear eosinophil influx 
into the airways, nor increased airway wall thickness. The basement membrane thickness was 
not specifically measured. What was reported was an increase in the thickness of the smooth 
muscle layer when expressed as a percentage of the squared basement membrane length. 
Further analysis, using BrdU pretreatment to identify replicating cells, suggested this was due 
to smooth muscle hyperplasia (Panettieri, Jr. et al, 1998). In these studies a weak correlation 
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was found between the quantity of airway smooth muscle in the large airways and the 
PD200RL. No correlation was found with the maximal increase in RL obtained in individual 
animals. Both the increase in airway smooth muscle mass and the increase in airway 
responsiveness could be blocked by pretreating animals with a CysLT1-receptor antagonist 
(Wang et al, 1993).  
In our hands, repeated allergen exposure of BN rats also induced components of airway 
remodeling, albeit somewhat different in nature. We sensitize animals by the intraperitoneal 
injection of 1 mg ovalbumin + 200 µg Al(OH)3. A booster is given on day 7. The animals are 
then exposed to aerosolized ovalbumin 3 times per week for 2 weeks from day 14 onward 
(Palmans et al, 2000). The protocol induces quite patchy inflammatory infiltrates, which are 
located predominantly around the airways and contain mononuclear cells in addition to 
eosinophils. Airway epithelium shows an increase in the relative proportion of goblet cells. In 
addition, the epithelium contains an increased number of BrdU+ cells, indicating increased 
proliferative activity. The basement membrane does not appear thickened. Collagen 
deposition in the airway mucosa is slightly, but not significantly increased. The smooth 
muscle layer is not thickened and, in contrast to the findings from Martin’s group, does not 
show signs of hyperplasia, as judged by BrdU staining. However, morphometric analysis 
shows an overall increase in the thickness of the airway wall area, in both small and large 
airways. This coincides with an increase in airway responsiveness to aerosolized carbachol, as 
illustrated by a leftward shift of the dose-response curve. We could not reach a plateau. Of 
particular interest is that the increase in airway wall thickness and airway responsiveness 
persisted for at least 14 days after the last of seven ovalbumin exposures. 
In addition, the airway changes induced in this model prove to be relatively insensitive to 
the effect of inhaled steroids. Pretreatment with inhaled fluticasone (FP) (10 mg), prior to each 
allergen inhalation, reduces the ovalbumin-induced peribronchial eosinophilic infiltration, the 
increase in BrdU+ cells in airway epithelium, and goblet cell hyperplasia. However, the increase 
in airway wall thickness and airway responsiveness are not fully prevented (Vanacker et al, 
2001). Furthermore, once the increase in airway wall thickness and hyperresponsiveness have 
been induced, they remain unaffected to treatment with FP (10 mg) during the ensuing 14 
days. These observations arguably add to the value of the model, as this lack of 
responsiveness to steroids is quite similar to the limited and variable effect of steroids on 
airway responsiveness and subepithelial fibrosis observed in human asthma. This also seems 
to indicate that the thickening of the airway wall area and increase in airway responsiveness are 
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not caused by acute inflammatory changes and cannot be readily reversed by steroids. What 
the exact pathophysiological mechanism is that cause both phenomena and whether they are 
causally linked remain to be further established. 
However, that the increased airway wall area can indeed be the cause of this altered 
airway behavior is further suggested by experiments during which the sensitized BN rats were 
exposed to ovalbumin over more prolonged time periods. When animals are repeatedly 
exposed to ovalbumin over 12 weeks, as opposed to 2 weeks, the airway morphology 
further changes. Collagen deposition increases further in the mucosa, whereas in the 
adventitial area large amounts of fibronectin were present. The smooth muscle layer remains 
unaffected, showing no signs of hyperplasia or hypertrophy. Strikingly, the overall thickness 
of the airway wall is reduced in comparison to animals exposed to allergen over a 2-week 
period, and is not different from control animals. Correlating with these morphological 
observations, airway responsiveness also wanes, and even turns into a slight 
hyporesponsiveness of the airways, in comparison to control animals (Palmans et al, 2000). 
These observations suggest not only that the elements in the remodeling process that cause an 
increase in airway wall thickness are indeed the cause of airway hyperresponsiveness, but also 
that when these elements are replaced by a scar-like tissue containing large amounts of 
collagen or fibronectin, this could possibly, through increased stiffness, appear to affect the 
airway smooth muscle, thus protecting against instead of enhancing increased airway 
responsiveness.  
 
 
3. Other animal models of airway remodeling  
 
3.1. Antigen-induced structural airway changes in other animal species 
The majority of the currently developed murine models have focused on acute 
inflammatory changes. However, in a few models, the effect of more prolonged allergen 
exposure has been evaluated. Blyth and co-workers reported that repeated intratracheal 
instillation of ovalbumin induced not only eosinophil infiltration in the airways, but also goblet 
cell hyperplasia in the airway epithelium. In contrast to the eosinophil infiltration, this was not 
influenced by treatment with dexamethasone. In this model, airway reactivity was not 
measured (Blyth et al, 1996). Temelkovski and co-workers recently reported that repeated 
exposure of BALB/c mice to low-dose antigen over 6-8 weeks induced goblet cell 
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hyperplasia as an early characteristic of airway remodeling, followed by epithelial thickening 
and subepithelial fibrosis. These changes are paralleled by increased sensitivity to 
methacholine. Of interest is that altered airway behavior was also observed in nonimmunized 
allergen-exposed animals, despite the absence of clear inflammatory airway changes 
(Temelkovski et al, 1998).  
 
3.2. Non-antigen-induced models of remodeling in genetically manipulated mice 
Overexpression of cytokines in murine airway epithelium, using transgene technology 
has been reported to induce structural airway changes. Interleukin-11 overexpression causes 
subepithelial fibrosis, due to increased expression of collagen I and III (Tang et al, 1996). 
This was accompanied by an increase in airway responsiveness, as indicated by a decreased 
PC100RL to inhaled methacholine. Others have reported some degree of subepithelial fibrosis 
in addition to eosinophil accumulation in IL-5 transgenic animals (Lee et al, 1997). In this 
model, penh as marker of airway caliber was used to demonstrate increased airway 
responsiveness. Others have reported that adenovirus-mediated gene transfer of TGF-ß or 
GMC-SF induces widespread pulmonary fibrosis in rats (Sime et al, 1997; Xing et al, 1997).  
These models obviously are of interest, illustrating the potential effect of high 
concentration of a given cytokine in inducing structural airway changes. However, they do 
not address the role of physiological concentrations of endogenously released cytokines in 
the pathogenesis of the remodeling process. 
 
3.3. Models of remodeling, using nonantigenic inhaled substances 
A number of models have exposed animals over prolonged periods to non-specific 
irritants including SO2 or endotoxin (Stolk et al, 1992), thus inducing structural airway 
changes that resemble more similarities to the changes observed in chronic bronchitis than in 
asthma. In dogs, prolonged exposure to SO2 increases the thic kness of epithelium and the 
smooth muscle layer as well as the size of the mucous glands. However these changes are not 
accompanied by altered airway behavior (Scanlon et al, 1987). In contrasts, in rats, increased 
airway responsiveness following chronic SO2 exposure has been observed, together with 
histological changes that are quite similar to those reported in dogs (Shore et al, 1995). In 
addition to epithelial changes, the thickness of the airway smooth muscle layer is also 
increased provided C fibers are destroyed by neonatal capsaicin treatment (Long et al, 1997).  
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To date the role of matrix -degrading enzymes, including collagenase and elastase, has 
been predominantly evaluated in animal models of emphysema, either by administering the 
enzymes exogenously or by evaluating the effect of cigarette smoke in genetically manipulated 
knockout mice (Otto Verberne et al, 1992). In developing S-D rats, chronic hyperoxia 
exposure resulted in an increased epithelial and airway smooth muscle layer thickness and 
increased airway wall thickening that correlated with airway (D'Armiento et al, 1992; 
Hautamaki et al, 1997; Massaro and Massaro, 1997). In most of these models, histological 
changes in the airways either were absent or were not specifically addressed. Likewise, altered 
airway reactivity was related to changes in the histology of the lung parenchyma (Bellofiore et 
al, 1989). These models are therefore less suited for investigating the interrelationship between 
airway remodeling and bronchial responsiveness as observed in asthma.  
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1. Summary 
 
Airway morphology in asthma not only displays characteristics of an acute inflammatory 
process, but also more structural changes. The functional consequences of this so-called 
airway wall remodeling in asthma remain however largely unknown. Hence, the necessities to 
further identify the characteristics and pathogenesis of airway remodeling and to link 
morphological alterations to physiological data. The application of representative in vivo 
animal models can help to better understand the processes of remodeling occurring in the 
asthmatic airway wall. 
 
In chapter 1 ovalbumin sensitized Brown Norway rats were exposed over increasing 
time periods to aerosolized ovalbumin. The animals developed an increase of ovalbumin-
specific IgE and a persistent eosinophilic airway inflammation. After 2 weeks exposure, 
limited structural changes were observed. Allergen exposure during this period resulted in 
goblet cell hyperplasia and a limited increase in fibronectin deposition was noted. Total airway 
wall thickness was increased. These alterations coincided with airway hyperresponsiveness. 
Repeated exposure over a period of up to 12 weeks induced far more pronounced structural 
changes, including increased mitogenic activity in the epithelium and an enhanced deposition 
of extracellular matrix components. Fibronectin deposition was far more intense than after 2 
weeks. Collagen deposition increased from a 4 week exposure period onwards, resulting after 
12 weeks exposure in an even more pronounced deposition both in the inner and outer 
airway wall. At the same time, the increase in airway wall thickness observed at 2 weeks 
subsided and the airway hyperresponsiveness waned, turning into hyporesponsiveness. 
Based on these observations, we speculate that in rats the airway wall stiffness increases 
through deposition of increased amounts of collagen and fibronectin both within and around 
the smooth-muscle layer. This altered deposition of extracellular matrix proteins together with 
the reduction of the airway wall thickness might constitute an attempt to protect against airway 
hyperresponsiveness. These observations therefore suggest that depending on the extent and 
distribution of airway wall fibrosis, airway remodeling might oppose against, rather than 
enhance airway hyperresponsiveness. 
 
The changes in different collagen types in the airway wall of sensitized and OA-exposed 
Brown Norway rats were characterized in chapter 2. After 12 weeks of allergen exposure, the 
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airways contained increased amounts of collagen type I, V and VI. An increase of the three 
collagen types was observed in the outer airway wall. Collagen type I was also deposited in 
the inner airway wall. Since type VI collagen forms fibrillar connections between other 
extracellular matrix components, the presence of more type VI collagens in the airway wall 
could increase the adhesion between interstitial collagen fibrils and other matrix structures, 
thus increasing the rigidity of the airway wall. In addition, Type I collagen forms a relatively 
rigid linear fibrillar network and changes in its deposition could further increase the stiffness of 
the airway wall. These changes could contribute to the loss of airway hyperresponsiveness 
observed in the rat model after 12 weeks of ovalbumin exposure. A positive correlation was 
found between the amounts of collagen type I and VI and the number of eosinophils 
infiltrating the airway wall. This suggests a role for eosinophils in the process of airway 
remodeling and in the deposition of collagen in the extracellular matrix. Which eosinophil 
derived mediators possibly contribute to the process remain to be further evaluated. In the rat 
model blood vessels were identified by immunostaining for collagen type IV that is the major 
collagen subtype present in the vascular basement membrane (chapter 2). Using this 
approach, we could not identify an increase in the total amount of vessels per square mm. 
However, in rats exposed to allergen for 12 weeks an increase in the total area of the mucosa 
occupied by blood vessels was found. This increase in vascular perfusion is  in line with the 
findings of increased vascularity in the airway wall of asthmatics. 
 
Repeated smooth muscle contractions during bronchoconstriction in asthmatics might 
contribute to the development of structural alterations in the airway wall, as this can result in an 
altered deposition of extracellular matrix proteins. To address this hypothesis in our rat model, 
we evaluated the effect of repeated smooth muscle contractions on airway structure in Brown 
Norway rats in chapter 3. Bronchoconstriction was repeatedly induced in the rats via 
intraperitoneal injections of carbachol. Neither inflammatory nor structural alterations were 
observed in the airway wall of these animals compared to control rats. Airway responsiveness 
to nebulized carbachol did not change. This experiment therefore indicates that repeated 
airway smooth muscle contractions in the absence of airway inflammation do not induce 
structural airway changes. 
 
In chapter 4, using a similar approach of allergen sensitization and repeated ovalbumin 
exposure a model of structural airway changes was developed in two inbred mouse strains. 
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After ovalbumin exposure for a period of up to 9 weeks both BALB/c and C57BL/6 mouse 
strains displayed structural changes in the airway wall including goblet cell hyperplasia and 
collagen deposition. Inbred mouse strains have well characterized genetic dissimilarities in 
immunologic, inflammatory and smooth muscle responses. This was confirmed in the present 
study. BALB/c had relative higher levels of OA-specific IgE and lower amount of cells in the 
bronchoalveolar lavage fluid compared to C57BL/6. Also at baseline, airways of BALB/c 
mice were more sensitive to nebulized methacholine as compared to C57BL/6 mice and 
BALB/c but not C57BL/6 mice developed airway hyperresponsiveness after a 2 week 
ovalbumin exposure period. These murine models are therefore of particular interest to 
address the impact of genetic differences on the remodeling process in the airway wall. 
However, despite the differences in the inflammatory response and in lung function alterations 
between BALB/c and C57BL/6 mice, both inbred mouse strains displayed a similar degree of 
goblet-cell hyperplasia and collagen deposition. 
 
Chapter 5 evaluated the effect of age on allergen induced airway inflammation and 
remodeling. The rat model was used to compare allergen induced inflammatory and structural 
airway changes in prepubertal and adult animals. The study indicated that for a same intensity 
of allergen exposure, synthesis of allergen-specific IgE was similar in both young and adult 
OA-exposed groups. In contrast, the airways of young animals were infiltrated with a larger 
number of eosinophils than those of adult rats. The airways of young rats also displayed 
more pronounced remodeling as indicated by the degree of goblet cell hyperplasia and 
fibronectin deposition. As the presence of fibronectin in the extracellular matrix facilitates the 
adhesion of inflammatory cells and prolongs eosinophil survival, the more pronounced 
remodeling in response to allergen exposure at a young age might increase the vulnerability of 
the lower airways to the development of a persistent allergic inflammation and promote its 
persistence. The current observations further strengthen the importance of avoiding stimuli in 
young atopic children.  
 
Chapter 6 discusses the shortcomings but also the potentials of in vivo animal models 
for the study of human asthma. An overview is also given of the existing models of airway 
wall remodeling. The observation in our rat model is compared to data obtained by other 
groups. Finally, a brief description is given of experiments that have evaluated the effect of 
steroids on the allergen induced structural changes in our model. These data indicate that 
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pretreatment with inhaled steroids partly prevents but does not reverse the allergen induced 
airway remodeling. 
 
In conclusion, we propose that the specific aims of the study were met, in that: 
1. By repeatedly exposing sensitised rats or mice to aerosolised allergen, we were able 
to induce, in addition to  acute inflammatory changes, structural alterations that bear 
similarities to airway remodeling observed in asthma. These structural changes 
cannot merely be attributed to repeated airway contraction, but seem to result from 
the presence of a chronic allergic inflammation. 
2. The structural changes relate to altered airway behaviour, the overall effect being 
dependent on the exact extent and location of the remodeling process. 
3. For a same degree of allergen-induced acute inflammatory changes, the airways of 
young animals are more prone to the development of structural changes than those 
of adult rats.  
 
 
2. Future perspectives 
 
We believe that this model represents a valid instrument for the further investigation of the 
mechanisms involved in the pathogenesis of remodeling, as well as for the evaluation of the 
effect of therapeutic measures on the prevention or regression of remodeling and the 
associated effects on lung function. 
 
To us, future experiments should include: 
1. Evaluation of the allergen induced expression of growth factors that are 
potentially responsible for the remodeling process. In a first approach, this will be 
based on an immunohistological assessment. Depending on the results obtained, 
the functional role of a given growth factor can then be assessed in specific 
knockout mice. 
2. Further evaluation of the functional consequences of remodelling, e.g. by relating 
morphological changes to indices of airway wall stiffness. 
3. Evaluation of the effect of currently available asthma maintenance treatment on 
the development, persistence and/or progression of remodeling. As a first 
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priority, the effect of inhaled steroids, alone or in combination with long-acting 
inhaled beta-agonists would need to be assessed. 
 
 
 
